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Abstract 
The multi-antibiotic resistant Staphylococcus aureus continues to be a worldwide clinical 
burden and there is an urgent need for novel therapeutic strategies. Neutrophils are essential 
during the innate immune response to S. aureus, yet this pathogen uses multiple evasion 
mechanisms to survive or even replicate within neutrophils. In addition, S. aureus induces 
rapid and profound neutrophil cell death, which further subverts the immune response.  
The aim of this project was to identify novel immune modulating genes of S. aureus through 
the screening of a genome-wide S. aureus mutant library of 1,920 strains in a neutrophil cell 
death assay. The mutant library was constructed by transposon insertion in the clinically 
relevant community acquired methicillin-resistant S. aureus (USA300) background. 
Individual S. aureus strains were co-incubated with primary human neutrophils isolated 
from healthy subjects, at an MOI of 10 for 3 hours before ToPro-3 staining and assessment 
of cell loss via flow cytometry.   
A number of internal controls with known pro-death functions including lukGH, agrA and 
saeS were among the 34 strains that resulted in attenuated cell death. Four gene mutations 
not previously associated with cell death: purB, lspA, clpP and pfo were also identified and 
subsequently verified by genetic transduction. The clpP and lspA were further validated by 
gene complementation. The purine synthesis pathway (purB) was found to be important for 
bacterial replication and pathogenesis in a zebrafish embryo model, yet this in vivo 
phenotype was proved to be neutrophil-independent. Lack of lspA led to significantly 
reduced phagocytosis, indicating the necessity of lipoproteins in bacterial recognition and 
regulation of neutrophil lysis. Pyruvate metabolism (pfo) was required for neutrophil cell 
lysis in vitro. Yet no attenuated phenotype of pfo or lspA was found in vivo, possibly due to 
host-dependent effects. The clpP mutant failed to grow or induce host mortality in wild type 
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zebrafish embryos, but virulence was restored in a phagocyte-depleted model, suggesting 
the importance of clpP in bacterial survival and pathogenesis, possibly via Clp ATPase 
regulated post-phagocytosis stress tolerance and clpP modulated expression of secreted 
toxins. This thesis identified novel gene functions and suggests possible mechanisms of  
S. aureus induced neutrophil cell lysis, which may aid the design of future antibiotic-
independent therapeutic strategies to restore failures of innate immunity.  
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CHAPTER 1 
Introduction 
1.1 Staphylococcus aureus  
S. aureus is a Gram-positive human pathogenic bacterium. This highly adaptive 
microorganism is capable of generating uncomplicated skin and soft tissue infections as 
well as a number of life-threatening and often fatal diseases through two main mechanisms: 
the production of toxins or direct infection of tissues (Lowy, 1998, Tenover and Gaynes, 
2000).   
1.1.1 Epidemiology of S. aureus 
Staphylococci include more than 40 ubiquitous species which infect humans, mammals and 
birds through skin, glands or mucous membranes. Compared with other major pathogenic 
staphylococci such as S. hemolyticus, S. saprophyticus, and S. lugdunensis, S. aureus plays 
the most predominant role in causing human infection and diseases (Kloos and Bannerman, 
1999).  
Approximately 30% to 50% of healthy adults are colonised with S. aureus in their anterior 
nares, which is mainly transmitted through hand contact (Lowy, 1998, Casewell and Hill, 
1986). The reason why anterior nares are frequently colonised is because S. aureus is 
capable of adhering to nasal epithelial cells (Aly et al., 1980). Nasal carriage of S. aureus 
depends on both host genetics and microbial factors, although their relative roles remain 
unclear (Johannessen et al., 2012). Patients with intravenous drug addiction, type 1 diabetes, 
haemodialysis therapy, recent surgical procedures, and impaired leukocytes are at higher 
risk of colonisation with S. aureus (Tuazon et al., 1975, Tuazon and Sheagren, 1974). 
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Furthermore, the risk of infection increases along with colonisation of S. aureus (Tuazon 
and Sheagren, 1974, Tuazon et al., 1975, Wenzel and Perl, 1995, Yu et al., 1986). 
As the leading threat of a range of infections including upper and lower respiratory tracts, 
bloodstream, skin and soft tissues, bone and joints, the spreading of S. aureus has been 
reported throughout the world, primarily in China, United States (US), Europe, Canada, and 
parts of the Western Pacific (Chuang and Huang, 2013, Diekema et al., 2001). Although the 
initial outbreak of CA-MRSA in the US was attributed to USA400, it was soon replaced by 
PVL positive USA300 which was reported from each continent except for Antarctica (Liu 
et al., 2008, David and Daum, 2010). Unlike the predominance in North America, Europe 
has comparatively lower prevalence but higher genetic diversity of CA-MRSA (Mediavilla 
et al., 2012). A range of MRSA clones including ST1, ST8, ST30, ST59, ST80, and ST152 
were identified on the Europe continent, as well as ST93 from UK (Sowash and Uhlemann, 
2014). The S. aureus epidemiology study reveals generally lower burden of CA-MRSA in 
Europe comparing to the US (Otter and French, 2010). The rate of MRSA in invasive 
isolates in Europe differs from <1% in Norway and Denmark, <5% in Netherlands, to >40% 
in UK and Greece (Otter and French, 2010). More than 12,000 cases of S. aureus were 
reported in England during the financial year of 2016/2017, which represents a 24.5% and 
7.7% increase from 2011/2012 and 2015/2016 respectively (PHE, 2017).  
1.1.2 Clinical significance of S. aureus  
1.1.2.1 Infections of skin and soft tissue 
Cutaneous invasion of S. aureus mostly occurs at open wounds, follicles or skin glands, 
which further causes skin and soft tissue infections (SSTI) including abscesses and cellulitis 
(Seeleang et al., 2013). Atopic dermatitis is an inflammatory skin condition closely related 
with S. aureus infection since 90% of atopic dermatitis patients were found to be colonized 
with S. aureus (Abeck and Mempel, 1998). S. aureus enterotoxin B, hemolysin invasion of 
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T cells and monocytes, together with family history of atopy were revealed as the pathogenic 
factors involved in S. aureus-triggered atopic dermatitis (Abeck and Mempel, 1998, 
Manders, 1998, Prince et al., 2012). S. aureus colonisation of wound infections was widely 
found among patients after surgery where elongated surgical time, extended surgical 
procedures, and presence of foreign material could all increase the risk of S. aureus infection 
(Nichols and Raad, 1999). In addition, nasal carriage of S. aureus increases the possibility 
of infection in wound patients (Kluytmans et al., 1997). 
1.1.2.2 Bone and joint infections 
S. aureus bone infections can arise as a complication of septicaemia in a haematogenous 
manner, or as a result of wound infection or surgery. Haematogenous spread of S. aureus is 
usually derived from skin infections to long bones, particularly at the metaphyseal area 
where a highly vascularized environment provides ideal spreading channels for S. aureus 
(Cunningham et al., 1996, Dhanoa et al., 2012, Lipsky, 1997).  
Septic arthritis refers to infection of joints by pathogenic bacteria which degrade cartilage 
via production of pro-inflammatory cytokines and proteolytic enzymes. S. aureus is the 
most prevalent aetiological agent in this context, leading to notable morbidity and mortality 
(Carreno Perez, 1999, Sharff et al., 2013). This joint infection can also arise as a result of 
both surgical infection and haematogenous spread of S. aureus (Goldenberg, 1998). 
Subsequently S. aureus-induced inflammation causes chronic damage to the cartilage, 
which leads to joint destruction (Goldenberg, 1998). The panton-valentine leukocidin (PVL) 
is a major S. aureus pathogenic factor in this context, which can make the infection fatal 
with complications of multiorgan failure (Rafai et al., 2013). 
1.1.2.3 Respiratory Diseases 
Pneumonia is a lung disease primarily caused by viruses, fungi and bacteria. Infection of 
alveoli in pneumonia prevents efficient gaseous exchange and leads to increased respiratory 
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burden and often death (McLuckie A, 2009). S. aureus infection counts for 500,000 
hospitalisations and 20,000 deaths among pneumonia patients in the US during 2005 (Klein 
et al., 2007). The morbidity of S. aureus-induced pneumonia has increased along with 
various risk factors, such as surgery, old age, and immunosuppressive treatment. S. aureus 
associated pneumonia is also highly life threatening in patients with lung diseases like 
chronic obstructive pulmonary  disease (COPD), where lung capacity is already impaired  
(Lowy, 1998). Post-influenza necrotizing pneumonia caused by S. aureus superinfection 
leads to 50% mortality among infections in Europe (Kumar et al., 2009), identifying  
S. aureus as a major risk factor in this disease. The secreted cytotoxins such as PVL enhance 
bacterial virulence and are closely associated with staphylococcal pneumonia. Bacterial 
multiplication following colonisation induces expression of PVL and newly synthesized 
toxins contribute to neutrophil cell death, particularly in a pneumonia model (Yoong and 
Pier, 2012, Loffler et al., 2010).  
1.1.3 Treatment and antibiotic resistance of S. aureus  
Antibiotics have been widely applied for clinical use since the discovery of penicillin in the 
1940’s. This important therapeutic breakthrough was short lived for S. aureus, when a 
penicillin resistant strain emerged in the presence of selective pressure (Lambert, 2005). A 
number of S. aureus antibiotic resistance genes (ARG) such as mecA, femA, erm, msrA, and 
blaZ have since been identified (Duran et al., 2012). Spreading of ARG through horizontal 
gene transfer mechanisms gives rise to rapidly increasing numbers of S. aureus with 
multiple ARG (Lambert, 2005, Chambers and Deleo, 2009). The emergence of S. aureus 
ARG kept in step with the development of novel antibiotics including penicillin, 
flucloxacillin, gentamicin, and vancomycin (Brumfitt and Hamilton-Miller, 1989, Charles 
et al., 2004), significantly disabling anti-S. aureus therapeutic strategies. The methicillin 
resistant S. aureus strain, also known as MRSA, emerged in 1959 and was first seen in 
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hospitals, and given the name of hospital-associated MRSA (HA-MRSA) (Jevons, 1961). 
Worryingly, community-associated MRSA (CA-MRSA) strains emerged in the early 
1980’s, illustrating the rapid dissemination of ARG and significantly increasing the chance 
of contracting MRSA infection (Estivariz et al., 2007, Hill et al., 2001, Baggett et al., 2003). 
By 2012, MRSA was widespread throughout the world. The rates of HA-MRSA strains 
among total HA-S. aureus strains were found to be higher than 50% in US and South Korea 
(Stefani et al., 2012). Meanwhile a dramatic increase of CA-MRSA infections in US was 
reported from 50/year in 1996 to 1100/year in 2004 (King et al., 2006), indicating a new 
infective environment at risk of MRSA.  
With the existence of prevalent multiple ARG, treatments of MRSA infections have become 
limited. Even though some prescribed novel anti-MRSA agents such as glycopeptides, 
linezolid, quinuristin-dalfopristin and ceftobiprole were developed, many shortcomings of 
these approaches have been reported including insufficient MRSA killing, relatively high 
incidence of severe or even fatal side effects, and antibiotic resistance (Charles et al., 2004, 
Longworth, 2001, Lentino et al., 2008, Tsiodras et al., 2001). 
1.1.4 Community-acquired S. aureus   
Unlike HA-MRSA which more commonly invades individuals at risk of infections such as 
immune-defective patients or individuals with preconditions, CA-MRSA is capable of 
causing infections in healthy people (Seeleang et al., 2013). CA-MRSA accounts for 26% 
of pneumonia cases and data indicate that CA-MRSA leads to a higher pneumonia mortality 
than HA-MRSA (Valour et al., 2013, Wunderink, 2013), although it is not clear why this is 
so. A study of 139 S. aureus isolates revealed that PVL was detected in approximately 94% 
of CA-MRSA strains, while only 7% of HA-MRSA are PVL positive (Bhatta et al., 2016). 
A possible explanation therefore of enhanced virulence of CA-MRSA is PVL gene 
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expression, which is also associated with 62% of pneumonia cases (Morgan, 2007, Tsuji et 
al., 2007). 
PVL production enables CA-MRSA attachment onto exposed collagen which is more 
commonly found on injured bronchial mucosa (Vaitkus et al., 2013). As a consequence of 
this, PVL makes chronic lung disease patients more vulnerable to CA-MRSA. Furthermore, 
PVL causes haemorrhage, infarction and necrotising vasculitis, which can result in fatal 
consequences (Morgan, 2007). To achieve this, PVL modifies immune cell function in ways 
such as neutrophil priming and cytokine release, as well as inducing neutrophil lysis (Naimi 
et al., 2003). It seems that PVL is very likely to be the reason why CA-MRSA has higher 
host cell killing efficiency than HA-MRSA.     
USA300, the most abundant CA-MRSA strain in Europe and US (97% of total CA-MRSA), 
has developed resistance against gentamincin, clindamycin, doxycycline and trimoxazole; 
and can lead to SSTI, necrotizing pneumonia and septic arthritis (Vardakas et al., 2013, 
Francis et al., 2005, McDougal et al., 2010, Tietz et al., 2005). USA300 expresses multiple 
virulence factors to enhance bacterial pathogenesis. For example the lytic toxin, leukocidin 
(Luk) GH, which synergizes with PVL to enhance bacterial pathogenesis (Ventura et al., 
2010). In Detroit, MI, 20% of nosocomial bloodstream infections were caused by the 
USA300 strain during 2005 to 2007 (Chua et al., 2008). More severe SSTIs and necrotizing 
pneumonia were found with PVL-expressing USA300 strain compared to non-PVL strains 
in rabbit models (Diep et al., 2010, Lipinska et al., 2011). Another pore-forming toxin, α-
toxin, is known to be produced significantly by USA300 strain, with regulation by accessory 
gene regulator (agr) system  (Kobayashi and DeLeo, 2009). In a murine model, reduced 
production of α-toxin led to fewer skin lesions (Weiss et al., 2009). The agr quorum sensing 
system mediates gene expression via the agrBDCA operon and plays an essential role in 
staphylococcal production of other neutrophil-lytic toxins in USA300 clones such as α-
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hemolysin (Thurlow et al., 2012). Consistently, the Dagr USA300 mutants resulted in 
attenuated sepsis, pneumonia and skin abscess formation in murine models (Cheung et al., 
2011, Kobayashi et al., 2011, Montgomery et al., 2010). The expression level of S. aureus 
exoprotein regulator/sensor kinase genes saeRS was found higher in USA300 than USA400 
strains in a mice model (Montgomery et al., 2008). The sae system senses changes 
environmental signals including hydrogen peroxide and regulates structural compounds of 
the cell envelope (Geiger et al., 2008). Active saeRS enhances the expression of virulence 
genes such as hla, sbi, and lukFS (PVL) (Nygaard et al., 2010).  In summary, it is evident 
that there is a strikingly high mortality of various diseases caused by widespread CA and 
HA-MRSA, among them USA300 has proven to be particularly successful to become the 
dominant strain in the western world, and that there is a worrying lack of effective therapies.  
1.1.5 Current strategies for treatment 
All MRSA strains are widely considered to possess resistance against β-lactam antibiotics. 
There is a general consensus that these antibiotics do not warrant clinical use due to their 
ineffective killing of MRSA. However, the degree of resistance against β-lactam antibiotics 
or other antimicrobial agents varies among different MRSA strains. 
Glycopeptides were first used against MRSA. Many limitations of this approach have been 
reported however, such as insufficient tissue penetration, low oral bioavailability, a 
requirement for monitoring of drug levels in serum, and limited therapeutic window 
(Ratnaraja and Hawkey, 2008). Vancomycin was provided as an empirical treatment for 
patients with CA-MRSA infections. However, vancomycin-resistant MRSA (VRSA, MIC > 
16µg/mL) generated by gaining vanA ARG have been identified (Charles et al., 2004). Even 
though it is challenging to treat VRSA infection, there is limited cases reported to date (14 
in the US) (McGuinness et al., 2017). An additional group of strains known as vancomycin 
intermediate-resistant S. aureus (VISA, MIC = 4-8µg/mL) brings relatively high burden and 
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the resistance mechanisms remains undefined (McGuinness et al., 2017). VISA are typically 
associated with heterogeneous VISA (hVISA), a mixed population consisting majority of 
little or no resistant S. aureus and a sub-population of VISA (Howden et al., 2010). To date 
hVISA has been reported worldwide from countries such as Japan, India, Korea, China, 
Thailand, Spain, Greece, Germany, Italy, and the UK (Ariza et al., 1999, Kim et al., 2000, 
Marchese et al., 2000, Trakulsomboon et al., 2001, Wong et al., 2000). The hVISA 
phenotypes include persistent infection, prolonged vancomycin uptake, and treatment 
failure (Liu and Chambers, 2003, Howden et al., 2006). Linezolid is one of the synthetic 
oxazolidinones used in MRSA treatments based on the principle of inhibiting MRSA protein 
synthesis by binding with the 23S subunit of ribosome to inhibit translation (Charles et al., 
2004). As the most prescribed anti-MRSA agent, linezolid use was approved in many 
countries including the US and UK. The drug has an impressive 100% bioavailability, which 
makes it an effective agent against MRSA either via oral or intravenous intake (Pfizer, 2007). 
However, it comes with a relatively high incidence of side effects. Approximately 3% of 
patients developed thrombocytopenia, and reversible bone marrow suppression is another 
severe side effect caused by prolonged therapy of linezolid (Longworth, 2001). Lactic 
acidosis is a rare but fatal side effect (Lentino et al., 2008). Moreover, after a few years of 
widespread use, MRSA isolates resistant to linezolid were reported (Tsiodras et al., 2001). 
Apart from linezolid, there were many other synthetic antimicrobial agents developed for 
MRSA treatment, such as dalbavancin, tigecycline, quinuristin-dalfopristin, and 
ceftobiprole. They all reduced MRSA pathogenesis, yet various side effects from mild 
headache and gastrointestinal illness, to diarrhoea, blurred vision and numbness have been 
described (Ratnaraja and Hawkey, 2008).  
Due to the emergence of multi-resistant MRSA and lack of safe and efficient agents to 
overcome those bacteria, pharmaceutical companies kept developing new antimicrobial 
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agents like lysostaphin (Von Eiff et al., 2003). However, clinical trials to show the efficacy 
of this agent in humans are still pending (Von Eiff et al., 2003). In light of this, developing 
novel treatments of MRSA infections in an unconventional, antibiotic-independent manner 
is a necessary and urgent task for eliminating S. aureus and other bacteria. A breakthrough 
of using intravenous application of phage therapy for antibacterial treatment has been 
achieved recently, where a patient was saved from severe infection of antibiotic resistant 
Acinetobacter baumannii (Gen, 2017).  Although full details of this study have not yet been 
disclosed, it provided an alternative natural drug development which can be potentially 
applied towards S. aureus treatment. In light of this, the development of highly-targeted and 
novel therapies towards enhancing human immune responses may be a way forward in the 
treatment of S. aureus infection, circumventing the problems associated with antibiotic 
resistance.  
1.1.6 Virulence factors of S. aureus 
A vast variety of virulence factors are expressed by S. aureus to achieve initial colonisation, 
host environmental adaptation, nutrient acquisition, host immune survival, and eventually 
successful infections (Lowy, 1998). Inhibition or removal of those factors, at both the 
genetic and molecular level, modifies the pathogenicity of S. aureus and leads to attenuated 
virulence (Casadevall and Pirofski, 1999). There are three main categories of virulence 
determinants: those affecting host adhesion, immune evasion, and tissue spread. Examples 
of these are cell-surface components including microbial surface components recognising 
adhesive matrix molecules (MSCRAMMs) and secretable expanded repertoire adhesive 
molecules (SERAMs) facilitate bacterial binding to the extracellular matrix and host cell 
surface (Clarke and Foster, 2006).  S. aureus is also capable of phagocyte evasion, 
particularly from neutrophils, the most prominent cellular component of human innate 
immunity (Rigby and DeLeo, 2012). A large number of enzymes and toxins such as PVL, 
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leukocidins, and g-hemolysin are secreted by S. aureus for resistance against host immune 
strategies. In addition, a range of extracellular molecules including proteases, nucleases, 
lipases, superantigens and collagenases have impact on generating tissue damage and 
promote S. aureus spreading (Foster, 2005).   
This study focuses on staphylococcal factors modulating immune cells. A list of S. aureus 
virulence factors involved in immune evasion strategies are shown in Table 1.1. Some 
virulence factors assist staphylococcal infections via preventing activation of inflammatory 
factors. For example, the prothrombin autoactivation results in simultaneous attraction of 
phagocytes to immobilise bacteria, but the process can be inhibited by superantigen-like 
protein SSL10 which inhibits prothrombin activation (Thammavongsa et al., 2015). S. 
aureus also inhibit neutrophil chemotaxis via the production of chemotaxis inhibitory 
protein of staphylococcus (CHIPS) and formal peptide receptor-like 1 inhibitor (FLIPr) 
(Thammavongsa et al., 2015). CHIPS and FLIPr binds to human formylated peptide 
receptor FPR1 and FPR2 separately to inhibit the receptor signalling functions and therefore 
block neutrophil recruitment (Prat et al., 2009). C5a, another signal of S. aureus infection, 
could be recognised by complement receptor C5aR and induce neutrophil activation. CHIPS 
exclusively binds the C5aR N-terminus and inhibits neutrophil recruitment efficiently 
(Rooijakkers et al., 2005b).    
Additionally, S. aureus is capable of regulating anti-opsonisation and anti-phagocytosis 
activities. Aureolysin (Aur) and staphylokinase (Sak) cleaves complement factor C3 to 
compromise opsonisation (Thammavongsa et al., 2015). Furthermore, Staphylococcal 
Binder of Immunoglobulin (Sbi) and Clumping factors (Clf) inhibit complement pathways 
by binding with C3 to prevent bacterial phagocytosis (Thammavongsa et al., 2015). An 
alternative mechanism protecting S. aureus from phagocytosis is via bacterial agglutination 
(Thammavongsa et al., 2015). The von Willebrand Factor-binding protein (vWbp), a S. 
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aureus secreted coagulase, converts prothrombin to staphylothrombin which further cleaves 
peptides of fibrinogen to form fibrin. The newly synthesised fibrin self-assembles and 
polymerises into cable structures, forming a shield-like protection around S. aureus to 
prevent phagocyte uptake. This carefully regulated, multi-step mechanism involves a 
number of S. aureus surface proteins such as ClfA and fibronectin binding protein (FnBP) 
(Thammavongsa et al., 2015). Staphylococcal complement inhibitor (SCIN) was identified 
as one of the most efficient complement inhibitors and inhibits neutrophil phagocytosis and 
killing of S. aureus (Rooijakkers et al., 2005a). It not only inhibits convertases by direct 
binding to the active pocket of Bb in C3bBb, but also prevents further convertase production 
via interaction with C3 convertases (Rooijakkers et al., 2005a). A similar complement 
inhibiting mechanism is applied by the extracellular fibrinogen biding molecule (EfB). It 
binds to the C3d region of C3 with a high affinity. Evidence was found that EfB blocks both 
classical and alternative pathways and further neutrophil phagocytosis (Lee et al., 2004).  
The S. aureus Defb mutant resulted in increased mice survival and reduced abscess 
formation (Jongerius et al., 2012).   
To prevent immune-mediated bacterial killing, S. aureus can cleave antimicrobial peptides 
(AMPs). MprF inhibits cationic lysozymes and AMPs such as histatin via modification of 
anionic phospholipids and introducing positive charges to the membrane surface (Ernst and 
Peschel, 2011). S. aureus also produce aureolysin, a major metalloproteinase, to cleave 
cathelicidin and thereby demolish the AMP (Sieprawska-Lupa et al., 2004). To promote the 
survival from neutrophil-mediated killing, extracellular adherence protein (Eap) of USA300 
counters neutrophil serine proteases such as elastase and cathepsin G (Stapels et al., 2014). 
More recently, a novel staphylococcal peroxidase inhibitor (SPIN) was characterised with 
specific anti human myeloperoxidase (MPO) binding activity and enhanced USA300 
survival by interfering with MPO-mediated killing (de Jong et al., 2017). Resistance to the 
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reactive oxygen species (ROS) attack provides S. aureus advantage within the phagosomes. 
All strains including USA300 produces catalase which impairs the neutrophil killing by 
inactivating hydrogen peroxide (Rooijakkers et al., 2005b). S. aureus also express regulator 
molecules to manipulate the adaptive immune responses. For example, immunoglobulins 
such as IgA, IgD, IgG and IgM can be modulated via staphylococcal protein A (SpA) 
binding (Forsgren and Nordstrom, 1974). A detailed description of known key virulence 
factors involved in neutrophil cell responses will be discussed in section 1.4.  
The regulation of S. aureus virulence determinants is clearly important for expressing 
specific factors at the appropriate time. The gene expression of virulence factors is 
controlled based on environmental signals from dynamic and complex bacterial interactions 
with host cells. Regulators of these regulatory genes are also classified as virulence factors, 
since disruption of these regulators result in attenuated S. aureus pathogenicity. For example, 
the agr system, consists of a sensor histidine kinase and a response regulator, and plays an 
essential role in secreting toxins including α-toxin and down-regulating surface adhesion 
molecule production (Novick et al., 1993, Recsei et al., 1986). Another two-component 
system, the sae system, regulates the transcription of a range of toxins and enzymes 
including heamolysin and extracellular fibrinogen binding protein (Giraudo et al., 1994, 
Liang et al., 2006). Mutations in sae results in attenuation in virulence in multiple animal 
infection models (Liang et al., 2006). A number of S. aureus virulence genes were 
evolutionarily acquired from mobile genetic elements such as plasmids, phages, and 
pathogenicity islands (Malachowa and DeLeo, 2010). The S. aureus pathogenicity islands 
(SaPI) identified to date mainly carry toxins encoding genes and antibiotic resistant cassettes. 
SaPI3, for example, consists of tst, a toxic shock syndrome toxins encoding gene, and 
enterotoxins encoding genes such as sek and seq (Yarwood et al., 2002).  Another important 
SaPI known as Staphylococcus cassette chromosome mec (SCCsec) was identified with 
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methicillin resistant genes such as metA,  and metR (Daum et al., 2002). Research focused 
on SaPIs not only identified novel virulence factors, but also initiated comprehension of 
staphylococcal virulence in the light of evolution  (Gal-Mor and Finlay, 2006).   
1.1.7 Nebraska transposon mutant library  
To promote the identification of key genetic components that play an important role in S. 
aureus biology, the Nebraska Centre for Staphylococcal Research has developed the 
Nebraska transposon mutant library which comprises of 1,952 CA-MRSA mutant strains. 
These strains are single protein coding sequence mutants in which non-essential genes in 
the USA300 genome have been disrupted. This sequence-defined transposon insertion 
library was obtained directly from the USA300_FPR3757 genome sequence (NCBI 
reference sequence NC_007793). The library was generated via bursa aurealis transposon 
insertions of plasmid pBursa into the genome of wild type USA300 strain (referred to as 
JE2) (Fey et al., 2013). To date, the NTML library has been applied in diverse screens to 
identify genes involved in polymicrobial interactions; haemolytic activity; and 
antimicrobial resistance of S. aureus (Vestergaard et al., 2016, Fey et al., 2013, Frydenlund 
Michelsen et al., 2016). Hence, this could be an appropriate approach for the identification 
of genes involved in immune cell responses, in order to better understand the host-pathogen 
interaction between S. aureus and the human host and also to define potential new 
therapeutic strategies for the treatment of S. aureus infections.   
The genome-wide association study (GWAS) is an alternative high throughput approach for 
identifying the associations between single-nucleotide polymorphisms (SNPs) and varying 
phenotypes of a particular trait or disease (Manolio, 2010).  Initially GWAS was applied for 
human risk-SNP identification for pathogenesis study and designing new therapy, 
particularly on transcriptional mutagenesis diseases (Kim and Gibson, 2010, Long et al., 
2016, Iadonato and Katze, 2009). Methods for using GWAS to bacterial research have been 
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developed more recently, and have been successfully adapted to study horizontal gene 
transfers involved in carbapenems resistance of Acinetobacter baumannii, and human 
specific biosynthesis factor related to Campylobacter pathogenesis (Suzuki et al., 2016, 
Sheppard et al., 2013).  A GWAS study conducted with 55,977 SNPs in S. aureus revealed 
association between a nonsynonymous mutation of the rpoB gene and increased 
vancomycin resistance (Alam et al., 2014). In a Mexican-American community from Texas, 
nasal swabs were collected from 858 participants for screening of S. aureus, 12 significant 
genetic regions including KAT2B were identified for intermittent or persistent carriage 
(Brown et al., 2015).  Nelson et al attempted to identify genetic variants associated with 
acquisition of S. aureus bacteraemia via GWAS method, yet no common genome-wide 
significance was found (Nelson et al., 2014). Although these studies demonstrated the 
potential value of GWAS in the bacterial arena, no CA-MRSA GWAS studies have 
previously been performed, it is therefore a more time-consuming process for this project 
considering the demand of a large number of candidate loci screening.  
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Table 1.1.  S. aureus virulence factors related to immune evasion.  
Name Gene  Function  
Aureolysin aur Resistant to AMP 
Catalase kat Moderation of ROS 
CHIPS  chp  Chemotaxis inhibition 
Clf clf  Phagocytosis inhibition 
Eap eap Phaogcytic killing inhibition 
EfB efb Complement inhibition 
FLIPr flipr Chemotaxis inhibition 
FnBP fnbp Phagocytosis inhibition, bacterial invasion 
γ-haemolysin hlg Neutrophil lysis 
Leukocidin lukAB, 
lukED 
Neutrophil lysis 
MprF mprF Resistant to AMP 
Phenol-soluble 
modulins 
psm Chemotaxis inhibition, neutrophil lysis 
PVL lukFS Neutrophil lysis 
Staphylokinase sak Phaogocytosis inhibition 
Sbi sbi Phagocytosis inhibition 
SCIN scn Complement inhibition 
SpA spa Phagocytosis inhibition 
SPIN spn Myeloperoxidase inhibition 
SSL ssl Chemotaxis inhibition, phagocytosis 
inhibition Super-oxide dismutases sod Phagocytosis inhibition 
vWbp vwb Phagocytosis inhibition 
AMP: antimicrobial peptides; MprF: multiple peptide resistance factor; CHIPS: chemotaxis 
inhibitory protein of staphylococcus; vWbp: von Willebrand factor binding protein; SSL: 
staphylococcal superantigen-like protein; SCIN: staphylococcal complement inhibitor; SpA: 
staphylococcal protein A; SPIN: staphylococcal peroxidase inhibitor; Sbi: staphylococcal 
IgG-binding protein; Clf: clumping factor; PVL: Panton-Valentine leucocidin; ROS: 
reactive oxygen species.  
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1.2 Neutrophils as important innate immune cells in S. aureus infection 
1.2.1 Major components of the innate immune system  
The innate immune system is an evolutionarily ancient part of the host defence against 
microbial pathogens. It is comprised of multiple cellular and non-cellular components and 
is often thought of as a ‘non-specific’ immune response. The physical barrier includes skin, 
mucous membranes and cough reflex, while the chemical barrier is conferred by pH, fatty 
acids and enzymes secretion (Benjamini, 1988).  
The innate immune system is an important defence against bacterial infection. S. aureus 
normally cannot penetrate healthy skin but can enter through hair follicles or sebaceous 
glands (Wang et al., 2009). The risks of those infection routes are minimized by acid pH of 
sweat and various enzymes. The high incidence of S. aureus infection amongst burn patients 
is due to the damaged skin barrier (Bang et al., 2002, Wang et al., 2009). To prevent 
infection of the respiratory tract, the nasal hairs and cough reflex eject invading bacteria. as 
part of this process, mucus traps bacteria which allows ciliated cells to drive the 
microorganisms upward, which are then expelled (Vareille et al., 2011).  
Once those barriers are penetrated by invading bacteria, the cellular innate immune system 
comes into play. This consists of multiple specialised cells that eliminate bacteria either 
through phagocytosis or extracellular killing (Benjamini, 1988).  Extracellular killing refers 
to the process of lysing target bacteria by releasing cytotoxic molecules (Benjamini, 1988). 
Natural-killer (NK) cells, a type of large granular lymphocyte, play a significant role in 
extracellular killing of infected host cells (John Clancy JR., 1998). NK cells recognise and 
bind to targeted bacteria, which leads to activation of intracellular signalling (Herberman, 
1986). Subsequently NK cells release granules containing pore forming protein perforin and 
cytolytic proteases to induce bacterial lysis (Bots and Medema, 2006). Extracellular 
bacterial killing mechanism was also found with neutrophils, via formation of neutrophil 
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extracellular traps (NETs) (Papayannopoulos et al., 2010). Details of NETs will be 
disclosed in section 1.2.2.5.          
Phagocytosis refers to ingestion of bacteria which is typically followed by bacterial 
destruction by granule-containing lysosomes and reactive oxygen species (ROS). Key 
phagocytic cells include monocytes macrophages, neutrophils, basophils, mast cells and 
eosinophils (Baggiolini, 1984). Eosinophils are granulocyte capable of releasing 
antimicrobial cytotoxic molecules through degranulation upon activation (Hogan et al., 
2013). Eosinophils are recruited to the site of infection as a rapid response to pathogens 
(Baggiolini, 1984). They behave as protective cells in patients with S. aureus ventilator-
associated pneumonia (Rodriguez-Fernandez et al., 2013). Macrophages are important for 
anti-S. aureus host defence and contribute to both the innate and adaptive immune responses 
by interaction with neutrophils, and presenting antigens to modulate lymphocyte immunity 
(Flannagan et al., 2015). Macrophages can phagocytose and eliminate invading pathogens 
through respiratory burst, reactive nitrogen intermediates, and phagolysosomal enzymes 
(Amer and Swanson, 2002, Fang, 2004). However, in vivo and in vitro studies evidently 
showed that macrophages failed to eradicate S. aureus (Flannagan et al., 2015). S. aureus 
biofilms function as a protector from macrophage phagocytosis and therefore attenuate host 
proinflammatory responses in a murine model (Thurlow et al., 2011). S. aureus USA300 
can successfully replicate within mature macrophage phagolysosomes which leads to host 
cell death and bacterial escape (Flannagan et al., 2016). 
1.2.2 Neutrophils  
1.2.2.1 Neutrophil function in immunity 
Neutrophils are short-lived, polymorphonuclear leukocytes containing an abundance of 
intracytoplasmic granules. Approximately 9x108 neutrophils are produced from the bone 
marrow per kilogram of body weight per day (Edwards, 2005). The development of mature 
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neutrophils in the bone marrow is a well-characterised, strictly regulated multi-stage process, 
including six stages of differentiation from stem cells: myeloblast, promyelocyte, myelocyte, 
metamyelocyte, band (non-segmented) cell, and mature (segmented) neutrophil (Bainton, 
1993). During this process, several attributes including granules and granule contents, 
phagocytic and chemotactic capacity and cell mobility are developed (Murphy, 1976). The 
mature neutrophil has a diameter of 10-12 µm, a segmented chromatin-dense nucleus, and 
fully functional cytoplasmic granules (Murphy, 1976). The newly produced neutrophils are 
in a non-activated state when released into the circulation. As well as being free in the 
circulation, they can loosely attach to the vascular endothelium, allowing rapid responses to 
local infections (Downey et al., 1990). After 8 to 12 hours in the circulation, a sub-
population of neutrophils undergo apoptosis and are cleared by macrophages in the spleen 
and liver (Furze and Rankin, 2008, Sasaki et al., 1995). Upon signals from the site of 
infection or injury, neutrophils migrate into tissues and engage survival pathways which 
prolongs their life span (1-2 days) (Downey et al., 1990). The process of the neutrophilic 
defence against bacterial infection consists of 5 main steps, namely neutrophil recruitment, 
neutrophil activation, neutrophil opsonisation, phagocytosis, and killing. 
1.2.2.2 Neutrophil recruitment  
Neutrophils migrate from the bloodstream to the tissue, slowing down as they reach the site 
of infection. The P-selectin glycoprotein ligand-1 (PSGL-1) on the neutrophil cell 
membrane binds with P-selectin and E-selectin on activated endothelial cells via a loosely 
reversible interaction. The blood flow aids neutrophil rolling along the vessel wall (Moore 
et al., 1995) (Figure 1.1). When neutrophils approach the infection site, firm adhesion 
between intercellular adhesion molecule 1 (ICAM-1) on endothelial cells with neutrophilic 
β2 integrins arrests the phagocytes completely. This procedure is achieved through high-
affinity interactions between β2 integrins on neutrophil surface with chemoattractants, 
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cytokines, selectins, and bacterial products (Ley et al., 2007). The infection induces and 
distributes various chemical signalling molecules on both neutrophils and the endothelial 
cell surface, which form an intricate signalling interaction network to modulate neutrophil 
transmigration either through endothelial junctions or through endothelial cells (Phillipson 
et al., 2006) (Figure 1.1).  Potent chemotactic factors synthesized by bacteria, such as S. 
aureus produced phenol-soluble modulins (PSMs) and proteins with N-formyl-peptides, 
can both act on G protein couple receptor (GPCR) and therefore result in neutrophil 
recruitment to the site of infection (Wang et al., 2007, Babior, 1999). 
1.2.2.3 Neutrophil chemotaxis and activation  
Activation of neutrophils occurs during and following their migration to the site of infection. 
This primes the cells to allow them to perform effector functions when required. Microbial 
molecules such as Toll-like receptor (TLR) ligands and chemoattractant ligands of GPCR 
are the main activation stimuli. For staphylococcal infections, TLR2 recognizes conserved 
bacterial structures such as lipoprotein that trigger conformational changes of GPCRs which 
in turn primes neutrophils and stimulates the inflammatory response (Bardoel and Strijp, 
2011, Bubeck Wardenburg et al., 2006). Known neutrophil priming agents include 
complement components C3a and C5a, CXCL8, granulocyte colony stimulating factor (G-
CSF), TNF-α, and lipopolysaccharide (Dang et al., 1999, DeLeo et al., 1998, Guichard et 
al., 2005, Brown et al., 2004). Bacterially derived products such as cytolytic toxins can also 
prime neutrophils (Guerra et al., 2017). Primed neutrophil responses enhance adhesion, 
phagocytosis, superoxide production and degranulation (Ellis and Beaman, 2004), and 
therefore are more efficient at bacterial killing processes. Some priming stimuli such as 
lipopolysaccharide induce NADPH oxidase complex assembly via structural changes and 
thereby increasing the efficiency of forming reactive microbicidal products such as singlet 
oxygen and hypochlorous acid, accomplished by translocation of cytosolic components 
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from granules to the plasma or phagosome membranes (DeLeo et al., 1998, Rosen and 
Klebanoff, 1979).  
1.2.2.4 Opsonisation and phagocytosis  
Opsonisation is the process where invading bacteria are identified to phagocytes for 
destruction. Opsonisation involves the addition of complement components and/or 
immunoglobulins (Ig) to the target bacteria in order to facilitate a physical interaction 
between the particle and receptors on the immune cell (Walport, 2001). Complement is a 
crucial process of the innate immune system for facilitating phagocytosis of invading 
pathogens. Phagocytosis can then take place upon contact with opsonised S. aureus 
(Surewaard et al., 2013).  
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Figure 1.1 Neutrophil recruitment, activation, priming, phagocytosis and bacterial killing. 
AMP, antimicrobial peptides; NETs, neutrophil extracellular traps; ROS, reactive oxygen 
species  
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Three complement activation pathways namely classical, alternative, and lectin pathways 
can initiate the complement system (Noris and Remuzzi, 2013). Immunoglobulins like IgG 
and IgM activate the classical complement pathway by interacting with C1q, which causes 
a conformational change leading to the subsequent activation of C1r and C1s. Then C2 and 
C4 are cleaved into fragments by activated C1s. The fragments form C4bC2a which is an 
enzymatic complex that cleaves C3, an irreplaceable molecule for C3 convertases formation, 
into C3a and C3b (Noris and Remuzzi, 2013). The lectin pathway also results in production 
of C4bC2a complex. Yet instead of recognising microorganisms by antibodies, the lectin 
pathway relies on sugar residues on surface structures. The alternative pathway is activated 
by bacterial components such as toxins. Unlike the classical and lectin pathway where 
C4bC2a complex is formed, the alternative pathway produces C3bBb complex to generate 
a C3 convertase (Noris and Remuzzi, 2013). The C3 convertases sequentially produces C5 
convertases when another C3b molecule is present. The C5 convertases further release C5a 
by cleaving C5, which is a proinflammatory molecule that primes phagocytes for bacterial 
intake (Bestebroer et al., 2010a). Meanwhile, C4b and C3b can also directly attach to 
bacteria or immune complexes via covalent binding (Noris and Remuzzi, 2013).  
Phagocytosis is a key neutrophil defence strategy against bacterial infection, and plays an 
essential role in the uptake and killing of invading pathogens (Murphy, 1976). Meanwhile, 
many studies demonstrate a close link between phagocytosis and the acceleration of 
neutrophil apoptosis (Surewaard et al., 2013, Kobayashi et al., 2010, Kobayashi et al., 2002). 
Phagocytosis-induced cell death (PICD) not only helps to clear the pathogen, by disposing 
of neutrophils containing bacteria, but also plays a significant role in the resolution of the 
inflammatory response that accompanies infection (Kobayashi et al., 2002).  
Phagocytosis is initiated when receptors on the neutrophil plasma membrane such as TLRs 
recognise a bacterium. This neutrophil-pathogen interaction leads to formation of 
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pseudopodia around the microorganism, and eventually encloses the bacterium within a 
phagocytic vesicle of which the membrane is derived from the plasma membrane 
(Klebanoff, 2005). Subsequently, a phagolysosome is generated by fusing of cytoplasmic 
granules with the vesicle (Figure 1.2). Then degranulation is triggered to release 
antimicrobial compounds into the phagolysosome, creating an inhospitable environment 
(Edwards, 2005). Neutrophil granule proteins are classified into four groups: azurophil (or 
primary) granules, specific (or secondary) granules, tertiary granules, and secretory vesicles 
(Lacy, 2006). The most toxic proteins such as elastase, myeloperoxidase and cathepsins are 
contained in primary granules (Borregaard and Cowland, 1997). Another molecule known 
as bactericidal-increasing protein (BIP) is capable of binding to and neutralising 
lipopolysaccharide (Segal, 2005). The secondary and tertiary granules are the storage sites 
of gelatinase, lactoferrin, lysozymes (containing acid hydrolases), and other substances 
(Kjeldsen et al., 1994, Edwards, 2005). Contents in the secretory vesicles include human 
serum albumin, indicating that endocytosis of the plasma membrane takes extracellular fluid 
into the granules (Lacy, 2006). These granule proteins assist in killing of microorganisms 
but are potentially harmful to host cells if released inappropriately (Borregaard et al., 2007). 
Thus, development and regulation of granulopoiesis are highly structured and complex 
processes. Granules are formed during all stages of neutrophil development in bone marrow 
(Borregaard et al., 2007). Primary granule proteins are synthesised during the promyelocytic 
stage while specific granule proteins are produced at the myelocyte stage. At the 
metamyelocyte stage, highly gelatinase positive granules are developed (Borregaard et al., 
2007).  Differentiation and maturation of granules are regulated by molecules such G-CSF 
(Dale et al., 1998). Granules are mobilised upon activation of cytokines, chemotactic 
peptide receptors, and membrane adhesion proteins (Lacy, 2006). For example, primary 
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granules can be selectively mobilised via Rho guanosine triphosphatese Rac2 activation 
induced by G protein-activated guanine nucleotide exchange factors (GEFs) (Lacy, 2006).  
Understanding of conditions in the neutrophil phagocytic vacuole facilitates identification 
of killing mechanisms. An opsonised bacterium can be taken up into the phagocytic vacuole 
within 20 seconds which triggers immediate killing (Segal et al., 1980, Segal et al., 1981). 
Contents of numerous granules are released into the vacuole and exposed to the bacterial 
surface in high local concentrations (Segal et al., 1980).  Both primary and secondary 
granules degranulate with similar kinetics approximately 20 seconds after bacterial 
phagocytosis (Segal et al., 1980), and it was estimated that granule enzymes occupy roughly 
40% of the vacuolar volume (Hampton et al., 1998). About 5 minutes later, pH reaches the 
optimal level for the acid hydrolases and these enzymes start to enter the vacuole (Segal, 
2005).  
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Figure 1.2 Neutrophil phagocytosis and microbicidal activity by ROS and granule proteins. 
MPO, myeloperoxidase; ROS, reactive oxygen species.    
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1.2.2.5 Pathogen killing by neutrophils   
Apart from bacterial killing via the antimicrobial compounds contained within granules, 
there are two main strategies neutrophils use to kill bacteria like S. aureus. One of them is 
the generation of ROS which accompanies phagocytosis. ROS includes high levels of 
superoxide proximal to both the phagosomal and plasma membranes (Rigby and DeLeo, 
2012). Specifically, electrons are transferred from cytosolic NADPH to oxygen outside of 
the cell or within the phagosome by NADPH-dependent oxidase, which reduces the oxygen 
to superoxide in between the membranes of the phagosome and engulfed S. aureus. By so 
doing, high levels of superoxide are generated, which leads to an influx of electrons into the 
phagosome (Babior, 1999, Klebanoff, 2005). Both superoxide and nitric oxide are potently 
bactericidal to S. aureus (Nunoshiba et al., 1995, Malawista et al., 1992), causing damage 
to bacterial DNA, lipids, and cellular proteins (Gaupp et al., 2012, Morgan et al., 2008). 
Protons are then capable of transforming superoxide to H2O2 which forms hypochlorous 
acid in the presence of the granule protein, myeloperoxidase (MPO). Subsequent secondary 
reactions generate a number of highly effective antimicrobial molecules, including singlet 
oxygen, hydroxyl radical, and chloroamines (Klebanoff, 2005) (Figure 1.2).  
Recently a third neutrophil killing mechanism has been discovered whereby a novel 
structure is formed: neutrophil extracellular traps (NETs). NETs consist of expelled 
neutrophil DNA bound with histones, azurophilic granule proteins, and several cytosolic 
proteins (Figure 1.1). NETs possess the capability of trapping and killing various 
microorganisms including S. aureus (Brinkmann et al., 2004). S. aureus secreted PVL, 
LukGH, LukDE, PSMs, and γ-hemolysin can cause formation of NETs by permeabilization 
of the cell membranes (Kobayashi et al., 2015). Release of DNA and granule enzymes for 
NET formation was found upon stimulation with both physiological stimuli such as CXCL8 
and lipopolysaccharide (Yousefi and Simon, 2016), and non-physiological agonists 
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including phorbol myristate acetate (PMA) (Yousefi and Simon, 2016). In vivo, NETs are 
found to be closely linked with TLR2 signalling and opsonisation (Yipp et al., 2012). It is 
also believed that NETs are tightly regulated with ROS synthesis, due to the fact that NETs 
cannot be formed without NADPH-oxidase (Fuchs et al., 2007, Yipp et al., 2012). NET 
formation is also regulated by myeloperoxidase (MPO) and neutrophil elastase (NE). The 
process is mediated by the release and migration of NE and MPO from granules to the 
nucleus, where NE degrades the linker histone H1 and regulates core histones, while 
chromatin decondesation is enhanced by MPO (Papayannopoulos et al., 2010). After 
clearance of infections, NETs are degraded by DNase 1 (Bratton and Henson, 2011). 
Increased NETs response was induced by inhibiting phagocytosis, indicating NETs might 
be a complementary pathogen killing mechanism when phagocytosis cannot take 
place.(Jablonska, 2014). As a result of the detection of histones in NETs, NETs were 
thought to comprise of chromosomal DNA. This came into question when it was discovered 
that antibodies used for the detection of histones also detected DNA, which could derive 
from the mitochondria (Yousefi and Simon, 2016). Subsequently, sequencing methods have 
established the main composition of NETs as mitochondrial DNA (Lood et al., 2016, 
Yousefi and Simon, 2016). Nevertheless, the possibility of chromosomal DNA in the 
formation of NETs cannot be excluded, considering nuclear DNA can be released under 
conditions of cell lysis. For instance, neutrophils release nuclear DNA and form NETs when 
encountering bacterial pore-forming toxins such as S. aureus secreted leukotoxin 
(Malachowa et al., 2013).  
1.2.2.6 Clinical significance of neutrophils for S. aureus infections 
Previous research has demonstrated that individuals with disorders of neutrophil functions 
are at high risk of S. aureus infection (Bogomolski-Yahalom and Matzner, 1995). Severe 
bacterial infections (including S. aureus) are often fatal among patients suffering congenital 
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neutrophil deficiencies (Amulic et al., 2012). Chronic granulomatous disease (CGD) refers 
to a neutrophil disorder with defective NADPH oxidase and cannot produce ROS and CGD 
patients present with a higher susceptibility to fungal and bacterial infections (including S. 
aureus) (Goldblatt and Thrasher, 2000, Edwards, 2005). Furthemore, neutrophils isolated 
from CGD patients are unable to kill S. aureus in vitro (Quie et al., 1967, Goldblatt and 
Thrasher, 2000). Specific-granule deficiency is an uncommon neutrophil defect, but leads 
to severe skin and lungs infection caused by S. aureus, Candida albicans, and Pseudomonas 
aeruginosa (Edwards, 2005). Neutrophils isolated from these patients lack specific granule 
compounds such as gelatinase and lactoferrin. The hyperimmunoglobulin E-recurrent 
infections (HIE) was first reported with S. aureus infection in 1966 (Edwards, 2005). The 
strikingly abnormal inflammatory response in HIE patients is possibly caused by delayed 
neutrophil recruitment to site of infection, leaving prolonged opportunity for bacterial 
replication (Edwards, 2005). Neutrophils in leukocyte adhesion deficiencies (LAD) patients 
fail to migrate to the site of infection. Skin and respiratory tract infections are commonly 
found among LAD patients, typically with S. aureus or Gram-negative bacteria 
(Rosenzweig and Holland, 2004). S. aureus bacteraemia is also a significant cause of 
morbidity and mortality (23%) in neutropenic patients on chemotherapy (Gonzalez-Barca 
et al., 2001). The abnormally low centration of neutrophils in blood of the patients increased 
risks of severe oral mucositis (12% to 32%) and S. aureus infection (33% to 57%) 
(Gonzalez-Barca et al., 2001).   
1.3 Neutrophil cell death programmes 
1.3.1 Apoptosis  
Apoptosis, also known as ‘programmed cell death’, is a strictly regulated process (Kennedy 
and DeLeo, 2009). Neutrophils are exquisitely sensitive to apoptosis, hence their short half-
life, and it plays a significant role in clearing effete neutrophils thus facilitating the 
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resolution of inflammation (Kennedy and DeLeo, 2009). Not only is apoptosis important 
for the balance between cell survival and cell death (homeostasis), but because it avoids loss 
of cell contents, it is also important for the prevention of neutrophil induced tissue damage 
(Luo and Loison, 2008, Iba et al., 2013).  
A notable feature of neutrophil apoptosis is chromatin condensation, which changes the 
multi-lobed nucleus into a single structure consisting of short (180 bp) DNA strands 
(Kitazumi and Tsukahara, 2011). This then further leads to nuclear fragmentation and 
apoptotic body formation (Klionsky, 2004). Caspases are responsible for the cleavage of 
cellular proteins and structures, allowing cells to shrink and be cleared by tissue 
macrophages (Kitazumi and Tsukahara, 2011). Importantly, the plasma membrane is 
preserved during apoptosis, preventing the loss of histotoxic cell contents.  
Initiation of apoptosis is via either intrinsic (e.g. ROS or mitochondria regulated) or extrinsic 
(by death receptor signalling e.g. FAS, TNFR) pathways (Kennedy and DeLeo, 2009). The 
intrinsic process, known also as the spontaneous pathway, refers to the apoptosis initiated 
by signals from within the cell. Many molecules are known to modulate spontaneous 
neutrophil apoptosis, and it is thought to be governed by a balance of pro- and anti-apoptotic 
proteins. For example, apoptosis can be initiated by the reduced expression of the anti-
apoptotic protein Mcl-1, a key Bcl-2 family protein found in cytoplasm and nucleus 
(Moulding et al., 2001). Bcl-2-asscoiated X protein (BAX) is a pro-apoptotic member of 
the Bcl-2 family (Sawatzky et al., 2006). Upon cleavage, BAX translocates to the 
mitochondria, forming pores in the mitochondrial membrane and subsequent release of 
cytochrome C from mitochondria into the cytosol, which activates caspases and DNA 
cleavage (Maianski et al., 2004). Inhibition of BAX cleavage results in prolonged 
inflammation in vivo (Sawatzky et al., 2006), suggesting the importance of BAX for the 
resolution of acute inflammation.  
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The extrinsic pathway is activated by binding between exocellular ligands with specific 
receptors on the cell surface, from which  a transmembrane signal is generated to activate 
caspase activity (Schulze-Osthoff et al., 1998). For instance, FAS-mediated apoptosis is 
stimulated by neutrophil produced FAS ligand (FASL), and can be suppressed by G-CSF, 
GM-CSF, and IFN (Liles et al., 1996). The FAS-FASL interaction results in clustering of 
FAS-associated death domain on the cytoplasmic side of plasma membrane and further 
promotes caspase activation and apoptosis (Kennedy and DeLeo, 2009).      
1.3.2 NETosis  
NETosis refers to cell death following the formation of NETs, and features a ruptured 
plasma membrane allowing collapse of the nuclear membrane and chromatin release as a 
DNA cloud (Fuchs et al., 2007, Yousefi and Simon, 2016). The objective of NETosis was 
believed to rescue and protect the local environment from the release of damage-associated 
molecular patterns (DAMPs) from this necrotic-like cell death, yet how the residues of 
neutrophils that underwent NETosis has cleared remains unknown (Yousefi and Simon, 
2016). Recently NETosis was considered as a destructive process in publications, since it 
has been reported that NETosis could represent a necroptosis (Desai et al., 2016), and the 
persistence of neutrophil remnants could exacerbate inflammation and may induce 
autoimmune responses (Yousefi and Simon, 2016). The controversy as to whether NETosis 
is a beneficial or potentially harmful cell death format to the host remains until further 
explanation of the mechanism is offered.   
1.3.3 Necrosis  
Necrosis (including necroptosis) is a regulated neutrophil cell death characterised by the 
exhibition of cytoplasmic swelling, disorganised organelles, ruptured plasma membrane, 
loss of intracellular contents, and a lytic nucleus (Yang et al., 2015). Unlike apoptosis and 
NETosis, necrosis is an accidental and turbulent cell death format. The process is triggered 
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by bacteria and toxic molecules released from necrotic cells such as proteolytic enzymes 
(Iba et al., 2013). Inflammation can be induced by DAMPs released from necrotic cells 
(Yang et al., 2015), including uric acid, heat shock proteins and antimicrobial peptides. 
These molecules interact with pattern-recognising receptors which stimulate 
proinflammatory mediators (Iba et al., 2013). Inflammatory responses can also be triggered 
via the Nlrp3 inflammasome sensing of ATP released from necrotic cells (Iyer et al., 2009).  
Recently, a receptor interacting protein kinase-3 (RIPK3) and mixed lineage kinase domain-
like (MLKL) dependent necroptosis pathway was described (Murphy and Vince, 2015). 
Necroptotic cell lysis and the secretion of pro-inflammatory molecules depends on RIPK3 
phosphorylation of MLKL. Several signalling receptors are capable of activating RIPK3-
MLKL necroptosis, such as TLRs, and IFN-regulatory factors (Murphy and Vince, 2015).  
Necrosis plays a pivotal role in host immune responses in microbial infections, as evidence 
was found that S. aureus is capable of inducing necrosis via LukGH secretion, and in turn 
promotes tissue damage and inflammation (Malachowa et al., 2012). Massive S. aureus 
replication was found within abscesses along with both viable and necrotic neutrophils 
(Kobayashi et al., 2015). Hence, S. aureus triggered necrosis induces inflammation and 
subverts host infection outcomes by eliminating immune cells and generating an ideal 
bacterial growth environment. Identification of necrosis-dependent mechanisms in S. 
aureus-neutrophil interaction may lead to novel specific therapeutic targets.    
1.4 S. aureus evasion of neutrophil immunity  
Neutrophil-modulated killing is the key defence against S. aureus in a healthy human 
immune system. Hence, it is not surprising that S. aureus has developed numerous evasion 
mechanisms to escape from this particular innate immune defence. This not only reveals the 
ongoing combat between host-pathogen interactions, but also reflects the importance of 
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each defence factor involved in the S. aureus infection (Rigby and DeLeo, 2012). The 
combat between neutrophils and S. aureus will be discussed step by step.  
1.4.1 Inhibition of neutrophil recruitment  
S. aureus impedes the process of neutrophil immunity at many steps, beginning with 
recruitment to the site of infection. The process of neutrophil rolling along the endothelial 
cell wall towards the site of S. aureus infection can be blocked by staphylococcal super 
antigen-like 5 (SSL5) which seizes the binding site of PSGL-1. Occupation of PSGL-1 
results in the prevention of P-selectin ligand binding and consequently neutrophils are no 
longer able to migrate towards the infection site (Bestebroer et al., 2007) (Figure 1.3 A). In 
addition to PSGL-1, SSL5 also competitively interacts with glucosaminoglycan-binding 
sites of other glycoproteins to abrogate integrin activation for neutrophil attachment 
(Bestebroer et al., 2007). Furthermore, the firm adhesion step is modulated by S. aureus 
synthesized extracellular adherence protein (Eap), which inhibits ICAM-1 from interacting 
with neutrophilic β2 integrins by direct binding (Chavakis et al., 2002) (Figure 1.3 A).  
1.4.2 Escape from neutrophil chemotaxis and activation  
S. aureus also secretes several proteins to reduce neutrophil activation and therefore 
potentially depressing immune responsivity. Chemokine-dependent neutrophil activation 
can be inhibited by direct binding of SSL5 with chemokine receptors (Bestebroer et al., 
2010b). SSL10 and SSL3 suppress chemokine CXCL12-mediated neutrophil response and 
TLR2-dependent neutrophil activation respectively (Bardoel et al., 2012, Walenkamp et al., 
2009). Another protease synthesized by S. aureus known as staphopain A (ScpA) cleaves 
CXCR2 chemokines (Laarman et al., 2012) (Figure 1.3 B). Besides the chemokine pathway, 
CHIPS to impair neutrophil chemotaxis via inhibition of FPR 1 and C5aR. Further studies 
revealed FLIPr which is an FPR1 inhibitory protein generated by S. aureus, and CHIPS act 
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as FPR antagonists and prevent S. aureus from recognising formyl peptides and PSM 
(Kobayashi et al., 2010, Kretschmer et al., 2010) (Figure 1.3 B).  
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Figure 1.3 S. aureus evasion of (A) neutrophil recruitment and (B) neutrophil activation. 
CHIPS, chemotaxis inhibitory proteins; EAP, extracellular adherence protein; ICAM, 
intercellular adhesion molecule 1; FPR, formyl peptide receptor; PSGL, p-selectin 
glycoprotein ligand; PSM, phenol-soluble modulins. SSL, staphylococcal super antigen-like; 
TLR, toll-like receptor; ScpA, staphopain A.  
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1.4.3 Escape from opsonisation and phagocytosis  
To overcome opsonisation-dependent phagocytosis, S. aureus produces the metalloprotease 
aureolysin to degrade C3 (Laarman et al., 2011). Together with staphylococcal complement 
inhibitor (SCIN) and staphylococcal binder of IgG (SBI), aureolysin blocks the neutrophil 
immune response by truncating C3 at the convertase site. An aureolysin knock-out study 
suggests the essential and sufficient role that aureolysin plays in C3 cleavage (Jongerius et 
al., 2010b, Rigby and DeLeo, 2012, Laarman et al., 2011). S. aureus extracellular 
complement-binding protein (ECB) and extracellular fibrinogen-binding protein (EFB) also 
bind with the C3 molecule and thereby prevent further phagocytosis (Jongerius et al., 2010a, 
Lee et al., 2004). Both ECB and EFB have been shown to enhance S. aureus survival and 
reduce neutrophil influx to the site of infection in a pneumonia model (Jongerius et al., 
2012).In addition to interfering with the core function of C3, S. aureus also modulates C5, 
C1q, and Ig signalling. SSL7 binds to IgA and strongly suppresses C5 induced S. aureus 
phagocytosis (Bestebroer et al., 2010a). While two other anti-opsonic molecules namely 
SSL10 and staphylococcal protein A bind with IgG to prevent antibody recognition of S. 
aureus by neutrophils (Diekema et al., 2001, Itoh et al., 2010). As a result, those occupied 
antibodies leave S. aureus in a neutrophil compromised environment without being 
opsonized and phagocytosed (Langone, 1982). 
1.4.4 Escape from neutrophil killing  
To resist ROS-mediated killing, S. aureus shields itself with various antioxidants and 
enzymes which destroy or neutralise oxidant molecules (Spaan et al., 2013b). 
Staphyloxanthin, for example, is an antioxidant which consumes oxidants and prevents the 
bacteria from neutrophilic oxidative burst via an unidentified mechanism (Liu et al., 2005). 
Catalase is a cytoplasmic staphylococcal enzyme which reduces hydrogen peroxide (H2O2) 
to its inactive components H2O and O2 (Mandell, 1975). Superoxide dismutase also 
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eliminates harmful ROS following phagocytosis by converting superoxide anion to H2O2 
(Deleo et al., 2009). Methionine sulfoxide reductase repairs oxidative damage and promotes 
S. aureus survival within neutrophils (Malachowa et al., 2011). A cell wall-anchored protein 
known as adenosine synthase can synthesise adenosine from adenosine monophosphate 
(Cronstein et al., 1990). The S. aureus adenosine can suppress neutrophil degranulation and 
superoxide burst, allowing S. aureus to escape from phagocytic clearance (Thammavongsa 
et al., 2009).  
Neutrophils induce bacterial lysis through lysozyme degradation of the peptidoglycan 
matrix in the cell wall. Yet S. aureus utilizes autologous O-acetyltransferase A to modify 
the peptidoglycan and therefore protects itself against lysozymic lysis (Bera et al., 2005, 
Herbert et al., 2007). Furthermore, S. aureus either secretes staphylokinase to bind with host 
defensins, or alters the phosphatidylglycerol content of the cell membrane. Both 
mechanisms result in changes to the S. aureus cell surface leading to the cationic 
antimicrobial peptides (AMP) being repelled (Mishra et al., 2011, Peschel et al., 2001). In 
addition to mediating cell wall changes, S. aureus is also capable of cleaving AMPs by 
producing proteases such as aureolysin (Sieprawska-Lupa et al., 2004).  
S. aureus also exploits an anti-NETs mechanism by staphylococcal nuclease degradation of 
NETs DNA and therefore escape from this environment (Berends et al., 2010). Extracellular 
nucleases have been also found in several pathogens including S. aureus (Thammavongsa 
et al., 2013), indicating S. aureus is capable of inducing both intracellular and extracellular 
neutrophil killing shut down.  
The effectiveness of neutrophil evasion turns out to be key to the pathogenesis of S. aureus. 
It is exemplified by the increase in susceptibility and mortality to S. aureus infection among 
patients with deficient neutrophil functions, such as neutropenia, CGD, HIE, and LAD 
(Goldblatt and Thrasher, 2000, Rosenzweig and Holland, 2004, Edwards, 2005, Gonzalez-
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Barca et al., 2001). It is evident that neutrophil immune activity is essential to eliminate S. 
aureus. However, research has found that bacterial survival inside neutrophils contributes 
to the pathogenesis of S. aureus infection and exacerbates diseases (Gresham et al., 2000). 
Moreover, this study also demonstrated enhanced host defence with neutrophil migration to 
the site of infection resulting in increasing pathogenic burden and host death (Gresham et 
al., 2000). The data may imply an underlying virulence mechanism where S. aureus use 
neutrophils as a niche for replication while inducing necrotic cell lysis and inflammatory 
responses. A conundrum is therefore raised as whether neutrophil activity contributes more 
for S. aureus survival or host immunity. Developing molecules that can control 
inflammatory responses while maintaining effective neutrophil antimicrobial activities is a 
key novel therapeutic strategy. 
1.4.5 S. aureus induced neutrophil lysis 
S. aureus has evolved additional mechanisms to escape from neutrophil defence, by 
generating a number of cytolytic toxins to kill neutrophils before, during and after 
phagocytosis, including PSMs, α-hemolysin, and leukotoxins (Teng et al., 2017). S. aureus 
synthesise three PSMs namely PSMα, PSMβ, and PSMγ (Surewaard et al., 2013). PSMα 
peptides possess the most pronounced neutrophil lysing ability by disruption of the 
cytoplasmic membrane from inside the phagosome, for which PSMα3 was identified with 
the strongest activity (Teng et al., 2017). PSMs lyse neutrophils in a receptor-independent 
manner, probably via membrane damaging activity bound with their strong amphipathy and 
α-helicity features of pore-forming peptides (Wang et al., 2007). PSMγ show moderate lytic 
activity and PSMβ peptides are non-cytolytic. The proinflammatory neutrophil responses 
such as chemoattraction, activation and CXCL8 release can be initiated by PSMα 
stimulation via FPR2 which senses the amphipatic α-helical structure of PSMs (Otto, 2014).  
     
 
38 
 
S. aureus β-Barrel pore-forming toxins including α-hemolysin induce leakage and 
ultimately lysis of leukocytes including neutrophils (Bhakdi and Tranum-Jensen, 1991, 
Valeva et al., 1997). As a water-soluble monomer, α-hemolysin oligomerises into a 
heptameric structure to assemble the lytic activity (Berube and Bubeck Wardenburg, 2013). 
In murine pneumonia studies, α-hemolysin is required to induce CXC chemokines which 
facilitates recruitment of neutrophils to the lung (Bartlett et al., 2008). Increased survival, 
decreased lung pathology, IL-1β secretion, and neutrophil recruitment to live bacteria was 
observed following α-hemolysin instillation in a pyrin domain containing protein (NLRP3) 
deficient model (Fink and Cookson, 2005), implicating the importance of NLRP3 in α-
hemolysin regulated pathogenesis in vivo. 
PVL is a bicomponent pore-forming exotoxin consisting of LukS-PV and LukF-PV subunits, 
and is an important virulence factor in necrotising diseases (Loffler et al., 2010). Interaction 
of LukS-PV with neutrophils triggers secondary binding of LukF-PV and subsequently 
initiates the pore-forming lytic activity. LukS-PV binds to human complement receptor 
C5aR as the target of PVL, which inhibits C5a mediated neutrophil activation (Spaan et al., 
2013a). S. aureus produced leukocidins such as LukED and LukGH lyse neutrophil 
membranes after phagocytosis (Aslam et al., 2013, Ventura et al., 2010). LukGH triggers 
neutrophil death by targeting αM/β2 integrin (DuMont et al., 2013) and promotes post-
phagocytosis S. aureus escape and subsequent bacterial outgrowth. Similarly, PSMs and α-
hemolysin have also been suggested to directly damage phagosome and facilities escape 
and replication of S. aureus in the cytoplasm (Surewaard et al., 2013, DuMont et al., 2013, 
Grosz et al., 2014). The neutrophil lysis caused by PSMs is independent of receptor binding 
and may be due to the lytic nature of the proteins (Haas, 2007).  
Previous related research from our group indicates that those and possibly other soluble S. 
aureus toxins subvert neutrophil apoptosis and switch cell death to necrosis, an undesirable 
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form of neutrophil cell death (Anwar thesis, 2014) (Figure 1.4). Resulting tissue damage is 
induced by potent proteases which are ordinarily bound within granules but released into 
the extracellular space (Anwar et al., 2009) (Hirsch et al., 1997). Evidently, S. aureus 
induced necrosis not only depletes valuable human immune cells, but also generates a 
proinflammatory environment and promotes their own survival within the host.   
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Figure 1.4. Neutrophil necrosis caused by exponential phase SH1000 at MOI of 0.5, 1, and 
5 after 1 and 3 hours co-incubation (Anwar thesis, 2014). Neutrophil necrosis caused by S. 
aureus increased with both MOI and co-incubation time.  Field width 200 µm. 
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1.5 Zebrafish embryos as a model of S. aureus infection 
Over recent decades, huge progress has been made in the development of infection models 
for human-pathogen studies in vivo. The use of animal models, either murine or zebrafish, 
have contributed greatly to our knowledge on staphylococcal pathogenesis. The zebrafish 
embryo, which possesses both genetic manipulability and transparency allows visualisation 
of immune cells during infection and inflammation. This model has been initially used for 
developmental studies, and their potential importance as a novel model organism for host-
pathogen interaction including for Streptococcus pneumoniae (Saralahti et al., 2014), S. 
aureus (Prajsnar et al., 2008), and mycobacteria (Swaim et al., 2006). Although S. aureus 
is not a natural fish pathogen, the zebrafish infection model has been established with clear 
acute infectious symptoms and host mortality, with both embryos (Prajsnar et al., 2008) and 
adults (Lin et al., 2007). Studies of zebrafish neutrophil biology advanced the understanding 
of neutrophil immune response and highlighted the importance of this model in human 
autoimmunity research (Henry et al., 2013, Shelef et al., 2013). The model has been widely 
used for identifying critical roles of phagocytes in immune response to S. aureus infection 
(Harvie and Huttenlocher, 2015, Torraca et al., 2014). Complete phagocytosis of S. aureus 
by zebrafish macrophages and neutrophils was shown by live imaging (Prajsnar et al., 2008). 
A subpopulation of zebrafish embryos showed phagocyte-dependent clearing of the 
infection, while remaining embryos displayed overwhelming outcomes, suggesting that S. 
aureus can subvert the phagocyte killing responses in vivo (Prajsnar et al., 2012). In light 
of this, the zebrafish embryo model was chosen in this thesis to study neutrophil-S. aureus 
interaction during infection.  
The development of the zebrafish embryo is more rapid compared to mammalian species, 
achieving growth from one cell to a recognisable body shape within 24 hours post 
fertilisation (hpf) (Westerfield, 2000). The wildtype zebrafish embryos are almost fully 
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transparent from fertilisation to 3 days post fertilisation (dpf) (Isogai et al., 2001), allowing 
bacterial injection into an observable circulation valley by using light microscopy. 
Morpholino-modified antisense oligonucleotides have been developed to selectively 
knockdown transient gene expression, to allow the interrogation of candidate host genes in 
infection (Summerton and Weller, 1997). In light of this, macrophages and neutrophils can 
be depleted by pu.1 morpholinos for 48 and 36 hours post fertilisation (hpf) respectively, 
allowing the study of these cells in host-S. aureus interaction (Klemsz et al., 1990).  
The zebrafish model shares many orthologs of phagocytes and signalling molecules with 
the human immune system (van der Vaart et al., 2012). Functional macrophages and 
primary neutrophils appear at 25 and 18 hpf respectively (Crowhurst et al., 2002), with the 
emergence of mature neutrophils at 2 days post fertilisation (Lieschke et al., 2001). In 
addition, the development of the adaptive immune system occurs 4-6 weeks after 
development of innate immune cells in zebrafish (Trede et al., 2001, Lam et al., 2004), 
which enables experiments focusing on S. aureus-phagocyte interaction at early embryo 
stages. There are three main limitations of using the zebrafish model. The necessity of 
maintenance at 28oC might have an impact in some virulence factors of S. aureus, of which 
the optimal temperature is 37oC. Human-specific immune evasion factors might not have 
same phenotypes in this model. Additionally, the divergence between zebrafish and humans 
occurred 450 million years ago. The genetic similarity is therefore less than other 
mammalian models such as mouse which diverged at 112 million years ago (Woods et al., 
2000).  
1.6 Hypothesis and aims  
S. aureus is an extremely powerful human pathogen. It is rapidly evolving with antibiotic 
resistance mechanisms and a multitude of pathogenesis factors that overcome the neutrophil 
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immune response in many different ways. Clearly, it is necessary to look further into the 
relationship between neutrophils and S. aureus to understand how to promote killing of this 
microorganism which may lead to important novel therapeutics which would reduce 
morbidity and mortality of S. aureus-related infections.  
We hypothesise that apart from known cytotoxin expression, S. aureus potentially induces 
neutrophil cell death via novel mechanisms. This PhD aims to identify immune modulating 
factors by screening S. aureus mutants of the NTML in flow cytometric neutrophil cell death 
assays. Strains attenuated in their ability to kill neutrophils will then be verified and 
subsequently, characterisation of the pathogenic mechanisms will take place, particularly 
focusing on neutrophil uptake of S. aureus and post-phagocytotic regulation of cell death. 
The overall aim is to identify viable targets for novel anti-MRSA therapy development to 
improve treatments for patients with severe and life-threatening S. aureus infections. 
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CHAPTER 2 
Materials and methods 
2.1 Media 
All media in this study were made in distilled water (dH2O) followed by autoclaving at 
121oC for 20 min, 103 kilopascals. 
2.1.1 Brain heart infusion (BHI)  
Brain heart infusion (Sigma) 37g/L 
2.1.2 BHI agar  
Brain heart infusion agar (Sigma) 52g/L 
2.1.3 Lysogeny broth (LB)  
Yeast extract (Oxoid) 10g/L 
Tryptone (Oxoid) 5g/L 
NaCl 5g/L 
2.1.4 LB agar  
Yeast extract (Oxoid) 10g/L 
Tryptone (Oxoid) 5g/L 
NaCl 5g/L 
Agar (Oxoid) 1.5% (w/v) 
2.1.5 LK  
Yeast extract (Oxoid) 10g/L 
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Tryptone (Oxoid) 5g/L 
KCl 7g/L 
2.1.6 LK agar  
Yeast extract (Oxoid) 10g/L 
Tryptone (Oxoid) 5g/L 
KCl 7g/L 
Agar (Oxoid) 1.5% (w/v) 
2.1.7 Baird-Parker agar  
Baird-Parker agar base (Oxoid) 63g/L 
Egg yolk tellurite emulsion (Oxoid) 5% (w/v) 
2.1.8 RPMI-1640 media  
Before use, 10% (v/v) heat inactivated foetal calf serum (Sigma-Aldrich) was added to 
RPMI-1640 media (Sigma-Aldrich and Thermo Fisher Scientific) and stored at 4oC.  
2.2 Antibiotics 
Stock antibiotic solutions used were prepared and filter-sterilised (0.2 µm pore size) 
(Millex). Corresponding volume was added into agar media below 55oC, or liquid media 
right before use to reach the working concentration. The antibiotics used in this project are 
listed in Table 2.1. 
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Antibiotics 
Stock concentration 
(mg/mL) 
Working 
concentration (µg/mL) 
Solvent 
Ampicillin (Amp) 100 100 dH2O 
Chloramphenicol 
(Cm) 
30 30 
95% (v/v) 
ethanol 
Erythromycin (Ery) 5 2.5 
95% (v/v) 
ethanol 
Kanamycin (Kan) 50 25 or 50 dH2O 
Lincomycin (Lin) 25 12.5 
50% (v/v) 
ethanol 
Tetracycline (Tet) 5 2.5 or 5 
50% (v/v) 
ethanol 
Table 2.1 Concentrations of antibiotic solutions.  
  
     
 
47 
 
2.3 Bacterial strains and plasmids 
2.3.1 Nebraska transposon mutagenesis library (NTML) 
The Nebraska transposon mutant library derived from CA-MRSA USA300 was used for 
this project. The WT strain JE2, is identical to the S. aureus strain isolated from the Los 
Angeles County jail, except that it has been cured of plasmids (Fey et al., 2013). The 
Nebraska Transposon Mutant Library was constructed based on USA300 FPR3757 
chromosomal genome sequence mapped transposition of bursa aurealis from the delivery 
plasmid pBursa into the nonessential protein coding sequences of JE2 genome (Fey et al., 
2013). 
The NTML was stored in twenty 96-well microtiter plates at -80oC. Plates were thawed on 
ice before incubation of 50µL of stock culture in 150µL of varied media in each well for 
varied times at 37oC, dependent on the experimental set up.  
2.3.2 Staphylococcus aureus strains 
S. aureus strains used in transformation and transductions are given in Table 2.2. Strains 
were obtained from -80oC Microbank vial stocks (Pro-lab Diagnostics) and inoculated onto 
BHI agar with antibiotics where appropriate to select the resistant marker. The plates were 
kept at 4oC for a week for short-term use. For long-term storage, a microbank bead stock 
was made from a single colony and stored at -80oC.  
For bacterial growth, a single colony was inoculated into 5 mL of BHI media, with or 
without antibiotics, in a 50 mL Falcon tube. The cultures were then incubated overnight at 
37oC with rotary shaking at 250 rpm. Subsequently, a sub-culture was made with 50 mL of 
BHI media in a sterile 250 mL conical flask to an OD600 of 0.05-0.1, and then grown to 
exponential phase at 37oC on a rotary shaker at 250 rpm.  
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Strains Relevant genotype/selection marker Reference 
SH1332 
RN4220 pYL112 Δ19, a plasmid carrying the L45a 
integrase gene; CmR 
(Lee et al., 1991) 
SH4861 
(USA300) Leukocidin family SAUSA300_1974 disrupted 
by Tn bursa aurealis EryR LinR  
This study 
SH4862 
(USA300) Leukocidin family SAUSA300_1975 disrupted 
by::Tn bursa aurealis EryR LinR  
This study 
SH4854 (USA300) lspA::Tn bursa aurealis EryR LinR  This study 
SH4851 (USA300) saeS::Tn bursa aurealis EryR LinR  This study 
SH4860 (USA300) purB::Tn bursa aurealis EryR LinR  This study 
SH4850 (USA300) tatC::Tn bursa aurealis EryR LinR  This study 
SH4859 (USA300) fumC::Tn bursa aurealis EryR LinR  This study 
SH4863 (USA300) hlgA::Tn bursa aurealis EryR LinR  This study 
SH4858 (USA300) udk::Tn bursa aurealis EryR LinR  This study 
SH4856 
(USA300) pyruvate ferredoxin oxidoreductase, α subunit 
SAUSA300)1182 Tn bursa aurealis EryR LinR  
This study 
SH4852 (USA300) clpP::Tn bursa aurealis EryR LinR  This study 
SH4857 
(USA300) Hypothetical protein SAUSA300_1494 disrupted 
by Tn bursa aurealis EryR LinR  
This study 
SH4848 
(USA300) Putative ribose operon repressor 
SAUSA300_0265 disrupted by Tn bursa aurealis EryR LinR  
This study 
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SH4853 
 
(USA300) Putative membrane protein 
SAUSA300_0917 disrupted by Tn bursa aurealis EryR LinR  
This study 
SH4847 
(USA300) Putative membrane protein SAUSA300_0230 
disrupted by Tn bursa aurealis EryR LinR  
This study 
SH4849 
(USA300) Glycerol-3-phosphate transporter 
SAUSA300_0337 disrupted by Tn bursa aurealis EryR LinR  
This study 
SH4855 
(USA300) Conserved hypothetical protein 
SAUSA300_1180 disrupted by Tn bursa aurealis EryR LinR  
This study 
SH4276 
(USA300) JE2, USA300 LAC strain cured of plasmids p01 
and p03 
(Fey et al., 2013) 
SH4868 (USA300) JE2 geh:: ezrA-eMos; KanR This study 
SH4866 (USA300) SJF4854 geh:: ezrA-eMos-lspA; KanR This study 
SH4867 (USA300) SJF4854 geh:: ezrA-eMos; KanR This study 
SH4864 (S. aureus 8325) ΔclpP, clpP depletion strain  
(Michel et al., 
2006) 
SH4865 (S. aureus 8325) ΔclpP, containing pHPS9clpP 
(Michel et al., 
2006) 
Table 2.2 S. aureus strains used in this project. EryR, erythromycin resistance; LinR, 
lincomycin resistance; CmR, chloramphenicol resistance; KanR, kanamycin resistance.  
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2.3.3 Escherichia coli strains 
E. coli strains were grown and stored with same method as S. aureus strains, except using 
LB broth and agar instead of BHI. All E. coli strains used in this study are listed in Table 
2.3. 
2.3.4 Plasmids 
Plasmids used in this study were purified by a GeneJET Plasmid Miniprep kit. Plasmids 
used in this study are given in Table 2.4.  
2.3.5 Bacteriophage 
For genetic transduction between strains, the bacteriophage Φ11 was used in this study 
(Mani et al., 1993) .  
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Strains Relevant genotype/selection marker Reference 
Top 10 
F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 
recA1 araD139 Δ(araleu)7697 galU galK rpsL (StrR) 
endA1 nupG 
Invitrogen 
SJF4179 Top10 pGM074; AmpR 
Gareth Mc 
Vicker 
SJF4045 
Top 10 pKASBAR with Tet cassette replaced by Kan 
cassette that was amplified from pGL433b; AmpR KanR 
Amy Bottomley 
 
SJF4056 Top 10 pGM073 is pKASBAR + ezrA-psmOrange; AmpR 
Gareth Mc 
Vicker 
Table 2.3. E. coli strains used in this study. KanR, kanamycin resistance; AmpR, ampicillin 
resistant.  
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Plasmids Relevant genotype/selection marker Reference 
pKASBAR 
Hybrid vector of pCL84 and pUC18 for integration into S. 
aureus lipase gene (geh) encoding the attP integration site 
of L54a phage; AmpR (E. coli), TetR (S. aureus) 
(Bottomley et al., 
2014) 
pKASBAR-
KanR 
Kanamycin resistant derivative of pKASBAR; 
AmpR (E. coli), KanR (S. aureus) 
(Bottomley et al., 
2014) 
pGM073 
pKASBAR containing ezrA-psmorange under the putative 
ezrA promoter; AmpR (E. coli), TetR (S. aureus) 
Gareth McVicker  
pGM074 
pKASBAR containing ezrA-psmorange under the putative 
ezrA promoter; AmpR (E. coli), KanR (S. aureus) 
Gareth McVicker  
Table 2.4. Plasmids used in this study. 
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2.4 Determination of bacterial cell density  
2.4.1 Spectrophotometric measurement  
Bacterial density was quantified by spectrophotometric reading at 600 nm (OD600). A 
Biochrom WPA Biowave DNA spectrophotometer and a Jenway 6100 spectrophotometer 
were used to measure OD600 of individual bacterial cultures. Samples were diluted 1:10 in 
fresh media to achieve a measurable concentration when appropriate.  
A Perkin VICTOR x3 2030 plate reader or a VARIOSKAN FLASH plate reader were used 
for OD600 measurement of NTML strains with orbital shaking at fast speed for 0.2 sec before 
reading.  
2.4.2 Direct cell count  
Colony forming unit (CFU) count results were obtained using the Miles and Misra method 
(Miles et al., 1938) as follows. The bacterial inoculum was serially diluted as 1x volume of 
suspension added to 9x volume of PBS buffer up to 108 fold, with a fresh pipette tip used 
for each dilution. Three 10µl drops of each dilution were applied onto the surface of BHI 
agar. The plates were kept on the bench (RT) to dry before overnight incubation at 37oC. 
The dilution which yielded 15-50 full-size discrete colonies was noted and in which the 
colonies were counted. The CFU count per ml was calculated by using the following 
equation: CFU/mL = Average number of colonies for a given dilution x 100 x the dilution 
factor. 
2.5 Buffers and solutions  
All buffers and solutions were made with dH2O, stored at RT, and sterilized by autoclaving 
when necessary, unless otherwise stated.  
2.5.1 Phosphate buffered saline (PBS)  
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NaCl 8g/L 
Na2HPO4 1.4g/L 
KCl 0.2g/L 
KH2PO4 0.2g/L 
The pH of PBS buffer was adjusted to 7.4 with NaOH. 
2.5.2 Phage buffer  
MgSO4 1mM 
CaCl2 4mM 
NaCl 0.6%(w/v) 
Tris-HCl pH 7.8 50mM 
Gelatin 0.1% (w/v) 
2.5.3 TAE (50x)  
Tris 242g/L 
Na2EDTA pH 8.0 0.05M 
Glacial acetic acid 5.7% (v/v) 
TAE working solution was made by diluting 50x stock solution 1:50 with dH2O. 
2.5.4 DNA loading buffer (6x)  
Bromophenol blue 0.25% (w/v) 
Xylene cyanol FF 0.25% (w/v) 
Glycerol 30% (v/v) 
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2.5.5 Chemicals and enzymes  
All chemicals and enzymes used in this study were of analytical grade level. Chemicals 
were purchased from Sigma or Fisher Scientific. All restriction enzymes, polymerases, 
Gibson assembly mix kit, DNase and corresponding buffers were purchased from New 
England Biolabs or Fermentas. The stock solutions’ concentrations and storage of chemicals 
used in this study is listed in Table 2.5.  
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Stock solution Concentration Solvent Storage 
Lysostaphin 5 mg/mL 
20 mM sodium 
acetate pH 5.2 
-20oC 
Saponin 1% (w/v)  RT 
Adenine 20 mg/ml 0.5 M HCl -20oC 
Inosine 50 mg/ml dH2O -20oC 
Table 2.5. Storage and concentration of stock solutions of chemicals used in this study.  
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2.6 DNA purification techniques  
2.6.1 Genomic DNA purification  
A QIAGEN DNeasy Blood & Tissue kit was used to extract and purify genomic DNA. S. 
aureus strains were incubated overnight, then 1 mL of the culture was centrifuged at 12,000 
g for 3 min. The cell pellet was resuspended in 190 µL of dH2O followed by addition of 10 
µL of stock lysostaphin and incubation at 37oC for 2 hr. The genomic DNA isolation was 
conducted following the manufacture’s protocol afterwards.  
2.6.2 Plasmid DNA purification  
A GeneJET Plasmid Miniprep kit was used to purify plasmids from E. coli based on the 
manufacturer’s instructions.  
2.6.3 PCR productions purification  
A GeneJET PCR Purification kit was used to purify amplified DNA fragments from PCR 
reactions based on the manufacturer’s instructions.  
2.6.4 Gel extraction of DNA  
The target band of DNA was excised from a 1% (w/v) TAE agarose gel strained with 0.5 
µg/mL ethidium bromide using a UV transilluminator. A GeneJET Gel Extraction kit was 
used to purify DNA from the gel slice following manufacturer’s protocol.  
2.7 In vitro DNA manipulation techniques  
2.7.1 Primer design  
Primers used for PCR reactions in this study are listed in Table 2.6. They were 
oligonucleotides (usually 20-50 nucleotides) synthesised based on the DNA sequences of S. 
aureus USA300 FPR3757 strains and plamids pGM073 and pGM074. Restriction enzyme 
cut sites were introduced at the 5’ end of primers when necessary for cloning.  Primers used 
     
 
59 
 
to amplify DNA fragments used in transformation were ~20 nucleotides while the primers 
for Gibson assembly were ~50 base pairs long. Primers were designed with NCBI Primer-
BLAST tool (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) and further checked using 
OligoAnalyzer tool (eu.idtdna.com/calc/analyser) to rule out potential hairpin formation. 
The primers were synthesised by Eurofins MWG operon (http://www.eurofinsdna.com) and 
prepared in sdH2O. The stock and working concentrations of primers were 100 µM and 10 
µM separately. Primers were stored at -20oC before use.  
2.7.2 PCR amplification 
2.7.2.1 Phusion polymerase  
High Fidelity phusion polymerase (Thermo Scientific) has 3’-5’ proofreading activity and 
therefore was used for PCR amplification in this study when the accuracy of product is 
required. The reaction mix was prepared as below:  
Phusion High Fidelity Master Mix (2x) 25 µL 
Template DNA 50-200 ng 
Forward primer (10 µM) 1 µL 
Reverse primer (10 µM) 1 µL 
sdH2O  To 50 µL 
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Primers Sequence (5’-3’) Application 
USA300_1974F ACACGTACAGCTACAACAAGTG Primers used to verify the 
existence of the transpon 
insertion in the strain 
corresponding to the 
USA300 strain number 
given in the primer name. 
USA300_1974R TCGCCCATAAATTTCCATTTCGT 
USA300_1975F GCAGCAACGACTCAAGCAAA 
USA300_1975R TGAATCGAATTTACCACCTGAGC 
USA300_0994F AGGCCCATACGATGCGAAAG 
USA300_0994R TGCTGCTGCAACTCTTCCAA 
USA300_1889F CGCTATGAAGCATGGTTAGAAGT 
USA300_1889R GCGTTGCAATGTTTGCGTTG 
USA300_2365F AGCCCCTTTAGCCAATCCAT 
USA300_2365R TGGACCAGTTGGGTCTTGTG 
USA300_0690F GTCACGAAGTCCCTATGCGT 
USA300_0690R TGTTGCGTAATTTCAGAAGCCA 
USA300_1801F CAGCTATTGCTACGGTTGAAGC 
USA300_1801R ACGTGCATAGCAGTTGGGAA 
USA300_0347F CCGTGCCATCGGTTCTACTT 
USA300_0347R GCAATGACAGGCGAAATGT 
USA300_0265F TGTTGCTAGAGAAGCTGGTGT 
USA300_0265R TAGCGAAGATTGCAGTGGCA 
USA300_0917F CGCTGATACTCCAGAAGAAGCAA 
USA300_0917R GCAATACCGAGCATCATAGCAC 
USA300_1089F AATGGTGCTGCATGGGGAAT 
USA300_1089R ACAACTGCAACATCGTCATCT 
USA300_1494F GCGATGTACAAACTAGCACTCA 
USA300_1494R ATTCGGATGCGATTCAGGCA 
USA300_1568F GGCATAGCTGGTGGATCTGG 
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USA300_1568R TTGAACGCCCACGCTCTTTA 
USA300_1180F TCTCATGTTTTGTTCATCCTCTCA 
USA300_1180R TGTAACACATCTTCTCTTCTGCAA 
USA300_0337F GCGGAAGTAAGACTGCCCTT 
USA300_0337R TGCCCATACCCATTTATTGTTCA 
USA300_0752F AGGAAAGAGAAAAGCTCAAACA 
USA300_0752R CCATTGATGCAGCCATACCG 
USA300_1182F AGGTGCTACTAGCGCATTGA 
USA300_1182R TCCATAACTTCAGACGCAGGT 
USA300_1092F AGGACTACCAATATCAGCAGCG 
USA300_1092R ACAAGCAAGGTTATCATTGCAACA 
USA300_0230F ACAAAGTGCCCAATCGAACA 
USA300_0230R TGCTGGCGTAGTTTTAGCAGT 
lspA-F 
GAATTCGTACGGGCCCGGGCTTACTTAA
CCTCCTTCTCC 
Amplification of each 
individual gene fragment 
with native promoter region 
from USA300 JE2 genome 
for Gibson assembly. 
lspA-R 
CCATGTAGGCCAAGTCAAATGAATAATT
AAGTTCATATTTAATGTCAAAA 
purB-F 
GTACGGGCCCGCGGCATCAGTATTAATC
TGCCATAGATAATTG 
purB-R 
ATCCGGCCATGTAGGCCAGATCTTATGCT
AATCCAGCGCG 
pfo-F 
TTCGTACGGGCCCGCGGCCTATACCATCT
CCTTTATTTCAG 
pfo-R 
CCATGTAGGCCAGATCAATTACGTAAGT
AAACATTCGAATTG 
clpP-F 1 
GTACGGGCCCGCGGCCTATATTTCCTCCT
TGTAATAACTG 
clpP-R 1 
ATCCGGCCATGTAGGCCAGATCTTATTTT
GTTTCAGGTACCATC 
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clpP-F 2 
GTACGGGCCCGCGGCTATATTTCCTCCTT
GTAATAACTGTTACTCATTATTTTACATA
TT 
clpP-R 2 
CGGGATCCGGCCATGTAGGCCAGATCTT
ATTTTGTTTCAGGTACCATCACTTCATCA
A 
lspA-F S TTAACCTCCTTCTCCTTTTTATTGGAAG Sequencing primers for 
confirmation of successful 
construction of integrated 
pGM073 plasmid 
lspA-R S GAGTTGTCTCATGGACGATTGATT 
purB-F S ATCAGTATTAATCTGCCATAGATAA 
purB-R S TTATGCTAATCCAGCGCGTTCGAA 
pfo-F S CTATACCATCTCCTTTATTTCAGTAGC 
pfo-R S CATTCGAATTGGACCCTATCGTC 
pGM074-F  GGTCATTCTCTAACGTACACGAGCGTC Amplify from each side of 
the insertion site of pGM074 
plasmid to verify successful 
complement plasmid 
construct. 
pGM074-R CTTTACACTTTATGCTTCCGGCTCGTA 
Table 2.6. Primers used in this study.  
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The Veriti Thermal Cycler (Applied Biosystems) was used to carry out PCR reactions. The 
lid was preheated to 105oC and the following thermal cycling setting was used:  
Initial denaturation 1 cycle 98oC  30 s 
Denaturation  30 cycles 98oC  15 s 
Annealing  48-60oC 15 s 
Extension  72oC  15-30 s/kb 
Final extension 1 cycle 72oC  7 min 
 
2.7.2.2 E. coli colony PCR  
For rapid screening of gene insertions in E. coli, DreamTaq Green Master Mix (Thermo 
Scientific) was used for PCR amplification. The reaction mix is prepared as below. A single 
colony was inoculated onto an agar plate with a sterile toothpick, and then mixed into the 
reaction mix.  
DreamTaq Green Master Mix (2x) 25 µL 
Forward primer (10 µM) 1 µL 
Reverse primer (10 µM) 1 µL 
sdH2O  23 µL 
 
The reaction was conducted in Veriti Thermal Cycler with pre-heated lid at 105oC followed 
by the reaction program as below: 
Initial denaturation 1 cycle 94oC  1 min 
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Denaturation  30 cycles 94oC  30 s 
Annealing  48-60oC 30 s 
Extension  72oC  2 min 
Final extension 1 cycle 72oC  7 min 
2.7.3 Restriction endonuclease digestion  
Restriction enzymes used in this study were purchased from New England Biolabs or 
Promega. The digestion was carried out with supplied buffer according to the 
manufacturer’s protocols. The reaction was performed at 37oC for 1-3 hr. Targeting DNA 
fragments were further purified (section 2.6.4) if needed for DNA cloning.  
2.7.4 Gibson assembly  
The DNA vector was restriction endonuclease digested (section 2.7.3) and purified (section 
2.6.4). Gene inserts were PCR amplified (section 2.7.2.1) and purified (section 2.6.3 and 
2.6.4). The Gibson assembly was completed in a final volume of 20 µL: 
Vector DNA 50 ng 
Gene insert 150-250 ng 
Gibson Assembly Master mix (2x) 10 µL 
sdH2O  To 20 µL 
 
The assembly mix was incubated at 50oC for 2 hr followed by transformation into competent 
E. coli cells.   
2.7.5 Agarose gel electrophoresis  
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Separation of DNA samples were performed in 1% (w/v) agarose gels stained with 10-15 
µL ethidium bromide (Fisher Scientific) in a horizontal electrophoresis gel tank (Life 
Technologies, Scie-Plas). In 1x TAE buffer, DNA samples were loaded after mixing with 
5x DNA loading dye (Thermo Scientific). In a neighbouring well to the sample, 10 µL of 
Gene Ruler 1kb DNA ladder (Fermentas) was loaded for assessing DNA fragment sizes. 
The size of DNA ladder fragments are showed in Table 2.7. Gels were run at 120 V for 45-
60 min at RT. Then the DNA was visualized at 260 nm and imaged using a UVi Tec Digital 
camera and UVi Doc Gel documentation system.  
2.7.6 DNA sequencing  
PCR amplified DNA products and plasmids were sequenced by GATC Biotech. Results 
were analysed by SnapGene v 3.0.3 or Geneious v 6.0.  
2.7.7 DNA concentration measurement   
A NanoDrop 3300 fluorospectrometer was used to detect DNA concentration with operating 
software v.2.8.0. A corresponding blank measurement of either 1 µL of sdH2O or elution 
buffer was used to compare to 1 µL of each DNA sample loaded to determine concentration 
at 260 nm.  
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Marker DNA fragment size (bp) 
Fermentas Gene 
Ruler 1 kb DNA 
ladder 
10000 
8000 
6000 
5000 
4000 
3500 
3000 
2500 
2000 
1500 
1000 
750 
500 
250 
Table 2.7 DNA fragments of ladder used as size markers for gel electrophoresis in this study. 
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2.8 Transduction techniques  
2.8.1 Phage lysate  
A single colony of S. aureus donor strain was inoculated in 5 mL of BHI media overnight 
at 37oC followed by a sub-culture. Phage lysate was made by mixing 5 mL of phage buffer, 
100 µL of Φ11 phage lysate and 50 µL of S. aureus culture. The lysate was incubated at 
25oC stationary for 8-24 hr. Once it had become clear, 50 µL of S. aureus culture was added 
and the lysate was incubated again. This was repeated until saturated S. aureus culture has 
cleared, following which the lysate was filter sterilized (0.2 µm pore size) and stored at 4oC.   
2.8.2 Phage transduction  
A single colony of S. aureus recipient strain was inoculated in 50 mL of LK media in a 
sterile 250 mL flask overnight at 37oC with shaking at 250 rpm. The culture was then 
centrifuged at 5,000 g for 10 min to harvest the cells. The pellet was resuspended in 3 mL 
of LK media. The transduction mixture was prepared by adding 500 µL of recipient culture, 
500 µL of phage lysate, 1 mL of fresh LK, and 10 µL of 1 M CaCl2 in a 25 mL Universal 
tube. The samples were incubated at 37oC stationary for 30 min, and incubated for another 
15 min with shaking at 250 rpm. 1 mL of pre-prepared ice cold 0.02 M sodium citrate was 
added to the samples immediately after the incubation. The mixture was incubated on ice 
for 5 min. Subsequently the cells were harvested at 5,000 g for 10 min in a centrifuge pre-
cooled to 4oC. The pellet was resuspended in 1 mL of ice cold 0.02 M sodium citrate 
followed by incubation on ice for 45-60 min. Aliquots of 200-300 µL were spread onto LK 
agar plates with 0.05% (w/v) sodium citrate and selective antibiotics. The plates were 
incubated at 37oC for 24-96 h. Colonies were spread onto BHI agar with selective antibiotics 
to confirm the existence of the correct resistance profile.  
2.9 Transformation techniques  
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2.9.1 Transformation of E. coli   
2.9.1.1 Transformation of chemically competent E. coli cells 
NEB5α chemically competent E. coli cells (New England Biolabs) were thawed on ice. For 
one 50 µL aliquot of competent cells, 4 µL of assembly reaction or 1 ng of plasmid DNA 
was added. The mixture was gently swirled and incubated on ice for 30 min. The cells were 
heat shocked at 42oC for 30-45 sec and removed to ice immediately for 2-5 min. 950 µL of 
pre-warmed SOC media (New England Biolabs) was added. The cells were incubated at 
37oC with shaking at 250 rpm for 1 hr.  100 µL aliquots were spread on LB agar with 
selective antibiotics. The plates were incubated at 37oC for 12-24 hr.   
2.9.1.2 Transformation of electrocompetent E. coli cells 
E. coli electrocompetent cells (Invitrogen) were defrosted on ice. For a 50 µL aliquot, 1 ng 
of plasmid DNA or 4 µL of assembly reaction was added and tube was gently swirled. The 
cells were transferred into a 1 mm electroporation cuvette (Bio-Rad). Electroporation was 
conducted at 1.75 kV, 25 µF and 200 Ω with a Bio-Rad GenePulser Xcell Electroporation 
system. The bacteria were covered immediately with 800 µL of pre-warmed SOC media 
(New England Biolabs) and removed to be incubated at 37oC with shaking at 250 rpm for 
1-2 hr.  100 µL aliquots were spread on LB agar with selective antibiotics. The plates were 
incubated at 37oC for 12-24 hr.    
2.9.2 Transformation of S. aureus     
2.9.2.1 Preparation of S. aureus electrocompetent cells 
S. aureus RN4220 (SH1332) was streaked on BHI agar and incubated overnight at 37oC. A 
single colony was inoculated into 400 mL of fresh BHI media and incubated at 37oC with 
shaking at 250 rpm for 10-12 hr. The cells were sub-cultured in 400 mL of BHI media with 
8 µg/mL of CM starting from OD600 of 0.1, incubated at 37oC with shaking at 250 rpm until 
they reach an OD600 of 0.4-0.6. The bacteria were harvested by centrifugation at 5,000 g for 
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10 min at room temperature (RT) in eight 50 mL aliquots. Cells were washed with 25 mL 
of sdH2O for 3 times and merged into one tube. The pellet was then washed once with 20 
ml of sterile 10% (v/v) glycerol and once, and resuspended in 10 mL of sterile 10% (v/v) 
glycerol. The bacteria were incubated at RT for 30 min before centrifugation at 5,000g for 
10 min. The pellet was resuspended in 1 mL of sterile 10% (v/v) glycerol. Cells were split 
into 50 µL aliquots and snap-frozen in liquid nitrogen and stored at -80oC.  
2.9.2.2 Transformation of electrocompetent S. aureus cells 
A 25 µL aliquot of electrocompetent S. aureus RN4220 cells (section 2.9.2.1) were 
defrosted on ice. 1 µg of plasmid DNA was added and the tube was gently swirled. The 
mixture was transferred to a 1 mm electroporation cuvette (Bio-Rad) and electroporated at 
2.3 kV, 25 µF and 100 Ω with a Bio-Rad GenePulser Xcell Electroporation system. 1 mL 
of pre-warmed SOC media (New England Biolabs) was added immediately to recover the 
cells. S. aureus were then transferred into a 15 mL centrifuge tube and incubated at 37oC 
with shaking at 250 rpm for 3 hr. 200-300 µL aliquots were spread on BHI agar with 
selective antibiotics. The plates were incubated at 37oC for 12-96 hr.    
2.10 Neutrophil cell culture  
2.10.1 Ethics   
Primary neutrophils were isolated from healthy human peripheral venous blood by Percoll 
gradient centrifugation. The donors had consented in accordance with a protocol approved 
by South Sheffield Research Ethics Committee (study number STH13927).  
2.10.2 Purification of neutrophils from peripheral blood 
Neutrophil isolation was carried out ex vivo by following an established Percoll gradient 
protocol which minimizes activation of neutrophils (Sabroe et al., 2005). The experiment 
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was performed in a sterile class II microbiological safety cabinet (Walker). All the media 
and solutions used were pre-warmed to 37oC. 
Venous blood was drawn and aliquoted into 50 mL centrifuge tubes containing 3.8% v/v 
sodium citrate (1mL sodium citrate per 9mL blood) (Martindale). Following centrifugation 
at 1,200 rpm for 20 min at RT, the platelet-rich plasma (PRP) was removed and centrifuged 
at 2,000 rpm for 20 min to obtain platelet-poor plasma (PPP). Six mL of 6% w/v dextran 
(Sigma) was added to the remaining blood and topped-up with 0.9% w/v saline to 50mL. 
After gentle mixing by rolling the sealed tubes, excess blood was removed from the lids and 
the tubes were left for 30 min (RT) to sediment erythrocytes. Following sedimentation, the 
upper white cell rich layer was centrifuged at 1,000 rpm for 6 min (RT). A leukocyte-rich 
population was obtained as a cell pellet. The cells were resuspended with 2mL of PPP and 
overlayed on to Percoll (Amersham Pharmacia Biotech) gradients prepared in 15mL 
centrifuge tubes consisting of 2mL of the 51% v/v Percoll/PPP lower phase (1.02mL of 
Percoll with 0.98mL of PPP) overlayed by 2mL of the 42% v/v Percoll/PPP upper phase 
(0.84mL of Percoll with 1.16mL of PPP). The gradients were centrifuged at 1,100 rpm for 
11 min without a deceleration brake. Three populations of cells were separated: above the 
upper Percoll layer was situated the PBMC layer, the neutrophils were located in between 
two Percoll layers (Figure 2.1), while the red cells were pelleted at the bottom of the tube. 
PBMC were firstly removed to 10mL of PPP. Neutrophils were aspirated from the 
intermediate phase to 10mL of PPP. Hank’s Balanced Salt Solution (HBSS) was added to 
neutrophils to make up 35mL, and cell counts were counted out using a hemocytometer. 
Neutrophils were further centrifuged at 1,500 rpm for 6 min (RT) and were resuspended in 
RPMI (+10% v/v fetal bovine serum (FBS)) at final concentration of 5x106/mL. 
2.10.3 Screening of NTML  
2.10.3.1 Preparation of S. aureus and S. aureus supernatant 
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USA300 wild type JE2, S. aureus strains identified from the screen, and S. aureus 
transductants and complements were prepared from beads stock. The strains were streaked 
out on BHI agar plates and incubated overnight at 37oC. A single colony was used to 
inoculate into 5 mL of BHI media and incubated overnight at 37oC with shaking at 250 rpm. 
The bacterial samples were diluted to OD600 of 0.05 in 10mL of BHI the following morning 
and cultured at 37oC with shaking at 250 rpm for 3 hr. The OD600 was measured (section 
2.4.1) and the CFU count was determined (section 2.4.2). The culture was split into 100 µL 
aliquots and stored at -20oC. Before use, the aliquots were thawed and centrifuged at 5,000 
g for 3 min. After transferring the supernatant for use, the cell pellet was resuspended in a 
corresponding volume of RPMI (+10% v/v FBS).  
For preparation of NTML bacteria, following Section 2.3.1, the NTML overnight culture 
was sub-cultured by adding 10 µL of library strains to 190 µL of fresh BHI media and 
incubated at 37oC for 3 hr before centrifugation at 5,000 g for 10 min to harvest the bacterial. 
The pellets were resuspended in 200 mL of RPMI (+10% v/v FBS) to maintain original 
density for use.  
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Figure 2.1 Isolation of primary human neutrophils using Percoll gradient centrifugation 
method.  
     
 
73 
 
2.10.3.2 Neutrophil culture/co-culture 
Neutrophil cultures were performed in a 96 well plate format. The Nunc 96-well 
Microplates (Thermo Scientific) were used to meet the requirements of the flow cytometer. 
50 µL of neutrophils at 5x106/mL (section 2.10.2) were added to each well together with 45 
µL of RPMI (+10% v/v FBS). Five µL of each S. aureus (section 2.10.3.1) strain was added 
to each well to achieve the desired multiplicity of infection (MOI). The plate was incubated 
in a tissue culture incubator (Sanyo) at 37oC with 5% v/v CO2. Cells were cultured in 
duplicate and were taken forward at target time points for cytospin analysis. Apart from 
NTML plates, an additional plate was included with controls in each experiment. A mixture 
of 50 µL of neutrophils at 5x106/mL and 50 µL of RPMI (+10% v/v FBS) was added to 
each of 3 wells as media controls. The 4th well consisted of 50 µL of neutrophils at 5x106/mL, 
45 µL of RPMI (+10% v/v FBS), and 5 µL of USA300 wild type JE2. The co-culture of 
neutrophils and S. aureus for the screen of NTML was performed at MOI of 10 and the 
plates were incubated for 3 hr (Figure 2.2). 
2.10.3.3 ToPro-3 staining  
ToPro-3 (Molecular Probes, Invitrogen) is a vital dye that only generates a fluorescent signal 
when entering cells lost membrane integrity, and intercalated with DNA. It is used for 
neutrophil cell lysis measurement. After 3 hr of neutrophil-NTML co-culture (section 
2.10.3.2), 100 µL of sterile PBS was added to the 1st media control (unstained); the 2nd media 
control sample was frozen at -80oC for 5 min, thawed and vortexed at highest speed, and 
strained with 100 µL of ToPro-3 (1:10,000 in sterile PBS) (positive control). 100 µL of 
ToPro-3 (1:10,000) was added to the 3rd media control (media control for baseline) and 
every well of neutrophil-S. aureus co-culture to make final volume of 200 µL. The ToPro-
3 staining was performed avoiding excessive exposure to light.  
2.10.4 Assessment of neutrophil viability  
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2.10.4.1 Morphological assessment  
A monolayer of neutrophil-S. aureus co-culture was generated by adding 100 µL cell 
suspension from each well and centrifuging onto glass slides at 300 rpm for 2 min in a 
neutrophil-monolayers-forming set chamber and a cytospin centrifuge (Sanyo). The cells 
were dried at RT and fixed by methanol. Red and blue Giemsa Wright dye (Diff Quick) was 
used to stain the bacteria and neutrophils. Subsequently a glass coverslip was fixed to the 
glass slide using DPX mount reagent (BDH) and dried overnight in a fume hood. The 
morphology of cells was assessed using light microscopy at 1,000x magnification under an 
oil immersion lens.  
Neutrophil cell lysis was assessed based on morphological features including lack of 
chromatin bridges, cell shrinkage, cell swelling, and nuclear condensation (Hamasaki et al., 
1998). In phagocytic index assays, duplicate slides of each sample were visually assessed, 
and the number of viable neutrophils with and without engulfed S. aureus, and engulfed S. 
aureus cells were counted from one slide. At least 300 neutrophils were counted per slide 
for phagocytic index quantification.  
2.10.4.2 Flow cytometric detection 
An Applied BioSystem Attune Acoustic Focusing Cytometer (Thermo Scientific) was used 
to assess neutrophil viability. The plates containing neutrophil media controls and co-culture 
samples were run through the Attune plate reader system at a speed of 500µL/min and 
stopped once 70µL of each sample has been aspirated. Neutrophils were recorded at a 
forward scatter (FSC) of 1600, side scatter (SSC) of 2700, and RL1 channel of 1250 for 
ToPro-3.  
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Figure 2.2. Working flow chart of the main procedures involved in the screen of NTML. 
Neutrophils isolated from healthy human blood by Percoll gradient centrifugation were 
incubated with each S. aureus mutant produced from an overnight culture and 3 hr sub-
culture in BHI at MOI of 10, in a 96 well plate format.  ToPro-3 (1:10,000) was used to 
stain the cells for cell death measurement. The assay result as identified by viable neutrophil 
cell count and ToPro-3 negativity was measured by Attune flow cytometry. The data was 
further analysed by FlowJo software.   
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2.10.4.3 Quantification of absolute viable neutrophil numbers and ToPro-3 intensity   
The recorded flow cytometric data was analysed by FlowJoTM cytometry analysis software 
(TreeStar). The FSC/SSC dot plot of PBS stained media control was used to verify the 
viability of neutrophils in each experiment. The area where viable neutrophils locate was 
gated to generate an automatic viable neutrophil cell count. The gate was applied to the 
whole group to count absolute viable neutrophils of each sample.  
The Cell count/RL1 histogram of PBS stained media control was used to set up the baseline 
of negative ToPro-3 intensity. The baseline was applied to all other samples and ToPro-3 
staining was verified by the positive intensity produced by the Freeze/thaw (F/T) media 
controls (section 2.10.3.3). The exported absolute viable neutrophil counts and ToPro-3 
intensity were further analysed using GraphPad Prism v. 6.0 (GraphPad). 
2.10.5 Lysostaphin pulse chase neutrophilic bacterial killing assay 
Lysostaphin pulse chase method was used in neutrophilic bacterial killing assay to quantify 
intracellular surviving bacterial without influences from extracellular activity. It relies on 
the principle that lysostaphin kills extracellular S. aureus rapidly, but not penetrating the 
neutrophils and therefore not affecting intracellular bacteria (Easmon et al., 1978). This 
assay was carried out to allow enumeration of surviving bacteria following an initial 
phagocytosis period.  
Neutrophils were infected at an MOI of 5 as described at section 2.10.3.2. Triplicates of 
each treatment was prepared for determining bacterial number at different time points. The 
time course for co-incubation was initial infection of 90 min, followed by 30 min with 
lysostaphin (20 µg/mL) (Sigma). After 30 min of incubation, one sample of each treatment 
was centrifuged at 2,000 rpm for 2 min. The pellets were resuspended with 200 µL of 1% 
saponin (w/v in PBS) (Sigma) and incubated at RT with regular pipetting and vortexing for 
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10 min. Following this the intracellular S. aureus load was determined by Miles and Misra 
method described in section 2.4.2. The intracellular bacterial number of a second sample of 
each treatment was measured again after 90 min of co-incubation. Meanwhile, lysostaphin 
was added to the 3rd group of samples at 90 min and incubated further for 30 min to kill 
extracellular S. aureus. The post lysostaphin neutrophils were lysed by saponin and plated 
out with same method.   
2.11 Fluorescent microscopy imaging  
To explore if mutant strains display different phagosome interactions comparing to WT, S. 
aureus and neutrophils were labelled with fluorescent markers for the phagocytic index 
assay.    The fluorescent staining and fixing of cells, and imaging was carried out at RT 
avoiding exposure to light. All buffers used for washing in staining procedures contain 1% 
BSA (w/v Sigma). 
2.11.1 Alexa Fluor 647 and pHrodo staining of S. aureus and pKH67 staining of 
neutrophils 
A total of 5x108 S. aureus (Section 2.10.3.1) were aliquoted and centrifuged at 5,000 g for 
3 min. The supernatant was removed and the pellet was resuspended in 200 µL of PBS (pH 
9). Then 5 µL of Alexa Fluor 647 (10mg/mL) (Thermo Scientific) and 0.2 µL of pHrodo 
(10mM) (Thermo Scientific) was added and vortexed. The mixture was incubated avoiding 
light at 37oC with shaking at 200 rpm for 30 min. The stained bacteria were washed with 
500 µL of PBS (pH 8) and centrifuged at 13,200 rpm for 3 min. The pellet was washed 
again with 500 µL of 25mM Tris (pH 8.5) and centrifuged at 13,200 rpm for 3 min. The 
sample was resuspended in PBS (pH 7.4) for use. 
The co-culture of stained S. aureus with neutrophils was performed with the same method 
as section 2.10.3.2 at MOI of 5. After the co-incubation, the samples were centrifuged at 
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400 g for 5 min. Supernatant was removed carefully and the pellet resuspended in 250 µL 
of Diluent C from the pKH67 kit (Sigma-Aldrich). Protected from light, 1 µL of pKH67 
(Signma-Aldrich), a green fluorescent dye used for neutrophil cell membrane labelling, was 
added and the mixture was incubated at RT for 5 min with regular mixing. 500 µL of heat 
inactivated FBS was added and incubated for 1 min at RT to stop the staining. The cells 
were harvested by centrifugation at 400 g for 10 min. The pellet was gently washed with 
500 µL of PBS (pH 7.2) three times and resuspended with 100 µL of PBS for fixing.  
2.11.2 Fixing and staining for fluorescence microscopy 
The stained S. aureus infected neutrophils (section 2.11.1) were centrifuged onto round 
coverslips (which were temporarily placed onto microscope slides) at 300 rpm for 2 min in 
a cytospin centrifuge (Sanyo). The slides were air-dried at RT and incubated with 50 µL 
paraformaldehyde (4% w/v) for 15 min. The slides were washed three times with 50 µL 
PBS for 5 min. The fixed cells were stained with 50 µL DAPI (1:10,000 in PBS) and 
incubated for 15 min. The slides were again washed three times with 50 µL of PBS for 5 
min. Fluoromount G-12 was used to fix the coverslip upside down onto a glass slide. The 
slides were dried in fume hood overnight and stored at -4oC.  
2.11.3 Olympus upright fluorescence microscope imaging   
The cells (Section 2.11.2) were visualised using an Olympus upright fluorescence 
microscope and fluorescence images were acquired using the imaging software. The 
wavelengths of the fluorophores and corresponding filters used are listed in Table 2.8. The 
exposure time, contrast and brightness was adjusted using the software settings before 
taking photos. 
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Fluorophores Excitation wavelength Emission wavelength Filter 
Alexa Fluor 647 633 Far-red Cy5 
pKH67  490 nm 502 nm FITC 
DAPI 358 nm 461 nm DAPI 
pHrodo 532 nm 585 nm TxRed 
Table 2.8 The excitation and emission wavelength and corresponding filters of fluorophores 
used in this study.  
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2.11.4 ImageJ analysis   
All fluorescent images (section 2.11.3) were analysed as type 8-bit using Fiji (ImageJ). 
Different channels were merged. Intact neutrophils were manually drawn around the cell 
area based on DAPI and pKH67 staining, and added to the software manager. A Bug-
counter program was used to count S. aureus numbers in each neutrophil.      
2.12 Zebrafish techniques 
2.12.1 Zebrafish strains  
London Wild Type (LWT) strains were used for all the fish experiments in this thesis. 
2.12.2 Ethics  
Zebrafish embryos under 120 hr post fertilization are not protected under the Animals 
(Scientific Procedures) Act 1986 and all experiments were carried out based on this premise.  
2.12.3 Zebrafish E3 medium (x10) 
The 10 x stock E3 is composed of chemicals below. A working stock (x1) was prepared by 
diluting in distilled water. A final concentration of 5x10-5% w/v methylene blue was added 
to prevent fungal growth (Nusslein-Volhard and Daham, 2002). Subsequently the 1 x E3 
medium was autoclaved for 20 min at 121oC and 15 psi.   
MgSO4 3.3 mM 
CaCl2 3.3 mM 
KCl 1.7 mM 
NaCl 50 mM 
 
2.12.4 Zebrafish anaesthesia  
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Zebrafish embryos were anaesthetised in 0.02% (w/v) tricaine for 8 min prior to bacterial 
injection. The stock solution of 0.4% (w/v) 3-amino bezoic acid ester tricaine (Sigma) was 
made in 20 mM tris-HCl (pH=7). The stock and working solution was kept in -20oC and -
4oC separately in dark.  
2.12.5 Methylcellulose    
Methylcellulose was prepared as 3.0% (w/v) in E3 medium. The solution was further 
aliquoted into 20mL syringes and kept in -20 oC. Each aliquot was thawed in 28.5 oC before 
use.  
2.12.6 Zebrafish embryo preparation  
LWT Zebrafish eggs were marbled from 4-5pm and collected at 10am the next day (Day 0). 
The eggs were transferred from the tank into a petri dish with aquarium water to prevent 
potential harm from chlorine. After visual examination using a dissecting microscope (Leica) 
to check the eggs had developed correctly (reaching the “High stage” in Figure 2.3), the 
eggs were selected and incubated in E3 medium at 28.5oC in petri dishes.  
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Figure 2.3. Zebrafish development and lifecycle. The embryos at high stage - high to oblong 
transition stage were picked on day 0 to obtain correct development for this study. The 
embryos were dechorionized before bacterial injection. Each treatment group contains 20-
30 embryos and the injection was performed on day 1. The needle injecting point is at the 
circulation valley highlighted by the arrow.  
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Prior to bacterial injection on Day 1, the chorion were removed to leave the embryo free. 
For survival studies of which around 35 embryos were injected per group, the 
dechorionation was performed manually. For determination of bacterial growth studies and 
morpholino oligonucleotide injection studies, of which approximately 120 embryos were 
injected per group, pronase dechorionation was used for higher efficiency. All zebrafish 
eggs were covered with pronase solution at a final concentration of 2mg/mL pronase in E3 
medium in a glass beaker for 20-25 min at RT. After visual confirmation of thinner chorion, 
the pronase solution was removed before washing off all the chorion with E3 medium.  
2.12.7 S. aureus preparation for zebrafish embryos injection 
All strains of S. aureus used for injecting into embryos were cultured overnight followed by 
a 3 hr sub-culture from OD600 of 0.05±0.01 in a 250mL flask of BHI medium. The bacterial 
culture was further aliquoted into 15mL centrifuge tubes and kept in -20oC for long-term 
storage. Each aliquot was thawed, centrifuged, and resuspended in an adjusted volume of 
PBS for the required dose.   
2.12.8 Microinjection of S. aureus in zebrafish embryos 
Microinjection needles were made by heating and pulling non-filament glass capillary tubes 
(Kwik-Fil). Then the prepared bacterial suspension was vortexed and loaded to the needle 
by using the 10µl microcapillary pipette tips (Fisher Scientific Ltd). After mounting the 
needle to the rig which connected with a pneumatic micropump (WPI, PV820 Pneumatic 
Picopump), a micromanipulator (WPI, Marzhauser etslar MM33 Rechts) and a gas tank 
(Boc Linda), the injected volume was calibrated using a graticule slide to approximately 
1nL.  
Immediately before injections, zebrafish embryos were immersed in 0.02% (w/v) tricaine 
solution for 8 min and removed onto 3.0% (w/v) methylcellulose. Bacteria was then injected 
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in the circulation valley of the embryo sideways from the top of the yolk (Figure 2.3). 
Afterwards, embryos were removed from the methylcellulose into E3 medium in Petri 
dishes and incubated in 28.5oC for 1 hr to dissolve the remaining methylcellulose. Following 
one wash with E3 medium, embryos were transferred to individual wells of 96 well plates 
with 100µL E3.  
To verify the amount of injected bacteria, both pre-injection and post-injection doses were 
quantified by diluting 4 injections in 1mL sterile PBS. Five 10µl drops were spotted onto 
BHI agar. After overnight incubation at 37oC, the number of CFU was calculated from the 
counts. 
2.12.9 Post injection determination of zebrafish embryo mortality 
Each S. aureus strain was injected into 20-30 embryos for survival studies. The mortality of 
zebrafish was carried out by visual assessment based on cessation of heartbeat and 
circulation. Standard time points are 20, 26, 44, 50, 68, 74, 92 hr after injection.   
2.12.10 Bacterial growth determination of S. aureus in zebrafish  
Five viable and all dead zebrafish embryos of each standard time point (showed in section 
2.6.9) were transferred along with 100µl E3 medium to ceramic bead-containing 0.5mL 
microtubes (Alphalabs,). Embryos were homogenised for 30 seconds (Precellys 24) and 
serially diluted in sterile PBS followed by full plating of 100µl onto BHI agar. CFU were 
calculated accordingly based on colony counts obtained after overnight incubation at 37oC. 
2.12.11 Microinjection of pu.1 morpholino modified antisense oligonucleotides in 
zebrafish embryos  
Pu.1 morpholino modified antisense oligonucleotides sequence is showed below (Gene 
Tools). The injection of morpholinos binds to complementary bases specifically and 
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prevents translation of the genes (Rhodes et al., 2005). The existence of morpholino 
oligonucleotides knocked down the translation start codon (ATG).  
Morpholino target Sequence 5’-3’ 
Pu. 1 GATATACTGATACTCCATTGGTGGT 
2.12.12 Microinjection of pu.1 morpholino oligonucleotides into zebrafish eggs  
A working solution at concentration of 1 mM of pu.1 morpholino was made from 2 mM 
stock solutions in distilled water. The oligonucleotides were injected into the yolk sac of 
embryos within 30 min after fertilisation (1 to 4 cells stage in Figure 2.3). The same method 
of microinjection was used as described in section 2.6.8.  
2.13 Statistical analysis   
All survival studies and pu.1 experiments were repeated for 3 times with around 30 injected 
zebrafish embryos per strain. The Kaplan-Meier method was applied for the survival curves. 
The log-rank (Mantel Cox) test was done to compare survival curves of different strains. 
Regarding the determination of bacterial growth in zebrafish experiments, 96 zebrafish 
embryos were injected per strain for N of 1. The replicates of data were not combined due 
to zebrafish batch variation. 
All statistical analysis was completed by GraphPad Prism Version 6.0. Representative data 
are shown from repeating experiments. The significant difference was labelled as: * p<0.05, 
** p<0.01, *** p<0.001, ns=non-significant.  
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Chapter 3 
Optimisation for the NTML Screen 
3.1 Introduction  
S. aureus has long been recognised as a highly adaptive and dangerous human pathogen. It 
has rapidly evolved antibiotic resistance mechanisms and has a multitude of pathogenesis 
factors that subvert the host innate immune system. Neutrophils and macrophages are 
crucial elements of our defence against S. aureus yet S. aureus renders neutrophils 
ineffective on many levels. S. aureus produces several exotoxins, most notably PVL, to 
cause rapid and profound neutrophil cell lysis. In order to identify novel S. aureus factors 
involved in neutrophil cell death, a genome-wide S. aureus screen in a human neutrophil 
cell death assay was carried out.  
The Nebraska Transposon Mutant Library (NTML) containing 1952 mutated S. aureus 
strains has been used in several studies of antimicrobial resistance and virulence gene 
function (Fey et al., 2013). The library was previously screened for increased susceptibility 
to antimicrobials including vancomycin, gentamicin, linezolid, ciprofloxacin, oxacillin, and 
daptomycin. Sixty-eight mutants were identified with roles in intrinsic antimicrobial 
resistance of S. aureus (Vestergaard et al., 2016, Johnston et al., 2016). In addition, the 
NTML was used to analyse the modulation of sigS expression (Burda et al., 2014). Finally, 
in a S. aureus- P. aeruginosa interaction study, the NTML revealed the importance of nine 
S. aureus genes in forming a thickened colony morphology at the cooperative S. aureus- P. 
aeruginosa interface (Frydenlund Michelsen et al., 2016). 
These studies demonstrate that an unbiased screening methodology is a powerful strategy 
to identify genes involved in bacterial function. Yet none of the previous NTML screens 
     
 
87 
 
involved the study of human immune responses to S. aureus. I have set out to establish a 
novel NTML screen in a human neutrophil cell death assay in order to identify genetic 
mutants which fail to induce neutrophil death. The specific aim of this chapter is to establish 
and optimise the screening protocol.  
The interaction of S. aureus and neutrophils can be assessed by flow cytometry, as a widely-
used laser-based technology which can be applied to the detection and characterization of 
different cell types in a heterogeneous population (Anwar et al., 2009). The analysis of 
individual cells is carried out simultaneously across multiple parameters. Measurements of 
cell size, granularity, and fluorescence intensity of ToPro-3 (for neutrophil cell death 
measurement) allow accurate assessment of neutrophil viability. The Attune flow cytometer 
comes with laser trimming technology which enables automatic counting of cells in each 
sample, thereby estimating cell loss. Another distinct advantage of the Attune for high-
throughput studies is the plate reader component with automatic washing and re-sets, 
allowing sample acquisition from a 96 well plate. Therefore, the Attune flow cytometer was 
selected for the high-throughput screen of NTML. 
Results  
3.2 Growth curve and CFU assessment of JE2  
The numbers of S. aureus required for the screen co-incubation was calculated based on 
three MOI (Table 3.1). The absolute neutrophil number per well was 2.5x105 based on using 
50µl of cell suspension at 5x106/ml in a final volume of 100µl.  
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Neutrophils/well MOI S. aureus Volume (µl) S. aureus CFU/ml 
5x106/ml x 50µl  
=2.5 x105 
2 50 1.0 x107 
5 50 2.5 x107 
10 50 5.0 x107 
Table 3.1. Neutrophils vs S. aureus screen parameters. The bacterial density of S. aureus 
required was calculated under screen design as 50 µl neutrophils added with 50 µl bacterial 
suspension per well. Neutrophils were cultured at an optimal density (5x106/ml) prior to co-
incubation. Therefore, the concentration of S. aureus required for screen at different MOI 
was calculated based on the equation below. MOI: multiplicity of infection; CFU: colony 
forming unit. 
CFU of S. aureus = (No. of neutrophils/well) x MOI / S. aureus Volume 
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Since the screen would need to be carried out in RPMI (+10% v/v FBS), because the first 
optimization experiment was to verify the growth of WT S. aureus in RPMI (+10% v/v 
FBS). Sub-culturing S. aureus in RPMI before incubating with neutrophils in the screen will 
allow the bacteria to become acclimatised to a ‘non-standard’ growth medium. BHI was 
used as control since it is a rich media for S. aureus growth.  
JE2 follows a typical growth curve and grows exponentially after 2 hrs in both BHI and 
RPMI (Figure 3.1). In RPMI, S. aureus enters stationary phase after 4 hr (Figure 3.1, B), 
compared with 6 hrs for BHI (Figure 3.1, A). The maximal density in RPMI (+10% v/v 
FBS) (OD600=0.554±0.03) is ten-fold lower than in BHI cultures (OD600=5.59±0.02). This 
therefore raised concerns that sub-culture in RPMI media prior to infection with neutrophils 
in the screen will not yield sufficient CFU/mL.    
To assess if S. aureus can grow to an appropriate density in 96 well plates, taking into 
consideration the NTML screen format, JE2 was cultured in 96 well plates as per the 
planned screen design: 3 hr incubation of a single colony in BHI followed by 1:20 culture 
in BHI or RPMI (+10% v/v FBS) for overnight incubation, followed by a 2 or 3-hr sub-
culture (1:20) in corresponding media (i.e. BHI to BHI & RPMI to RPMI).  
The average OD600 value of BHI culture was higher than that of RPMI (+10% v/v FBS) 
cultures at both 2 and 3 hr (Table 3.2), which is consistent with the CFU counts (BHI: 
5x108/mL compared to 5x107/mL for RPMI at 3hr). For infection of neutrophils at the 
highest MOI of 10, the CFU/mL required for original S. aureus inocula is 5.0 x107/ml (Table 
3.1). which equals the CFU yield at 3 hr of RPMI sub-culture (Table 3.2). Therefore, 
sufficient wild type S. aureus cells were produced from both BHI and RPMI (+10% v/v 
FBS) after 3 hrs sub-culture. 
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Figure 3.1 Growth curves of S. aureus JE2. Standard deviations are shown as error bars. 
(A). JE2 was grown in BHI media after an inoculation to an OD600 of 0.05 at 37oC in a 5mL 
culture. N=3 
(B). JE2 was grown in RPMI (10% v/v FBS) after an inoculation to an OD600 of 0.05 at 
37oC in a 5mL culture. N=3  
Notes: the standard deviation of some timepoints are too small to be visualized.  
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Media Sub-culture Average OD600 CFU/ml±SD 
BHI 
2hr 0.334±0.028 (4.5±1.5) x108 
3hr 0.401±0.032 (5.0±1.9) x108 
RPMI 
(+10% v/v FBS) 
2hr 0.165±0.018 (7.0±3.0) x106 
3hr 0.241±0.011 (5.0±1.6) x107 
Table 3.2. Growth and CFU of S. aureus JE2 in 96 well plate format.  
JE2 was sub-cultured (1:20 v/v) in either BHI or RPMI (+10% v/v FBS) after an overnight 
culture in 96 well plate format at 37oC in 200µL media. N=3 
SD: standard deviation   
     
 
92 
 
3.3 Growth curve of the NTML library  
In order to further develop the screen protocol, the growth conditions for the NTML library 
required optimisation. After validation of wild type S. aureus growth, a single NTML plate 
(plate 1B, containing 96 mutants), chosen at random, was cultured in combinations of RPMI 
(+10% v/v FBS) and BHI to ascertain the growth rates of the mutants. Under the conditions 
of the screen, combinations of media were used in order that S. aureus could be sub-cultured 
in RPMI (+10% v/v FBS) immediately prior to the neutrophil screen. This is important to 
know, since culturing S. aureus entirely in BHI and then transferring to neutrophil cultures 
in RPMI (+10% v/v FBS) may mean the bacteria undergo a period of shock and therefore 
turn off important genes involved in pathogenesis.    
Plate 1B was thawed on ice for 30min, sub-cultured to another plate and incubated overnight 
in either RPMI (+10% v/v FBS) or BHI and then sub-cultured for 1-5 hrs, in either RPMI 
(+10% v/v FBS) or BHI. Initial experiments showed a lack of growth in RPMI (+10% v/v 
FBS) under the conditions to be used for the screen (data not shown). For bacteria that were 
cultured overnight in BHI and sub-cultured in BHI, a consistent increase in OD600 was 
observed between 1 hr (0.075 ± 0.011) and 5 hr (0.461±0.050), which demonstrates regular 
S. aureus growth (Figure 3.2). Hence, to ensure productive growth of S. aureus, NTML 
strains will be incubated overnight in BHI media followed by a 3 hrs sub-culture in BHI for 
the screen. Although changing the culturing media from BHI to RPMI (+10% v/v FBS) is 
not the most ideal condition for NTML strains, sufficient bacterial growth was prioritised 
over S. aureus functionality.   
  
     
 
93 
 
 
Figure 3.2. Representative bacterial yields during growth of 96 NTML strains in plate 1B. 
Cultures were obtained by adding 10µL library strain to 190 µL BHI media followed by 
overnight incubation at 37oC. The growth yields of different time points were generated 
from a sub-culture in BHI media. OD600 of the 96 S. aureus mutants are showed in 
descending sequence. N=2 
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3.4 Confirmation of neutrophil viability in bacterial growth media  
During handling, it is possible that BHI media could be carried over from the S. aureus sub-
culture. It was therefore important to determine if BHI had any effects on neutrophil cell 
loss which would make interpretation of the screen difficult. Neutrophils were incubated 
with addition of BHI at 5%, 10%, 20% and 50% v/v for 4 hrs, and subjected to Attune flow 
cytometry (Figure 3.3 A). The forward scatter (FSC) and side scatter (SSC) of the dot plot 
distinguishes a mixture of cells based on their size and granularity, respectively. The FSC 
and SSC parameters and gating strategies applied in this study are well established for 
identification of viable human neutrophils (Nagelkerke et al., 2014, Brittan et al., 2012). 
Attune flow cytometry automatically counts numbers of cells without the need for reagents 
such as CountBright beads. Therefore, absolute cell number within the gating area was 
estimated. In comparison with RPMI (+10% v/v FBS), the addition of BHI media results in 
a similar percentage of healthy neutrophils for all BHI conditions (Figure 3.3 B).  
3.5 ToPro-3 staining of neutrophils 
ToPro-3 is a fluorescent vital nuclear dye which cannot penetrate the cell membrane unless 
there is significant damage (Mioulane et al., 2012). Importantly ToPro-3 distinguishes 
between cells that have died by apoptosis and necrosis since apoptotic cells have an intact 
plasma membrane (Hart et al., 2000). The basic principle of these experiments is to validate 
ToPro-3 staining as a robust and sensitive high-throughput assay for neutrophil cell death 
caused by S. aureus.  
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Figure 3.3. Effect of bacterial growth media on neutrophil cell loss.  
(A) Representative flow cytometric dot plot of 10% v/v BHI media treated neutrophils 
showing a gated region around intact and viable neutrophils based on their forward scatter 
(FSC) and side scatter (SSC) profile.    
(B) Neutrophils were incubated in RPMI (+10% v/v FBS) with 5%, 10%, 20%, and 50% 
v/v of BHI media in 96-well plates. Percentage of viable neutrophils over total cell 
population was determined by Attune flow cytometer detection and FlowJo data analysis. 
N=2     
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Unpublished work from a previous group member (Dr. Sadia Anwar) shows that JE2 
supernatant has potent killing activity towards neutrophils. Therefore, JE2 culture 
supernatant was used to optimise neutrophil lysis and cell loss. To do this, a single colony 
of JE2 was inoculated overnight in BHI media. The bacterial suspension was centrifuged to 
remove cells and the supernatant was filter sterilised, diluted 1:1 with sterile media and 
incubated with neutrophils for 1 hr. 
The Attune flow cytometer was used to detect neutrophil FSC and SSC profiles, cell number 
and ToPro-3 positivity. ToPro-3 is a fluorescent vital dye that enters cells that have 
undergone a necrotic/lytic cell death . Negative and positive internal staining controls were 
included: neutrophils without ToPro-3 in order to set the background threshold of 
fluorescent intensity (Figure 3.4 A) and as a positive staining control, neutrophils were 
frozen at -80oC for 10 min and thawed (Figure 3.4 B). By so doing, the plasma membrane 
of the neutrophil is directly damaged, which allows ToPro-3 to penetrate and bind with 
nuclear DNA (McGann et al., 1988).  
Neutrophils incubated with media (media control, Figure 3.4 C) along with the PBS control 
sample (Figure 3.4 A) generates FSC/SSC and ToPro-3 profiles depicting typically healthy 
cells. A damaged cell debris profile (low FSC/low SSC, 81.6% ToPro-3 positive) was 
generated following F/T treatment (Figure 3.4 B). JE2 supernatant treated samples produced 
a higher level of ToPro-3 positivity (42.1%) compared with the media control (1.04%), and 
the FSC/SSC profile displaying increased density of debris and fewer neutrophils in the 
viable FSC/SSC region, indicating cell lysis (Figure 3.4 D).  
To further confirm the robustness of the Attune flow cytometry ToPro-3 assay, the same 
samples were run through both Attune and FACSCalibur flow cytometers. The 
FACSCalibur is one of the most well established and commonly used flow cytometers and 
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a good validation of the sensitivity of the Attune. The FSC/SSC profiles generated by the 
two flow cytometers displayed a very similar population for each sample (Figure 3.5). The 
healthy neutrophil population in the PBS staining control was detected by both 
FACSCalibur (Figure 3.5 A) and Attune (Figure 3.5 I). The F/T samples displayed dead 
cells in both flow cytometric FSC/SSC profiles (Figure 3.5 C&K). JE2 supernatant treated 
samples showed neutrophil activation (shift towards higher FSC) and loss of live cells 
(lower density of viable population) (Figure 3.5 E, G, M & O). The ToPro-3 fluorescence 
detected by both flow cytometers correlates with the FSC/SSC profiles in that the more cell 
loss showed in dot plots, the higher ToPro-3 signal was measured. The ToPro-3 positivity 
of the F/T and both JE2 supernatant treatments from FACSCalibur were 76.7%, 38.8% and 
50.2% respectively (Figure 3.5 D, F & H) which was comparatively higher than the intensity 
detected by Attune (58.1%, 25.4% and 32.7%, Figure 3.5 L, N & P). The reason for this is 
likely to be because the FACSCalibur was set to a lower fluorescence threshold (FL4: 410) 
than the Attune (RL1: 1250), resulting in increased reading (2.33% of PBS control, Figure 
3.5 B). Overall, a highly consistent pattern of the corresponding samples was found 
comparing the two flow profiles.    
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Figure 3.4. Validation of ToPro-3 staining for neutrophil cell death. Representative Attune 
flow cytometry profiles showing cell size and granularity (dot plots) and ToPro-3 
fluorescent intensity (histograms) of (A) PBS stained neutrophil media control, (B) ToPro-
3 (1:10,000 in PBS) stained neutrophils freeze-thaw (F/T) condition, and (C) ToPro-3 
stained media control. (D) One hr of 50% v/v S. aureus supernatant treatment resulted in 
rapid and massive viable cell loss in FSC/SSC, and increased ToPro-3 positivity. Numbers 
in histograms refer to the percentage of ToPro-3 positive population.    
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Figure 3.5. Validation of flow cytometric detection by Attune. Flow cytometry profiles 
generated by (A-H) FACSCalibur flow cytometer and (I-P) Attune flow cytometer. 
Numbers shown in histograms are percentage of ToPro-3 positive population. N=1 
(A-B & I-J) PBS stained neutrophil media control. (C-D & K-L) ToPro-3 (1:10,000 in PBS) 
stained neutrophils that have been freeze-thawed (F/T). (E-F & M-N) Neutrophils incubated 
with 5% of JE2 supernatant for 1 hr. (G-H & O-P) Neutrophils incubated with 50% of JE2 
supernatant for 1 hr. 
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3.6 Quantification of neutrophil cell death  
S. aureus supernatant was used to quantify the absolute viable neutrophil cell count in the 
flow cytometrical assay. Neutrophils were treated with media or JE2 supernatant at 5% and 
50% v/v for 3 hr after which they were stained with ToPro-3 for measurement of cell counts 
and fluorescence positivity by Attune flow cytometry (Figure 3.6). As expected, the ToPro-
3 staining controls suggest robust staining results: 96.6% positivity for the F/T sample, and 
only 1.56% positivity for the media control. The dot plots of samples treated with 5% and 
50% v/v S. aureus supernatant displayed obvious cell loss compared with the media control 
as illustrated by lack of viable neutrophil population (as shown by the gated region), while 
the histograms showed a higher level of ToPro-3 positivity generated by JE2 supernatant 
treatment (42.1% and 48.6%) compared to the media control (1.56%) (Figure 3.6A). The 
absolute viable neutrophil counts showed consistent results with the flow FSC/SSC profiles, 
neutrophil cell lysis caused by JE2 supernatant was revealed by determining cell counts 
(Figure 3.6 B). After a 3 hr incubation, the media control has approximately 10x104 viable 
neutrophils. Treatment with 5% and 50% v/v staphylococcal supernatant reduced the 
number to 4x104and 3.5x103, respectively. 
Hence, the broad parameters for neutrophil cell death assay was established for NTML 
screening. The virulence of S. aureus towards neutrophil cell lysis can be analysed by 
assessing viable cell counts and ToPro-3 positivity. Meanwhile, in order to rule out potential 
impact of S. aureus excreted toxins, as the screen is aimed for post phagocytosis death of 
neutrophils, the supernatant of NTML strains would be removed before infecting 
neutrophils.     
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Figure 3.6. Quantification of neutrophil cell death assay by ToPro-3 staining and Attune 
flow cytometric detection. Representative result of neutrophils treated with JE2 supernatant 
at 5% and 50% v/v for 3 hr. Viable neutrophil numbers and ToPro-3 positive intensities 
were assessed using Attune flow cytometry. (A) Attune flow cytometric results of FSC/SSC 
files and ToPro-3 histograms (numbers refer to ToPro-3 positive percentage). (B) 
Quantification of neutrophil cell death assay established with healthy neutrophil cell counts 
and ToPro-3 intensity. Viable cell counts were generated by gating strategy shown in A.     
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3.7 Determination of effective MOI for NTML screen 
It was necessary to optimise the S. aureus MOI to ensure sufficient neutrophil cell lysis 
caused by WT JE2, while allowing the opportunity to identify attenuated NTML strains. To 
find out the optimal MOI, co-culture with JE2 cells at an MOI of 1, 10 and 20 for 3 hrs was 
carried out. ToPro-3 staining was verified with positivity for PBS only (0%), F/T (33.2%) 
and media control (1.49%) (Figure 3.7A). Neutrophils treated at an MOI of 10 and 20 lost 
the majority of viable cells (Figure 3.7 B). The dot plots show a distinct healthy neutrophil 
population with JE2 at an MOI of 1. Consistently, in comparison with cells infected at MOI 
of 1 (2.14%), higher ToPro-3 positivity was associated with S. aureus treatment at MOI of 
10 (11.1%). The infection at an MOI of 20 resulted in a similar FSC/SSC profile and lower 
ToPro-3 intensity (8.71%) compared to MOI of 10 (11.1%), suggesting saturated cell death 
with an MOI higher of 10. This experiment was repeated 3 times and results were highly 
consistent (Figure 3.7 C&D). The MOI of 10 was therefore selected for screen use.   
Apart from revealing the optimal MOI, it was important to verify phagocytosis of the 
bacteria since the screen is designed to identify pathogenic factors mediating post-
phagocytosis neutrophil death. Monolayer cytospins of neutrophils cultured with alive JE2 
at MOI of 10 for 1 hr were prepared and S. aureus were clearly visible inside neutrophils, 
validating phagocytosis during the co-incubation (Figure 3.8). A population of neutrophils 
engulfed multiple S. aureus while the remaining did not ingest any. Infected neutrophils 
appeared vacuolated and bacteria were visible within these vacuoles. No morphological 
changes associated with cell death were observed, indicating longer time required for 
staphylococcal neutrophil cell lysis at an MOI of 10.  
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Figure 3.7 Determination of optimal MOI for the NTML screen. Attune Flow cytometry 
profiles of neutrophils treated with exponential growth phase JE2 at MOI of 1, 10, and 20 
for 3 hr. Results from 3 independent experiments (1st:A-B, 2nd: C, 3rd: D) are shown. PBS: 
unstained neutrophil media control. F/T: ToPro-3 (1:10,000 in PBS) stained neutrophils 
after freeze-thawed (F/T) condition. Media control: ToPro-3 stained neutrophils in RPMI 
(+10% v/v) media.  
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Figure 3.8 Visual validation of neutrophil uptake of S. aureus. Qualitative imaging showing 
neutrophils infected by JE2 at an MOI of 10 for 1 hr. The lines are intrinsic within the light 
microscopy setup. Samples were stained with red and blue Giemsa Wright dye (Diff Quik). 
Intracellular S. aureus were observed in a number of neutrophils, verifying the occurrence 
of phagocytosis during NTML screening. Four independent fields, each showing S. aureus 
as small purple dots within vacuolated neutrophils (green arrows).   
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3.8 Verification of S. aureus-neutrophil co-incubation time  
To verify optimal S. aureus-neutrophil co-incubation time for the NTML screen, JE2 
treatment at an MOI of 10 was carried out for 1, 1.5, 2, 2.5, and 3 hr. The assay was repeated 
twice with duplicates and representative profiles are showed in Figure 3.9.  
After 1 hr of JE2 infection, 45.3% of events were healthy neutrophils. The percentage of 
viable neutrophils reduced with time to 35.3% and 36.6% at 1.5 and 2 hr respectively. 
Correspondingly, the increasing ToPro-3 positivity indicates more neutrophil cell death 
(5.85%, 10.4% and 11.4% at 1, 1.5 and 2 hr respectively). At 2.5 hrs of co-incubation, the 
viable neutrophil population can no longer be observed from the FSC/SSC profiles. With 
17.6% viable cells and 14.8% of ToPro-3 positivity, it is demonstrated that JE2 requires at 
least 2.5 hr to cause massive neutrophil cell loss. After 3 hrs of co-incubation, only 15.8% 
of cells stayed viable. The slight reduction in the percentage of ToPro-3 positive events 
(13.8%) reflects cell lysis and loss of nuclear material. The results validated the optimal 
time length for S. aureus-neutrophils co-incubation as 3 hrs for thorough cell lysis caused 
by JE2.        
3.9 Testing response of neutrophils from different donors 
Considering the amount of time required to set-up and run each NTML plate, the screen was 
designed to assay 2 NTML plates per day over 5 days (not necessarily consecutive). This 
requires neutrophils from at least 10 donors to complete a total of 20 plates. It is therefore 
necessary to rule out potential variation in S. aureus mediated neutrophil cell death between 
individual donors.  
An MOI response experiment was performed at MOI of 1, 10, 20, and 100 with cells from 
2 different donors. As Figure 3.10 shows, neutrophils from both individuals responded to 
JE2 treatment in a similar way. Compared to infection at an MOI of 1, decreased viable 
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neutrophil cell density was shown in the FSC/SSC files at an MOI of 10 (Figure 3.10 A). 
Although the difference between absolute viable cell counts was less obvious (Figure 3.10 
B), the infection at an MOI of 20 and 100 led to loss of live neutrophil population in 
FSC/SSC files (Figure 3.10 A). Consistently, the ToPro-3 positivity of samples at an MOI 
of 10 (11.1% and 16.7%) were higher than samples at an MOI of 1 (2.14% and 3.99%), 
suggesting increasing neutrophil cell death (Figure 3.10 A). The ToPro-3 positivity of 
samples at MOI of 20 (8.71-13.2%) or more (11-11.3%) were at similar level, illustrating 
saturation of infection at MOI higher than 20. Overall, the pattern of responses was highly 
similar between donors at different MOIs. The only variation revealed by this experiment 
that might have an effect on screen results analysis is the different starting cell counts. The 
media control of donor B (approx. 1.2x105) had 32.6% fewer cells compared with donor A 
(approx. 1.6x105) (Figure 3.10 B). This is probably due to the inevitable difference in the 
neutrophil isolation preparation rather than donor variation. Considering the ultimate 
control for screen is the neutrophil cell death caused by WT S. aureus, reliability of the 
screen would not be compromised by variation of neutrophil number within an acceptable 
range. To minimize the potential effect of this, the screen of NTML was to be conducted 
with ToPro-3 staining and JE2 control every day. Data of each plate would be analysed 
separately with corresponding controls.        
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Figure 3.9. Determination of co-incubation time for the NTML screen. N=3 
Representative flow cytometry profiles of neutrophils infected by exponential growth phase 
JE2 at an MOI of 10 for 1, 1.5, 2, 2.5, and 3 hr. The response towards S. aureus treatment 
started to display distinct changes in neutrophil population (FSC/SSC) by 2.5 hours co-
incubation. The central gate in FSC/SSC files was used for quantification of viable 
neutrophils. The outer gate excluding cell debris and was applied for ToPro-3 measurement.  
PBS: unstained neutrophil media control. F/T: ToPro-3 (1:10,000 in PBS) stained 
neutrophils at frozen-thawed (F/T) condition. Media control: ToPro-3 stained neutrophils in 
RPMI (+10% FBS) media. Numbers in histograms are percentage of ToPro-3 positive 
population.  
PBS                  F/T Control           Media Control
JE2        1 hr 1.5 hr 2 hr 2.5 hr 3 hr
0                                         39.0                               0.59
5.85                            10.4                                     11.4                                       14.8                                 13.0
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Figure 3.10 Verification of responses of neutrophils from different donors.  
(A) Attune flow cytometry profiles of 3 hr co-incubation results generated by neutrophils 
from two donors at an MOI of 1, 10, 20 and 100. (B) The viable neutrophil counts and 
ToPro-3 positivity of each sample. N=1.   
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3.10 Discussion 
The main aim of this chapter was to identify the optimal experimental conditions for a 
genome wide S. aureus screen in a flow cytometric neutrophil cell death assay. The research 
has shown that BHI is the preferred bacterial growth media, generating consistently high 
CFU/mL and ideal growth curve trends. It is also demonstrated that the WT strain, JE2 
caused neutrophil cell death as determined by ToPro-3 positivity and cell counts. The 
optimal concentration and co-incubation time of S. aureus treatment on neutrophils was 
determined to be MOI of 10 and 3 hr. Any potential differences in neutrophil responses to 
S. aureus treatment appear independent of donor variation. The design of screen was now 
fully optimized and could be carried out.  
3.10.1 Optimisation of S. aureus growth 
In order to carry out the screen, it is important to standardize the conditions for the 
interaction. The expression of a number of S. aureus virulence factors are growth phase 
regulated (Casadevall and Pirofski, 1999). Virulence factors can be broadly categorized into 
those affecting attachment (exponential phase), immune evasion (both exponential and 
stationary phase), and tissue penetration (stationary phase) (Novick, 2003a, Novick, 2003b). 
Several studies revealed upregulated endotoxins and exotoxins expression at post-
exponential phase of S. aureus growth (Cheung et al., 2004, Shaw et al., 2005). The actively 
expressed genes include lukS/F, hlgA and psm, which are well-established inducers of 
neutrophil lysis (Oogai et al., 2011). Nevertheless, prior to the secreted toxins having an 
effect, the virulence factors involving in regulation of S. aureus-neutrophil interactions 
greatly influence the outcomes for both bacteria and host cell (Greenlee-Wacker et al., 2015) 
For instance, clumping factor A (ClfA) is a staphylococcal surface protein with fibrinogen-
binding activity. The expression of its corresponding gene, clfA, is highly activated during 
exponential phase of growth (Novick, 2003b). ClfA is a virulence factor leading to sepsis 
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and arthritis (Josefsson et al., 2001). During the bacteremia phase of infection, ClfA 
enhances S. aureus virulence by coating the microbial with fibrinogen, and therefore 
shielding it from phagocytosis (Foster, 2005). This protective role of ClfA, was observed as 
inhibiting phagocytosis from both murine macrophages and human neutrophils (Josefsson 
et al., 2001). Another key virulence factor regulator of S. aureus, sae, is most active during 
the exponential phase of growth (Benson et al., 2012, Bronner et al., 2004). A key role for 
saeR in regulation of purine synthesis and amino acid metabolism in mid-log phase (Voyich 
et al., 2009). Mutation of the saeRS system attenuated S. aureus virulence in a murine sepsis 
infection study (Voyich et al., 2009). Hence, in order to maximise expression level of S. 
aureus virulence factors related to the modulation of immune responses, and to reduce effect 
of secreted toxins, the screen of NTML would be carried out with S. aureus in exponential 
phase of growth.  
3.10.2 Optimisation for Attune flow cytometry detection method 
For neutrophil assessment, ToPro-3 is a widely used vital dye (Mioulane et al., 2012) and I 
have shown it is suitable for use in this assay. It was important to evaluate the use of ToPro-
3 using the 96 well plate format, since vital dyes such as this, can leach into intact cells over 
time. The staining method was validated by ToPro-3 staining controls so all screen 
experiments would be carried out with unstained (PBS), F/T, and media control samples 
(Figure 3.4). The accuracy of the Attune measurement of ToPro-3 positivity was further 
validated by using the FACSCalibur as a comparator.  
The flow cytometry assay was based upon a previous study from our group (Anwar thesis, 
2014). Quantitative data analysis revealed that S. aureus causes reduction of neutrophil cell 
counts together with increased ToPro-3 positivity (Figure 3.6), which is consistent with 
previous results obtained from S. aureus treatment of eosinophils (Prince et al., 2012). It is 
important to analyse the absolute neutrophil cell numbers and ToPro-3 positivity in parallel 
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since low viable cell numbers may falsely lead to low ToPro-3 positivity simply because 
there are few nucleated intact cells remaining. For example, each of the cell debris fragments 
is counted by Attune flow cytometer as one cell event, which leads to a high absolute cell 
count, even though cell death has occurred.  
An MOI of 10 was found to be the most reliable MOI in terms of causing a consistent 
amount of neutrophil lysis. The highly similar response of neutrophils from different donors 
to JE2 treatment suggests there was no influential effect generated by donor variation. 
However, the variation of overall neutrophil cell counts indicate that the number of 
neutrophils obtained from prep each time was different. Consequently, an additional 
neutrophil sample incubated with JE2 should be added to each experiment for comparison. 
To confirm the neutrophil death pattern, cytospins of 1 hr JE2 treated neutrophils at an MOI 
of 10 was prepared and shows significant phagocytosis of S. aureus. This is consistent to 
previous findings showing neutrophil necrosis following phagocytosis of S. aureus (Anwar, 
2004, PhD thesis; (Flannagan et al., 2016). The phagocytosis of S. aureus confirms bacterial 
uptake by neutrophils, which generates confidence in conducting the screen to investigate 
pathogenic factors that may affect S. aureus virulence following phagocytosis.  
Multiple methods were applied for flow cytometric data analysis during the optimisation. 
In early experiments the entire cell population of each sample was used for ToPro-3 
measurement (e.g. Figure 3.4). Subsequently, the absolute viable neutrophil number was 
generated automatically from gating of the viable population (e.g. Figure 3.9). To further 
improve the accuracy of ToPro-3 staining specifically on neutrophil lysis, damaged cell 
debris (low FSC/low SSC) was removed from the data set for ToPro-3 histogram analysis 
(e.g. Figure 3.9). This duel gating strategy will be used throughout the NTML screening and 
validation experiments for maximal accuracy.   
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3.10.3 Novelty of NTML screen for neutrophil related virulence factors  
Similar screening techniques have been widely used for identifying virulence factors of S. 
aureus. To discover essential genes for S. aureus survival in porcine blood, a transposon 
mutant library was made in ST398 background and screen in vitro. Twenty-four genes were 
identified (Christiansen et al., 2014). A selectively made sub-library of USA300 mutants 
containing 251 strains from NTML was screened for transcriptional regulators involved in 
staphylococcal leukocidin expression (Balasubramanian et al., 2016) Another 
staphylococcal toxin-focused study used CRISPR technology to perform a genome-wide 
loss-of-function screen. A number of myeloid cell membrane microdomains associated 
proteins were identified as necessary for S. aureus to attach and mediate α-hemolysin 
toxicity (Virreira Winter et al., 2016). 
Screening has also been successful for the identification of S. aureus virulence factors in 
vivo. Das et al generated a transposon mutation library consists of 25,000 S. aureus (6850 
background) mutants, which was screened in a mice infection model for underpinning genes 
involved in prolonged intracellular survival (Das et al., 2016). A gene encoding 
transcription factor repressor of surface protein named rsp was identified from the screen. 
Moreover, it exhibited a great positive influence on S. aureus survival in human neutrophils. 
Twenty-four genes have been identified with attenuated virulence in a murine model, by 
screening a collection of S. aureus insertion mutants (Benton et al., 2004). Including saeS, 
a histidine kinase sensor-response regulator gene, the identified mutants showed 
significantly less bacterial growth in the spleens and localised abscess infections than the 
WT.       
Instead of looking into key genetic factors involved in secreted toxin production, the screen 
of S. aureus mutants in a neutrophil death assay allows identification of virulence factors 
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that are associated with post-phagocytosis cell death, and possible mechanisms involved in 
S. aureus escape from phagosomes. In this study, NTML will be screened with human innate 
immune cells for the first time. Recently, the quick-developed flow cytometry technique 
provided a novel output for high-throughput experiments. The Attune flow cytometer was 
applied to develop a novel model of genome-wide screen. 
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CHAPTER 4 
Identification of S. aureus strains with altered neutrophil 
interaction 
4.1 Introduction 
Mutational analysis is a widely-applied method for exploring microbial components 
associated with environmental adaptation, including interactions with host cells. A common 
approach for generating mutations in genes of interest is through allelic replacement. By 
comparing to the wild type strain, phenotypic differences in the mutant correspond to roles 
of the gene product (Beasley et al., 2011, Bubeck Wardenburg et al., 2008, Palmqvist et al., 
2002). However, this well-established methodology is only appropriate for the study of 
candidate genes, since it would be arduous and time consuming to cover genome-wide 
mutagenesis.  
Transposon-mutagenesis strategies have been developed as a powerful tool for functional 
analysis of multiple essential and pathogenicity-related genes from a single screen. 
Transposons were first discovered by Barbara McCintock and refer to genetic elements that 
can change their location within a genome (McClintock, 1948).  Among the two major 
classes of transposons, Class II including mariner, are DNA transposons. Their typical 
structures consist of terminal inverted repeats flanking a transposase encoding gene and 
functional genes such as antibiotic resistance. The insertion and excision of Class II 
transposons are highly regulated by interaction of transposase with the inverted repeats. The 
transposon inserts in random loci in host DNA can cause mutations and influence gene 
expression (Hamer et al., 2001, Hayes, 2003). Unlike recombination-associated 
chromosomal DNA manipulation, transposon integration can take place without 
     
 
117 
 
homologous gene fragments, and therefore can be used for creating a full gene complement 
of a species (Choi and Kim, 2009).   
Transposon mutagenesis generally starts with its delivery into the background of interest 
via a plasmid. During bacterial growth, transposition events occur with mediation by 
transposase. Subsequently, the carriage plasmid is lost by growth on media without 
antibiotics at a temperature non-permissive for plasmid replication. Identification of 
insertion mutants with the phenotype of interests allows gene function to be acetated (Fey 
et al., 2013, Bae et al., 2008). By using transposon mutagenesis methodology, S. aureus 
genes involved in virulence factor regulation have been widely studied (Balasubramanian 
et al., 2016, Christiansen et al., 2014, Das et al., 2016, Shaw et al., 2005).  
A genome-wide S. aureus mutant library has been created at the University of Nebraska. 
The background strain is the CA-MRSA strain USA300 (JE2 background), which is a 
clinically relevant strain isolated from a soft tissue infection in the Los Angeles County Jail 
LAC (Fey et al., 2013). It has been characterised as a valuable resource for host-S. aureus 
interaction study. A Mariner based bursa aurealis transposon was used to generate the 
NTML.  Detailed procedures used to produce the library are showed in Figure 4.1. The 
NTML consists of 1,952 S. aureus mutants each with single transposon inserted in the 
coding sequence of a non-essential gene. Genomic DNA sequences of all mutants were 
aligned with S. aureus USA300 FPR3757 chromosomal DNA to identified transposon 
insertion sites. Upon the production of NTML, haemolysis, protease activity, and pigment 
formation were assessed and the library is available to all researchers for S. aureus studies 
(Fey et al., 2013). This chapter aimed to screen the NTML with primary human neutrophils 
in vitro to identify genes involved in S. aureus virulence. A neutrophil cell death model was 
applied for the screen.  
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Figure 4.1. Plasmids and procedures applied for producing NTML.  
(A) Map of transposase plasmid pFA545 with ampicillin resistance (bla) marker, 
tetracycline resistance cassettes (tetBD), mariner transposase (tnp), and temperature-
sensitive plasmid replicon (repCts) (Bae et al., 2008).  
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(B) Map of plasmid pBursa containing a mariner transposon, Bursa aurealis. The 
transposable element consists of mariner terminal inverted repeats (TIR), green fluorescent 
protein gene (gfp), replication origin (R6K), and erythromycin resistance gene (ermB). The 
plasmid possesses a temperature-sensitive plasmid replicon (repts) and chloramphenicol 
resistance gene (cat) (Bae et al., 2008).  
(C) Construction of the NTML. Tn: Transposon 
(1). The pFA545 and pBursa plasmids were transduced into JE2.  
(2). The transductants were incubated on solid media at 30oC for 48 hr for transposition to 
take place.  
(3). A single colony was suspended in 45oC water to inhibit replication of plasmids. 
Antibiotics were used to select positive transposon inserts and incubate bacteria at the non-
permissive temperature to remove plasmids. Bacteria that showed erythromycin resistance, 
but tetracycline and chloramphenicol susceptibility were selected.  
(4). Transposon insertion sites of the 18,797 strains were sequenced to identify the 
transposon insertion sites.  
(5). The sequences of transposon inserts were aligned with genomic DNA of USA300 
FPR3757 to identify the DNA flanking the transposon position.  
(6). By discarding strains with transposon inserted into intergenic fragments and last 10% 
of coding sequences, the remaining 1,952 strains were arrayed in 96 well plates as NTML. 
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4.2 First round of NTML screen  
Following optimisation experiments to establish the screen conditions (Chapter 3), the 1st 
round of screening was carried out using exponential phase NTML S. aureus mutants at an 
MOI of 10 for 3 hr at 37oC with 5% CO2. This was followed by high-throughput flow 
cytometric detection of viable neutrophil count and ToPro-3 positivity. Neutrophils from 9 
donors were used to complete the 1st round of screen (n=1).  
4.2.1 Identification of S. aureus mutants with attenuated neutrophil lysis by viable 
neutrophil count and ToPro-3 negativity 
The aim of the 1st round of screening was to identify mutants that were attenuated in their 
ability to cause neutrophil cell death. To do this, the viable neutrophil population was gated 
in dot plots based on FFC/SSC parameters as per Chapter 3. ToPro-3 positive and negative 
events were also counted. The absolute viable neutrophil number and percentage of ToPro-
3 negative events of each sample were quantified by FlowJoTM analysis (section 2.10.4.3). 
Figure 4.2 presents data for every mutant strain collected across 9 independent neutrophil 
experiments. Each panel represents an individual 96 well plate (1A-5D). Two plates were 
screened on the same day (e.g. 1A & 1B, 1C&1D etc) except for plate 5C and 5D.  For each 
treatment condition/mutant, the viable neutrophil count (left hand axis) and ToPro-3 
negativity (right hand axis) was plotted as a single line together with media control, JE2 
WT, and average of the plate (orange dotted line) (Figure 4.2). The average of each plate 
refers to the mean viable neutrophil cell number and mean ToPro-3 negative percentage of 
the 96 wells. The average value of the plate is considered as an important reference point 
since the majority of mutants will not be attenuated and therefore should theoretically be 
similar to WT.  
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Figure 4.2 Selection of S. aureus mutants from the NTML showing attenuated neutrophil 
cell lysis based on absolute viable neutrophil count and ToPro-3 negativity (%) result in the 
1st round of screen. Data shown in 20 96-well plates format with corresponding media 
control (green solid line), JE2 wild type treatment (red solid line) and mean value of each 
plate (orange dotted line). Each plate consists of 96 S. aureus mutants from the NTML. 
Neutrophils were incubated at 37oC for 3 hr with individual NTML mutant at MOI of 10, 
followed by staining withToPro-3 (1:10,000) and Attune flow cytometry detection. Viable 
neutrophil counts were generated by healthy cell gating. The majority of S. aureus mutants 
resulted in massive neutrophil cell loss. To identify the attenuated mutants, mean value plus 
two times of standard deviation of viable cell count was applied to distinguish potential ‘hits’ 
from the rest of strains. Identified strains are highlighted in blue boxes.  
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Each plate was analysed individually. Initial identification of attenuated mutants (ie. those 
that were less effective at inducing neutrophil lysis) was done by identifying mutants that 
resulted in a high number of viable neutrophils and a high percentage ToPro-3 positivity. 
These strains are highlighted by blue dotted boxes. This was initially done visually and later 
verified by showing the viable neutrophil count of each attenuated strain was >2 standard 
deviations from JE2. For instance, in plate 1C, the media control (green solid line) suggests 
the co-incubation started with approximately 38,000 viable neutrophils in each well. After 
3 hr incubation with JE2 WT, more than 25,000 neutrophils were lysed and ToPro-3 
negative population decreased to 85% (red solid line). The majority of S. aureus mutants 
resulted in less than 18,000 viable cells and 95% ToPro-3 negativity, indicating massive 
neutrophil cell loss. To identify the attenuated mutants, mean value (12,323) plus two times 
standard deviation (7,038) of viable cell count of plate 1C were applied (19,361) to 
distinguish potential ‘hits’ from the rest of the strains. Then the mutants with ToPro-3 
negativity that was lower than JE2 mean value was further ruled out, leaving 2 identified 
strains from this plate (Figure 4.2, 1C).  
Throughout the screen of 20 NTML plates, neutrophil media control showed viable cell 
counts of 30637±7183 and high ToPro-3 negativity (99.73%±0.17%). JE2 treatment 
consistently led to massive neutrophil cell loss (19778±7168) and low ToPro-3 negativity 
(84.45%±11.45%) (Figure 4.2), suggesting a robust screen model for neutrophil cell death 
in the assay. The average of 9 NTML plates displayed similar killing efficiency compared 
to JE2, and highly representative neutrophil cell death result of major mutants (1C, 2A, 2B, 
2D, 3B, 3D, 4B, 5B, 5D plates). Six plates showed comparatively more variation of viable 
cell count and ToPro-3 intensity among the 96 strains (1A, 3A, 4C, 5A, 5C plates). Typically, 
1-6 attenuated mutants were identified from each plate with the exception of 2C, 2D, 3A, 
and 4A plates which yielded none (Figure 4.2). In total, 42 S. aureus mutants were selected 
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as having an attenuated ability to lyse neutrophil in vitro based on viable neutrophil count 
and ToPro-3 negativity results.  
4.2.2 Identification of S. aureus mutants with attenuated neutrophil lysis by FSC/SSC 
profiling  
In addition to performing data analysis based on viable neutrophils and ToPro-3 negativity, 
flow cytometric dot plots were also used to identify attenuated S. aureus mutants. This is 
important, as it is a more discriminatory strategy since it allows to observe changes in the 
cellular shape and size as a result of cell lysis, which is not possible just by counting viable 
neutrophils. This extra level of analysis allows us to identify as many potential candidates 
as possible. Flow cytometric FSC/SSC profiling (dot plot) of all 1,920 NTML mutants were 
therefore visually assessed and arbitrarily ranked to select attenuated strains.      
The data file of NTML screen dot plots exceeded the space restriction of this thesis (Google 
Drive). As a representative of strains from plate 1A, the media control displays 81.4% of 
viable neutrophils, which appear within the viable neutrophil gate as a compact population, 
with a smaller sub-population with increased FSC and SSC (Figure 4.3 A). The JE2 treated 
sample is visibly different, with the cell dense area appearing outside the viable gate, in the 
lower left corner where the debris is typically found (Figure 4.3 B). A mutant in well E7 
resulted in 53.3% of viable neutrophils (Figure 4.3 C), which is much higher than JE2 
(12.6%). This strain was selected based on viable neutrophil and ToPro-3 analysis (Figure 
4.2), but also is clearly attenuated by looking at the FSC/SSC distribution. A mutant in well 
C6 led to similar cell loss (17.8%) compared to JE2, indicating full staphylococcal virulence 
of this strain (Figure 4.2 F). Strains in well A1(36.8%) and D7 (27.8%) showed a clear 
viable population suggesting attenuated immune cell lysis (Figure 4.3 D & E), yet were not 
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identified in Figure 4.2. Consequently, the S. aureus mutants corresponding to A1 and D7 
were added as attenuated candidates from the screen.  
The flow cytometric cell scatter plots of all NTML strains were assessed in this way and 
compared to JE2. A total of 113 S. aureus mutants with a clearly different FSC/SSC profile 
were selected. The mutants identified from both methods described above are listed in the 
following table, labelled by their corresponding well in NTML (Table 4.1). Among the 118 
strains, 37 were identified by both methods (common). Of the remaining 80, mutants were 
picked from either flow cytometric cell scatter assessment (76) or viable neutrophil and 
ToPro-3 data analysis (4). All 118 strains were listed in Table 4.2 and taken forward into 
the 2nd round of screening.  
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Figure 4.3 Flow cytometric cell scatter plots (FSC/SSC) of the media control (A), JE2 
treated neutrophils (B), and co-incubation results of 4 wells in plate 1A (C-F) from the 1st 
round of screen. Neutrophils were co-incubated with S. aureus strains for 3 hr at MOI of 10. 
The FSC and SSC indicates size and granularity of cells. Gated area refers to the viable 
neutrophil population (%).   
     
 
129 
 
Plate 
Viable Neutrophils 
and ToPro-3 
FSC/SSC Profiling  Common 
1A E7 G11 A1 B2 D7 D11 E1 E10 
F10 F11 D12 H1 
F12 F7 
1B   B12 F10 F11 G11 B11 
1C     G5 H5 
1D     E11 
2A   B6 D4 D5 D6 D7 G6 E6 
2B     E1 D6 
2C 
None 2D 
3A 
3B   B9 D6 E6 D12 
3C   B12 H4 
3D H5   F9 
4A None 
4B     H2 D12 F7 G2 
4C   
B4 C2 C11 D1 D8 D9 D10 E1 E2 E7 E9 
E10 F2 F7 F8 F9 G4 G8 
E8 D4 
4D   
A5 B8 B9 C7 C8 D5 D7 D8 D9 E7 F7 
F9 G7 G8 H8 
H7 H6 G9 C9 B7 
5A   B4 C10 D1 D6 D9 F2 E8 E9 G2 
5B   B10 G5 G7 E10 F10 F11 
5C C4 
B5 C5 F7 A3 A4 A5 B1 B10 C1 C7 D1 
E5 H12 
D5 C6 E12 
5D     F8 
Table 4.1. Combination of identified wells of each plate with S. aureus mutants generating 
attenuated neutrophil cell lysis result from the 1st round of screen. The strains are referred 
to their well and plate numbers in NTML library. The mutants selected by both methods are 
only listed under ‘common’ column. 
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Plate Well Strains Gene Description  
1A 
A1 USA300_1327 cell surface protein  
B2  AUSA300_2406 putative transporter  
D11 USA300_1393 
phiSLT ORF2067-like protein, phage tail tape measure 
protein  
D12  USA300_0210 maltose ABC transporter, permease protein  
D7 USA300_2242 urease accessory protein UreF  
E1 USA300_0217 DNA-binding response regulator, AraC family  
E10 USA300_2551 anaerobic ribonucleotide reductase, large subunit  
E7 USA300_0319 putative membrane protein  
F10 USA300_0648 ABC transporter, permease protein  
F11 USA300_0640 putative membrane protein  
F12 USA300_2504 acyltransferase  
F7 USA300_2573 immunodominant antigen B  
G11 USA300_1980 acetyltransferase, GNAT family  
H1 USA300_2149 6-phospho-beta-galactosidase  
1B 
B11 USA300_0181 non-ribosomal peptide synthetase  
B12  USA300_0341 putative membrane protein  
F10 USA300_0230 putative membrane protein  
F11 USA300_1939  
phi77 ORF015-like protein, putative protease / phage portal 
protein  
G11 USA300_2360 multidrug resistance protein  
1C 
G5 USA300_0720 
putative iron compound ABC transporter, ATP-binding 
protein  
H5 USA300_2452 transcriptional regulator, MarR family  
1D E11 USA300_0662 acetyltransferase, GNAT family  
2A 
B6 USA300_1140 cell wall hydrolase  
D4 USA300_2089 pyrimidine nucleoside phosphorylase  
D5 USA300_0265 putative ribose operon repressor  
D6 USA300_0347 Sec-independent protein translocase TatC  
D7 USA300_1801 fumarate hydratase, class II  
E6 USA300_0161 capsular polysaccharide biosynthesis protein Cap5J  
G6 USA300_0917 putative membrane protein  
2B 
D6 USA300_1889 adenylosuccinate lyase  
E1 USA300_0017 adenylosuccinate synthetase  
3B 
B9 USA300_1182 pyruvate ferredoxin oxidoreductase, alpha subunit  
D6 USA300_1732 putative transposase  
D12 USA300_0752 ATP-dependent Clp protease proteolytic subunit  
E6 USA300_1938 phi77 ORF006-like protein capsid protein  
3C 
B12 USA300_0667 hypothetical protein  
H4 USA300_1092 uracil permease  
3D F9 USA300_0064 arginine/oirnithine antiporter  
3D H5 USA300_1536 hypothetical protein  
4B D12 USA300_0690 sensor histidine kinase SaeS  
4B F7 USA300_0899 adaptor protein  
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4B G2 USA300_2042 hypothetical protein  
4B H2 USA300_1494 hypothetical protein  
4C 
B4 USA300_1255 oxacillin resistance-related FmtC protein  
C2 USA300_0728 conserved hypothetical protein  
C11 USA300_1596 S-adenosylmethionine:tRNA ribosyltransferase-isomerase  
D1 USA300_2541 malate:quinone-oxidoreductase  
D4 USA300_0957 hypothetical protein  
D8 USA300_0337 glycerol-3-phosphate transporter  
D9 USA300_1225 aspartate kinase  
D10 USA300_0709 5'(3')-deoxyribonucleotidase  
E1 USA300_2490 TetR family regulatory protein  
E2 USA300_0213 Gfo/Idh/MocA family oxidoreductase  
E7 USA300_2365 gamma-hemolysin component A  
E8 USA300_2389 putative drug transporter  
E9 USA300_1853 conserved hypothetical protein  
E10 USA300_0590 hypothetical protein  
F2 USA300_0409 conserved hypothetical protein  
F7 USA300_1244 large conductance mechanosensitive channel protein  
F8 USA300_0683 transcriptional regulator, DeoR family  
F9 USA300_1180 conserved hypothetical protein  
G4 USA300_1003 conserved hypothetical protein  
G8 USA300_2069 conserved hypothetical protein  
4D 
A5 USA300_1797 conserved hypothetical protein  
B6 USA300_1283 phosphate ABC transporter, phosphate-binding protein PstS  
B8 USA300_1843 
D-isomer specific 2-hydroxyacid dehydrogenase family 
protein  
B9 USA300_0385 conserved hypothetical protein  
C7 USA300_2300 transcriptional regulator, TetR family  
C8 USA300_2023 anti-sigma-B factor, serine-protein kinase  
C9 USA300_2048 hydroxyethylthiazole kinase  
D5 USA300_1687 FtsK/SpoIIIE family protein  
D7 USA300_1934 phi77 ORF020-like protein, phage major tail protein  
D8 USA300_1718 aresenical pump membrane protein  
D9 USA300_2083 acetyltransferase  
E7 USA300_2055 UDP-N-acetylglucosamine 1-carboxyvinyltransferase  
F7 USA300_1519 hypothetical protein  
F9 USA300_0630 ABC transporter ATP-binding protein  
G7 USA300_1563 acetyl-CoA carboxylase, biotin carboxylase  
G8 USA300_2030 hypothetical protein  
G9 USA300_2620 hypothetical protein  
H6 USA300_1368 L-asparaginase  
H7 USA300_0505 glutamine amidotransferase subunit PdxT  
H8 USA300_1992 accessory gene regulator protein A  
5A B4 USA300_0706 
putative osmoprotectant ABC transporter ATP-binding 
protein  
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C10 USA300_0431 hypothetical protein  
D1 USA300_0141 phosphopentomutase  
D6 USA300_0945 isochorismate synthase family protein  
D9 USA300_2350 hypothetical protein  
E8 USA300_2359 amino acid ABC transporter amino acid-binding protein  
E9 USA300_2482 hypothetical protein  
F2 USA300_2040 hypothetical protein  
G2 USA300_0996 dihydrolipoamide dehydrogenase  
5B 
B10 USA300_0657 hypothetical protein  
E10 USA300_2548 hypothetical protein  
F10 USA300_0244 zinc-binding dehydrogenase family oxidoreductase  
F11 USA300_0471 hypothetical protein  
G5 USA300_0566 amino acid permease  
G7 USA300_1051 hypothetical protein  
5C 
A3 USA300_2456 hypothetical protein  
A4 USA300_1274 peptide ABC transporter ATP-binding protein  
A5 USA300_0827 hypothetical protein  
B1 USA300_1356 3-dehydroquinate synthase  
B5 USA300_1926 phi77 ORF044-like protein  
B10 USA300_2043 hypothetical protein  
C1 USA300_0936 ABC transporter ATP-binding protein  
C4 USA300_0646 sensor histidine kinase  
C5 USA300_1089 lipoprotein signal peptidase  
C6 USA300_0994 pyruvate dehydrogenase E1 component, beta subunit  
C7 USA300_1097 orotidine 5'-phosphate decarboxylase  
D1 USA300_1187 hypothetical protein  
D5 USA300_0857 hypothetical protein  
D6 USA300_1139 succinyl-CoA synthetase subunit alpha  
E5 USA300_0334 MarR family transcriptional regulator  
E12 USA300_0982 hypothetical protein  
F7 USA300_0839 hypothetical protein  
H12 USA300_0035 hypothetical protein  
5D F8 USA300_1171 hypothetical protein  
Table 4.2. The 118 S. aureus mutants identified from the 1st round of screen of NTML. They 
were all taken forward for further study. The genetic background of the mutants was not 
decoded until completion of the 2nd round of screen, but is included here for reference.  
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4.2.4 Identification of internal control S. aureus mutants 
Until this point, the screen was performed blindly, which is to say that the genetic 
background of each strain was not revealed and each mutant was only identifiable by a well 
coordinate. It is highly important to do so, in order to completely exclude potential influence 
of researcher’s subjective consciousness of the screen, and therefore ascertain every strain 
in NTML is treated equally. Since there are already neutrophil lytic factors described for S. 
aureus, these represented an in-built positive control for this assay. In this instance, strains 
mutated in genes:  agrA refers to accessory gene regulator A. It plays an essential role in 
high-level expression of secreted proteins such as PSM and highly likely involved in abscess 
formation in S. aureus induced infections (Voyich et al., 2009, Thoendel et al., 2011, Boles 
and Horswill, 2008). Gene saeS is involved in membrane-associated protein kinase function 
which is essential for immune evasion mechanism of S. aureus (Benson et al., 2012, 
Bronner et al., 2004). Both genes are well known in producing factors that lyse neutrophils 
and therefore being selected as internal controls.    
Experiments which included the saeS and agrA mutants were identified in order to 
determine whether they failed to induce neutrophil lysis as hypothesised. Screening of 
NTML plates containing saeS mutant started with 14,745 healthy neutrophils and 99.4% 
ToPro-3 negativity (Figure 4.4). The treatment of JE2 leads to decreased viable neutrophils 
(8,703) and reduced ToPro-3 negativity (97.9%) and the mean viable neutrophil number for 
all strains was 5,209. The saeS mutant resulted in 14,149 viable cells and 99.4% ToPro-3 
negativity, suggesting attenuation of the neutrophil cell lysis. The media control from the 
screening agrA experiment contained 28,502 viable neutrophils and 99.7% ToPro-3 
negative population. JE2 resulted in 15,263 viable neutrophils and 76.5% ToPro-3 
negativity and the mean value of all mutants was 12,877 neutrophils. The agrA mutant 
resulted in 20,797 viable neutrophils and high ToPro-3 negativity (97.2%), also resulted in 
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a visible healthy neutrophil population in the dot plot, validating the observational method 
(Figure 4.4). Both agrA and saeS mutants result in greater number of viable neutrophils, and 
ToPro-3 negativity compared to the corresponding JE2 treated sample and mean of mutant 
values. These internal controls are a good validation and proof of principle for the screen 
and give confidence in the chances of identifying novel genes involved in neutrophil lysis.  
4.3 A second, focused round of NTML screening 
Of the 1,920 strains screened, 118 were identified as attenuated and to validate this further, 
each of the 118 strains was taken forward from the preliminary screen and rescreened a 2nd 
time. The S. aureus mutants identified from the 1st round of screen were sub-cultured (10 
µL culture in 190 µL of fresh BHI per well) to two new 96 well plates for the following 
focused 2nd round of screen. The 2nd round of screen was performed with same method as 
the 1st round of screen, but was repeated 3 times with 3 independent neutrophil donors.  
4.3.1 Identification of S. aureus mutants with attenuated neutrophil lysis by viable 
neutrophil count and ToPro-3 negativity 
Each experiment of the 2nd round of screening consists of two plates: plate A with 96 S. 
aureus mutants and plate B containing 22 strains. The absolute viable neutrophil number 
and ToPro-3 negative percentage of each S. aureus mutant infected neutrophil sample was 
quantified by the same method as described above (section 4.2.1), and plotted by a single 
line together with media control, JE2 WT, and average of each plate (Figure 4.5).  
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Figure 4.4 Illustrative FSC/SSC dot plots and ToPro-3 histograms of media and JE2 controls, 
and internal positive controls of the NTML screen namely agrA and saeS. Neutrophils were 
co-incubated with S. aureus strains for 3 hr at MOI of 10, followed by staining of ToPro-3 
(1:10,000) and Attune flow cytometry detection. The viable neutrophil count and ToPro-3 
negativity (%) of the strains are listed in the table below together with corresponding 
controls. T-3: ToPro3.   
  
Media Control JE2 agrA saeSedia ontrol J 2 agr saeS
Media Control JE2 Mean of Mutants agrA saeS
Viable Neutrophils 14745 8703 5209 14149
Negative T-3% 99.4 97.9 99.5 99.4
Viable Neutrophils 28502 15263 12877 20797
Negative T-3% 99.7 76.5 94.8 97.2
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Figure 4.5 Selection of attenuated S. aureus mutants based on the absolute viable neutrophil 
count and ToPro-3 negativity (%) result generated by each strain in the 2nd round of 
screening. Data shown in 96-well plate format with corresponding media control (green 
solid line), JE2 wild type treatment (red solid line) and mean value of each plate (orange 
dotted line). Plate A consists of 96 S. aureus mutants and plate B contains the remaining 22 
strains identified from the 1st round of screen. Neutrophils were incubated at 37oC for 3 hr 
with individual NTML mutant at MOI of 10, followed by staining with ToPro-3 (1:10,000) 
and Attune flow cytometry detection. Mean value plus two times of standard deviation of 
viable cell count was applied to identified attenuated strains highlighted in blue box. 
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The co-incubation started with 24,000-28,000 healthy neutrophils (100% ToPro-3 negative) 
per well. After 3 hr of JE2 treatment, less than 10,000 neutrophils remained viable and the 
ToPro-3 negative population decreased (66.7% ± 20.5%). Most S. aureus mutants resulted 
in less than 15,000 viable neutrophils and were therefore not considered to be attenuated 
(Figure 4.5). It is worthy of note that unlike data from the 1st round of screening, the average 
neutrophil cell death result of mutants in 2nd round of screen (orange dash line) display 
higher viable neutrophil amount than JE2 (red line), indicating comparatively attenuated 
virulence than WT which would be expected. The strains with viable neutrophil count or 
ToPro-3 negativity two times of standard deviation higher than the mean value were selected 
as candidate strains (highlighted in blue box) (Figure 4.5). From the 3 repeating experiments, 
10, 7, and 17 attenuated mutants were selected. The corresponding well and plate number 
of identified strains are listed in Table 4.3.  
4.3.2 Identification of S. aureus mutants with attenuated neutrophil lysis by flow 
cytometric cell scatter 
In addition to performing data analysis based on viable neutrophils and ToPro-3 negativity, 
flow cytometric FSC/SSC profiles were also used to identify attenuated S. aureus mutants 
from the 2nd round of screening.    
As a representative figure, the flow cytometric dot plots of media control, JE2 and two 
mutant strains are shown in Figure 4.6 A. The media control displays 80.6% of viable 
neutrophil population among all detected events. Infection of JE2 resulted in visible cell 
loss in the viable gating area (14.9%). The S. aureus mutant in well B4 led to 61.4% of 
healthy neutrophils after 3 hr of co-incubation. This strain has been selected from the viable 
neutrophils and ToPro-3 comparison analysis (highlighted in blue dashed box) (Figure 4.2, 
B). The screening of the mutant in well A2 produced result with a comparatively smaller 
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yet distinguishable cell population in viable gating area (36.8%). This strain was therefore 
added to the list of identified candidates. As the mean value showed in Figure 4.2 B, the 
majority of strains resulted in comparatively higher viable cell count and ToPro-3 negativity 
than JE2. The overall attenuated neutrophil cell death is the reason of not selecting well A2 
from the analysis.  
The flow cytometric cell scatter plots of all rescreened strains were assessed in this way and 
compared to JE2. In the three experiments, 40, 39, and 35 mutants with an obviously 
different dot plot profile which were selected from the three repeating experiments 
respectively. Among them, 10, 7, and 17 strains were identified by both methods. In total 
71 S. aureus strains have been picked up at least once from the analysis. Their corresponding 
well and plate numbers are listed in Table 4.3.    
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N Plate 
Viable 
Neutrophils and 
ToPro-3 
FSC/SSC Profiling Common 
1 
A  
A8 A12 B5 B6 B7 B8 B9 C2 C6 C8 D3 
D4 D6 D8 D9 D10 D11 E2 E6 E12 F6 
F7 G7 G9 G12 H11 
A9 A10 A11 D2 E7 
B  A2 A9 A7 B10 
B1 B2 B3 B4 B9 
B12 
2 
A  
B2 B3 B4 B11 C3 C6 C11 D2 D6 D10 
D11 D12 E2 E3 E5 E8 E12 F1 F6 F9 G3 
G6 G7 H4 H8 H11 G1 G2 
A10 A11 D3 D4 D7 
E7 
B  A3 A4 A5 B12 B4 
3 
A  
A8 B5 B6 B11 C5 C11 D1  D5 D3 D4 
D9 D11 E1 E6 F2 H2 
A9 A10 A11 C6 D2 
D7 D6 E2 E7 F1 F6 
G1 G2 
B A2 C6 A12 B4 B12 C1 C7 
Table 4.3. Combination of identified wells of each plate with S. aureus mutants generating 
attenuated neutrophil cell lysis result from the 2nd round of screen. The strains are referred 
to their well and plate numbers in a new sub-library I made that consists of two 96 well 
plates (A and B). The mutants selected by both methods are only listed under ‘common’ 
column.  
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Figure 4.6 (A) Flow cytometric FSC/SSC profiling of media and JE2 controls, and Well A2 
and B4 co-culture results of plate B in the 2nd repeating experiment of 2nd round of NTML 
screen. (B) The viable neutrophil number and ToPro-3 negativity (%) of the 22 S. aureus 
mutants were displayed together with media control (green), JE2 (red), and mean value of 
the plate (orange). The sample highlighted in blue box is Well B4.  
T-3: ToPro-3; -ive: negativity   
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4.3.3 Arbitrary ranking system of S. aureus strains 
The S. aureus mutants identified from each experiment of the 2nd round of screening were 
combined and listed in Table 4.3. Among the 118 strains, some S. aureus mutants were 
consistently attenuated in their ability to induce neutrophil cell death, such as well B4 in 
plate B. It was selected from either flow cytometric cell scatter and viable neutrophils or 
ToPro-3 comparison in all three repeating experiments. Strains such as well A11 of plate A 
was identified by both methods in 2 experiments and by FSC/SSC profiling in the 3rd 
experiment. Well A8 of plate A, consistently displayed healthy neutrophil population in 
flow cytometric dot plots, but the number of viable neutrophils were not high enough to be 
selected by this method.  
To determine which of the S. aureus mutants identified from 2nd round of screen resulted in 
the most robust attenuated neutrophil cell lysis, an arbitrary ranking system was introduced 
to comprehensively compare the attenuation among the 118 strains. If a S. aureus mutant 
appeared once from either FSC/SSC profiling, or from viable neutrophils and ToPro-3 
counts, 1 point was scored. For instance, well A8 of plate A scored 3 points for being 
identified three times by FSC/SSC profiling only. S. aureus strains that were commonly 
selected by both methods scored 2.5 points. For example, well B4 of plate B scored 7.5 
points in this ranking system. Well A11 of plate A therefore scored 6 points.  
Based on the points by the ranking system, 74 S. aureus mutants were recorded with either 
0 or 1 point, while the remaining 34 strains scored greater than 2 points (Figure 4.7). The 
mutants were ranked and the top scoring 34 strains were selected from the 2nd round of 
screen as S. aureus showing robust attenuation in neutrophil cell lysis. The identified 34 
strains are listed in Table 4.4.   
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Rank/34 Points Gene ID Gene description Name 
1 7.5 USA300_1974 Leukocidin/Hemolysin toxin family protein   
1 7.5 USA300_1975 Aerolysin/leukocidin family protein   
1 7.5 USA300_1494 hypothetical protein   
4 6 USA300_0265 putative ribose operon repressor   
4 6 USA300_1089 lipoprotein signal peptidase lspA 
4 6 USA300_0994 pyruvate dehydrogenase E1 component, beta subunit pdhB 
7 5 USA300_0690 sensor histidine kinase SaeS saeS 
7 5 USA300_1889 adenylosuccinate lyase purB 
7 5 USA300_0347 Sec-independent protein translocase TatC tatC 
7 5 USA300_1801 fumarate hydratase, class II fumC 
7 5 USA300_0917 putative membrane protein   
7 5 USA300_2365 gamma-hemolysin component A hlgA 
13 4.5 USA300_0230 putative membrane protein   
13 4.5 USA300_1092 uracil permease pyrP 
15 3.5 USA300_1992 accessory gene regulator protein A agrA 
15 3.5 USA300_1182 pyruvate ferredoxin oxidoreductase, alpha subunit   
15 3.5 USA300_0752 ATP-dependent Clp protease proteolytic subunit clpP 
18 3 USA300_0337 glycerol-3-phosphate transporter   
18 3 USA300_1180 conserved hypothetical protein   
18 3 USA300_1568 uridine kinase udk 
21 2.5 USA300_0566 amino acid permease   
21 2.5 USA300_1051 hypothetical protein   
21 2.5 USA300_2088 S-ribosylhomocysteinase luxS 
21 2.5 USA300_1356 3-dehydroquinate synthase aroB 
25 2 USA300_1393 phiSLT ORF2067-like protein, phage tail tape measure protein   
25 2 USA300_0210 maltose ABC transporter, permease protein   
25 2 USA300_0648 ABC transporter, permease protein   
25 2 USA300_0662 acetyltransferase, GNAT family   
25 2 USA300_1732 putative transposase   
25 2 USA300_2042 hypothetical protein   
25 2 USA300_0957 hypothetical protein   
25 2 USA300_1843 D-isomer specific 2-hydroxyacid dehydrogenase family protein   
25 2 USA300_0505 glutamine amidotransferase subunit PdxT   
25 2 USA300_0141 phosphopentomutase deoB 
Table 4.4. The 34 S. aureus mutants identified from the screen of NTML in human 
neutrophil cell death assay.  
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Figure 4.7 Distribution of the number of S. aureus mutants with different scores based on 
the selection of attenuated neutrophil cell lysis result during 2nd round NTML screen. If a S. 
aureus mutant appeared once from either FSC/SSC profiling, or from viable neutrophils and 
ToPro-3 counts, 1 point was scored. S. aureus strains that were commonly selected by both 
methods scored 2.5 points. This figure displays the points added from 3 independent 
experiments. The 34 S. aureus scored higher than 2 points were identified as strains with 
robust attenuated NTML mutants.   
  
³ 7 .5 7 .5³ 4 .5 4 .5³ 2 .5 2 1 0
0
1 0
2 0
3 0
4 0
5 0
A r b itr a r y  r a n k in g  r e s u l t
P o in t s
N
u
m
b
er
 o
f 
S
tr
ai
n
s
     
 
145 
 
4.3.4 Verification of NTML mutant growth in 2nd round of screen   
Although the bacterial culture preparation has been optimized and the screen was carried 
out aiming at MOI of 10, it is not feasible to standardise the actual number of S. aureus and 
neutrophils from one prep to another. To determine if potential mutants showing attenuated 
neutrophil lysis was because of a growth defect, bacterial growth of the 118 strains was 
measured during the 2nd round of screen to quantify the variation. A Perkin VICTOR x3 
2030 plate reader was used to detect the OD600 of the strains.   
The OD600 of S. aureus mutants were measured following 3 hr of sub-culture, immediately 
before the neutrophil co-culture. In each repeated experiment, the OD600 of the S. aureus 
strains was plotted with a corresponding viable neutrophil number after 3 hr of treatment, 
together with JE2 marked in red and media control in green (Figure 4.8). There was no 
correlation between OD600 and neutrophil number (R square values for the three 
experiments are 0.0225, 0.0695, and 0.0050), suggesting that the attenuation of neutrophil 
cell lysis was not because of differences in bacterial cell number.   
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Figure 4.8 The OD600 of the 118 S. aureus mutants in the 2nd round of screen with 
corresponding viable neutrophil count after 3 hr of treatments. The bacterial density was 
measured after 3 hr of sub-culture in fresh BHI media. The viable neutrophil counts were 
generated by gating of the healthy neutrophil population from the flow cytometry data. The 
green and red dots indicate data of media control and JE2 treated sample.  Linear regression 
analysis was carried out and the R square value of the 3 repeating experiments are 2.25%, 
6.95% and 0.50% separately.    
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4.4 Transduction of selected mutations into a wildtype USA300 
background 
4.4.1 Transduction of transposon insertion into JE2  
The aim of the transduction experiment is to verify that the mutant phenotype of attenuated 
neutrophil cell lysis was directly associated with the transposon insertion, and not the result 
of non-related genome mutation. The process of transduction involves the transfer of DNA 
flanking transposon insertion site from the S. aureus mutant to JE2 by a bacteriophage. Due 
to time limitation, transduction of only the top ranked 20 ranked mutants (Table 4.4) with 
the exception of agrA (since its role in neutrophil cell death has been well-studied) was 
performed into the USA300 background. Although repeated attempts were made, two 
transposon inserts failed to be transduced into JE2 (USA300_0994 and USA300_1092). The 
methods used for transduction are described in section 2.8.2.  
4.4.2 Confirmation of successful transduction 
The precise transposon insertion site of each S. aureus mutant was provided from the NTML 
database. Based on the S. aureus USA300 FPR3757 genomic DNA, primers were designed 
400 bp upstream and 400 bp downstream of the insertion sites. The primer sequences are 
listed in section 2.7.1. The transductant colonies with correct inserts would generate PCR 
products of the full transposon of approximately 4,000 bp (Figure 4.9). The colonies without 
transposon inserts would amplify a small fragment about 700 bp. The PCR amplification 
products from 3 colonies of each strain were examined by gel electrophoresis (Section 2.7.5) 
and the genomic DNA extracted from JE2 was used as negative control. The results showed 
that 17 of the 19 S. aureus strains that produced colonies after transduction were successful 
transductants (Figure 4.9). The verified colonies were stored as beads stock at -80oC for 
further study.  
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4.4.3 Identification of transductants showing robust attenuated neutrophil cell lysis 
The neutrophil cell death assay was carried out with the transductants in two batches with 
the same method as the screen. Apart from the neutrophils and JE2 controls, 5 internal 
positive and 8 internal negative control strains were added for validation of the phenotype 
assay (Table 4.5). The internal positive controls consist of NTML mutants that showed 
consistent of attenuated virulence against neutrophils from the 2nd screen of NTML. The 
internal negative controls were randomly chosen from the NTML strains that were not 
attenuated. Three colonies of each strain’s transductants were used in this study apart from 
SAUSA300_1089 (2), SAUSA300_1494 (1) and SAUSA300_2365 (1) due to limited 
number of given colonies. Both batches of transductants were assessed in 3 independent 
neutrophil cell death assays. 
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Neutrophil controls 
PBS 
1st Batch 
Transductants 
SAUSA300_0265 
ToPro-3  SAUSA300_0347 
Media control SAUSA300_0690 
S. aureus control JE2 SAUSA300_0917 
Internal positive 
controls 
USA300_1974 SAUSA300_1801 
USA300_1975 SAUSA300_1889 
agrA SAUSA300_1974 
saeS SAUSA300_1975 
luxS SAUSA300_2365 
Internal negative 
controls 
USA300_0872 SAUSA300_1494 
USA300_1056 SAUSA300_1089 
USA300_0116 
2nd Batch 
Transductants 
SAUSA300_0230 
USA300_2468 SAUSA300_0337 
USA300_2549 SAUSA300_1180 
USA300_0099 SAUSA300_1182 
USA300_0629 SAUSA300_1598 
USA300_0915 SAUSA300_1752 
Table 4.5. Controls and two batches of S. aureus transductants studied in the neutrophil cell 
death assay.  
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Figure 4.9 Confirmation of genetic transduction result for the 19 S. aureus mutant’s genes 
identified from the 2nd round of screen. PCR products of 400 bp upstream and 400 bp 
downstream of transposon insertion site of each gene were assessed by 1% (w/v) agarose 
gel electrophoresis. Positively transduced strains would give full transposon product at 
approximately 4,000 bp. In exception of USA300_1092 and USA300_0994, the rest 17 
genes were successfully transduced into USA300 background.      
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4.4.4 Evaluation of S. aureus transductants by the neutrophil cell death assay 
The absolute viable neutrophil number and ToPro-3 negativity of each S. aureus 
transductant infected neutrophil sample was compared with the media control (green line), 
JE2 (red line), and internal controls (purple symbol for attenuated and olive symbol for non-
attenuated) (Figure 4.10). The media control consistently displayed high viable neutrophil 
number (33,000±5527) and ToPro-3 negativity (>99%). JE2 treatment resulted in 
25,000±6183 cell loss and reduced ToPro-3 negative intensity (60.3%±5.4%). The internal 
non-attenuated controls shown similar viable cell count and ToPro-3 profiling compared to 
JE2. Majority of internal confirmed controls caused less neutrophil death (15,833±4488) 
and higher ToPro-3 negativity (76.5%±9.3%) compared to JE2. Transductants showing 
higher viable cell number and ToPro-3 negativity than JE2 and internal negative controls 
were selected (blue box) (Figure 4.10).     
Take the 2nd repeating experiment result of 1st batch as an example, the media control 
consists of approximately 39,000 viable neutrophils. After 3 hr infection of JE2, less than 
10,000 neutrophils remained alive and ToPro-3 negativity decreased to 60%. The treatment 
of internal non-attenuated controls resulted in less than 10,000 viable neutrophils and low 
ToPro-3 negativity (44%-64%). The internal attenuated controls displayed much higher 
viable neutrophils (19,000-30,000) and ToPro-3 negativity (72%-97%), suggesting robust 
attenuated neutrophil cell death. Eleven sets of transductants showing attenuated neutrophil 
cell lysis were selected from this experiment (blue box).  
As per the data analysis of the NTML screen results, the FSC/SSC profiling with viable 
neutrophil populations were determined. The profiling of 1st repeat of 2nd batch of 
transductants is shown as a representative (Figure 4.11). JE2 treatment leaded to massive 
viable neutrophil cell loss compared to media control. The internal positive controls 
displayed a clear population in the viable neutrophil gating area. Internal negative controls 
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generated highly similar cell loss to JE2 WT, indicating profound neutrophil cell lysis. The 
FSC/SSC profiles of three biological repeats of SAUSA300_1182 and SAUSA300_1889 
treated samples also shown visibly clear viable neutrophil populations. Thus, FSC/SSC 
profiles of all transductants were assessed to select strains resulted in visibly clear healthy 
neutrophil population.  
Out of the 11 strains transduced from 1st batch, 4 strains were selected by both methods and 
one extra strain was added from FSC/SSC profiling assessment. From the 2nd batch of 
transduced strains, 2/6 strains were identified. The transductants selected from two methods 
were highly consistent (Table 4.6). A total 7 identified NTML transposon inserted genes are 
listed in Table 4.7. Among these 7 transduced genes, there are saeS and leukocidin genes, 
which are known to induce neutrophil lysis and which gives confidence in both the screen 
and molecular engineering processes. 
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Batch N 
Viable Neutrophils and 
ToPro-3 
FSC/SSC Profiling Common 
1 
1  C3 C6 C12 D1 D2 
B7 B8 B9 C1 C2 C4 C5 C10 
C11 
2  C6 D1 D2 
B7 B8 B9 C1 C2 C3 C4 C5 
C10 C11 C12 
3  
C1 C3 C4 C5 C6 
D1 D2 
B7 B8 B9 C2 
2 
1  B9 C3 C1 C2 B7 B8 
2  C1 C2 C3 B7 B8 B9 
3   B7 B8 B9 
  
Batch Well Strain  
1 
B7 B8 B9 SAUSA300_ 0690  
C1 C2 C3 SAUSA300_ 1974  
C4 C5 C6 SAUSA300_ 1975  
C10 C11 C12 SAUSA300_ 1889  
D1 D2 SAUSA300_ 1089  
2 
B7 B8 B9 SAUSA300_ 1752  
C1 C2 C3 SAUSA300_1182  
Table 4.6 Combination of identified wells of each plate with transductants generating 
attenuated neutrophil cell lysis results. The strains are referred to by their well numbers in 
a sub-library I made in a 96 well plate containing each batch of transductants. The strains 
selected by both methods are only listed under ‘common’ column. The corresponding 
transductant strains of identified wells are listed below. 
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Gene Locus Gene Description Gene Name 
USA300_1889 Adenylosuccinate lyase purB 
USA300_0752 ATP-dependent Clp protease proteolytic subunit clpP 
USA300_1182 Pyruvate ferredoxin oxidoreductase, alpha subunit pfo 
USA300_1089 Lipoprotein signal peptidase lspA 
USA300_1974 Leukocidin/Hemolysin toxin family protein lukG 
USA300_1975 Aerolysin/leukocidin family protein lukH 
USA300_0690 Sensor histidine kinase SaeS saeS 
Table 4.7 Description of the 7 identified NTML transposon inserted genes.  
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Figure 4.10 Selection of attenuated transduced strains based on the absolute viable cell count 
and ToPro-3 negativity (%) result generated by the neutrophil cell death assay. Data is 
shown in two batches with corresponding result of media control (green), JE2 (red), internal 
attenuated controls (purple) and internal non-attenuated controls (olive). The 1st batch 
includes transductants corresponding to 11 S. aureus genes and the 2nd batch contains the 
remaining 6 gene transductants. Neutrophils were incubated at 37oC for 3 hr with individual 
transductants at an MOI of 10, followed by staining of ToPro-3 (1:10,000) and Attune flow 
cytometry detection. Transductants showing higher viable cell number and ToPro-3 
negativity than JE2 and internal negative controls were selected (blue box). 
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Figure 4.11 Representative flow cytometric FSC/SSC profiling of neutrophil cell death assay results of the 2nd batch transductants. The experiment 
was carried out with a media and JE2 control, 5 internal attenuated and 8 non-attenuated controls selected from NTML. Neutrophils were incubated 
at 37oC for 3 hr with individual transductants at MOI of 10, followed by staining of ToPro-3 (1:10,000) and Attune flow cytometry detection. 
Transductants with visibly different FSC/SSC profiles compared to JE2, namely SAUSA300_1182 and SAUSA300_1889 were identified as 
attenuated strains and are displayed as representatives 
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4.4.5 Growth curve of purB, lspA. clpP and pfo 
Among the 7 transduced strains identified from the screen, leucocidin family genes 
(USA300_1974 and USA300_1975) and saeS are well studied key virulence genes of S. 
aureus. The remaining genes namely purB, lspA, clpP, and pfo have not previously been 
associated with neutrophil cell death or functions. Therefore, these four genes were selected 
for further study of potential pathogenicity involved in S. aureus-neutrophils interaction. 
The transductants of these gene mutant strains are named as purB, lspA. clpP and pfo in this 
thesis.  
Growth curves of the four transduced strains were established in order to ensure no growth 
defects may be responsible for the attenuation observed (as per section 2.4.1). The JE2 
growth curve demonstrated exponential growth after 2 hr of sub-culture in fresh BHI (Figure 
4.12). After 7 hr of incubation, the OD600 reached 6.1. Both lspA and pfo produced a similar 
growth pattern and resulted in a comparable bacterial density (OD600 of 6.4-6.8 at 7 hr). 
purB grew exponentially from 2nd hr of culture and entered stationary phase after the 6th hr. 
clpP started exponential growth from 4th hr and resulted in similar bacterial mass (OD600 of 
5.1) with purB (OD600 of 4.5) (Figure 4.12). Although one way ANOVA analysis of 
individual time points indicated significantly different growth pattern from1st to 4th hr 
(p1=0.014, p2=0.0058, p3=0.0008, p4=0.0014), the statistics of complete data set showed no 
significant difference between any of the transductants and JE2 (one way ANOVA, 
p=0.8873).  
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Figure 4.12. Role of lspA, purB, clpP and pfo in S. aureus growth in vitro. OD600 measured 
hourly shows comparable growth between the transductants with JE2. The growth was 
established in BHI media at 37oC with shaking at 250 rpm. Mean value and standard 
deviation of measurements from 3 independent experiments are shown. No significant 
difference was found among the strains (p=0.9567). 
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4.4.6 Bioinformatic analysis of the 4 strains of interest 
Since none of the 4 mutants have been previously associated with neutrophil functions, it is 
important to obtain known information for these genes based on the gene IDs. The sequence 
features such as length of gene and protein, protein description and function were searched 
from NCBI protein databases. Known pathways that each gene has a role in were confirmed 
from Biocyc (https://biocyc.org/) and Kegg PATHWAY databases 
(http://www.genome.jp/kegg/pathway.html). The key information of each strain is listed in 
Table 4.8. PurB catalyses purine biosynthesis pathway. Pfo refers to pyruvate ferredoxin 
oxidoreductase α submit which has a role in pyruvate oxidation via the tricarboxylic acid 
cycle (TCA). ClpP produces caseinolytic protease which forms clp protease complex with 
clpQ. The clp protease complex hydrolyses proteins into small peptides with an ATP-
dependent mechanism. lspA produced lipoprotein signal peptidase function as signal peptide 
cleavage for maturing membrane proteins of S. aureus.      
The transposon insertion site was identified from the NARSA website. The position and 
flanking genes for each of the 4 genes of interest was obtained from Biocyc website and 
diagrammatically displayed in Figure 4.13. Flanking genes analysis was carried out using 
Biocyc website and the results indicated that lspA and pfo genes might be part of operons.  
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Gene 
Name 
Gene 
Length  
Protein 
Length 
Function Pathway 
purB 1296 bp 431 aa Catalyses 2 steps in purine synthesis 
Purine 
biosynthesis 
clpP 588 bp 195 aa ATP-dependent protein hydrolysation  N/A 
pfo 1761 bp 586 aa Catalyses pyruvate oxidation  
Tricarboxylic 
acid cycle  
lspA 492 bp 163 aa 
Catalyses the removal of signal peptides 
from prolipoproteins 
Lipoprotein 
biosynthesis 
Table 4.8 Information of sequence features, function, and pathway for the four NTML 
transposon inserted genes.  
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Figure 4.13 Transposon insertion position and surrounding genes for each of the 4 genes of 
interest.  The lspA (A) and pfo gene (D) are likely in operons with the downstream genes. 
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4.5 Complementation of verified transductants 
4.5.1 Complementation of the 4 genes of interest with pGM073 derivative plasmid  
To determine if the gene mutants of lspA, purB, clpP, and pfo were the reason for the 
phenotype of attenuated neutrophil cell lysis, attempts were made to genetically 
complement the four transductants of interest. The four mutations were genetically 
complemented with derivatives of the pGM073 plasmid expressing the corresponding genes 
to demonstrate their role in neutrophil cell lysis (Figure 4.14). The pGM073 plasmid is a 
pKasbar (pKB) derivative with ezrA and PSmOrange fragments (Bottomley et al., 2014). 
The ezrA and PSmOrange region was replaced by promoter and gene of interest to construct 
the complementation plasmid which was further amplified in E. coli. S. aureus RN4220 
CYL316 strain possessing an integrase expressing plasmid was used as an intermediate 
strain, to allow site specific incorporation of the plasmid through recombination between an 
attP site encoded in pGM073 and attB site located at glycerol ester hydrolase (geh) gene of 
S. aureus after electroporation. The integration of plasmid DNA results in the loss of lipase 
activity (Lee & Iandolo, 1986). Although one study reported that isogenic mutants of the 
lipase genes reduces biofilm and abscess formation, and bacterial replication in the spleen, 
liver, and kidneys in an infected mice model, the experiments were conducted by chemically 
mutagenised S. aureus RN4220 (Hu et al., 2012). More recent studies using USA300 ∆geh 
suggested that the most convincing role of lipase production was to enhance S. aureus 
colonisation and persistence on human skin (Cadieux et al., 2014).  
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Figure 4.14 Diagram of the methods employed to genetically complement S. aureus 
transductants with the pGM073 system. 
(1). The pGM073 plasmid is derived from pKasbar-TetR with ezrA and PSmOrange 
fragments. The ezrA and PSmOrange region was replaced by promoter and gene insert of 
interests to construct the complementation plasmid. 
(2) The constructed plasmid was further amplified in E. coli.  
(3) S. aureus RN4220 CYL316 possessing an integrase expressing plasmid was used as an 
intermediate strain, to have site specific incorporation of the plasmid into the geh of the 
corresponding transductant by electroporation. The complemented sector consists of 
promoter and gene of interest.  
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4.5.1.1 Construction of complementation plasmids  
The native promoter and gene sequences of lspA, purB, clpP and pfo were PCR amplified 
from genomic DNA of JE2 WT by primers lspA-F-R, purB-F-R, clpP-F-R, and pfo-F-R. 
pGM073 derivatives were digested with BglII and NotI to remove the ezrA and PSmOrange 
region and ligated with gene inserts by Gibson assembly. All DNA fragments were verified 
by 1% w/v gel electrophoresis and the construction of the pKB-lspA-tetR is shown 
diagrammatically as an example (Figure 4.15). Several attempts were made to amplify clpP 
promoter and gene sequence with additional clpP-F-R 1 and clpP-F-R 2 primers, yet no 
PCR product was synthesised. The pKB-lspA-tetR and pKB-pfo-tetR plasmids were 
constructed (Figure 4.16) and sequenced by GATC Biotech to confirm the correct gene 
inserts with primers lspA-F-R S, and pfo-F-R S. Although multiple attempts were made to 
isolate and send high concentration of pKB-purB-tetR DNA inserts (418-440 µg/µl) to 
GATC Biotech, the sequencing consistently failed to produce any signal.  
4.5.1.2 Integration of complementation plasmids into S. aureus RN4220 
Electro transformation was carried out to integrate the verified pKB-lspA-tetR and pKB-pfo-
tetR plasmids into competent RN4220 CYL316 cells. No colonies of S. aureus RN4220 
grew on the plates. Attempts were made with optimizations of the protocol including 
increasing DNA concentration (80-250 µg/µl with 260/280 < 2); multiple pulses; using 
different batches of freshly made competent cells; reducing tetracycline concentration in the 
selective BHI agar; and elongating the incubation time of agar plates. Unfortunately, after 
several attempts this was proved unsuccessful.   
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Figure 4.15 Construction of the pKB-lspA-tetR complementation plasmid. 
The lspA promoter and gene was PCR amplified from FPR3757 WT S. aureus genomic 
DNA and Gibson assembled into NotI and BglII cut pGM073, resulting in pKB-lspA-tetR.  
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Figure 4.16 Physical map of the promoter and gene inserts in the complementation plasmids 
of the lspA and pfo.  
A. pKB-lspA-tetR 
B. pKB-pfo-tetR 
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4.5.2 Complementation of lspA with pGM074 derivative plasmid 
The pGM074 plasmid shares same backbone as pGM073 but the resistance marker was 
replaced by a KanR cassette. Due to time limitation of this project, lspA was chosen for 
continuation of genetic complementation.  
A constructed clpP transductant strain and φ85 phage complemented clpP+ strain 
(EryR CMR) in the S. aureus 8325 background were obtained from Knut Ohlsen’s group 
(Michel et al., 2006).  
4.5.2.1 Construction of a pKB-lspA-kanR complementation plasmid  
Map of construction procedures involved in pKB-lspA-kanR complementation plasmid is 
shown in Figure 4.17. The native promoter and gene sequence of lspA was PCR amplified 
from genomic DNA of JE2 by primers lspA-F-R and verified by 1% w/v gel electrophoresis 
(Figure 4.18 C). pGM074 derivative was cut by BglII and Not 1 to remove the ezrA and 
PSmOrange region and the plasmid backbone was purified after 1% w/v gel electrophoresis 
validation (Figure 4.18 B). After Gibson assembly of the digested plasmid with lspA 
sequence, the ligation was assessed by HindIII restriction enzyme digestion. With one 
HindIII cut site in the plasmid backbone and another one in lspA fragment (Figure 4.18 A), 
only successful constructed pKB-lspA-kanR plasmid would generate 2 bands of expected 
sizes (1349 and 3686 bp) (Figure 4.18 D). The pKB-lspA-kanR plasmid DNA was then 
verified by sequencing (GATC Biotech) using primers pGM074-F-R.  
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Figure 4.17 Construction of pKB-lspA-kanR complementation plasmid. 
The lspA promoter and gene was PCR amplified from FPR3757 WT S. aureus genomic 
DNA and Gibson assembled into NotI and BglII cut pGM074 derivative plasmid, resulting 
in pKB-lspA-kanR. 
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Figure 4.18 Verification of pKB-lspA-kanR. Standard 1 kb DNA ladder was used for all gel 
eletrophoresis. 
A. Map of pKB-lspA-kanR construction with HindIII cutting sites.  
B. NotI and BglII digested pGM074 derivative by gel electrophoresis for Gibson assembly.  
C. PCR amplification of lspA promoter and gene fragments. 
D. HindIII digestion of pKB-lspA-kanR (triplicates) and gel electrophoresis. 
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4.5.2.2 Integration of pKB-lspA-kanR plasmid into S. aureus 
The pKB-lspA-kanR plasmid was transformed into the RN4220 CYL316 strain, which 
contains the pYL112SA19 plasmid and therefore expresses the integrase enzyme required 
for site specific integration into the geh gene. Integration of the pKB-lspA-kanR plasmid 
into RN4220 is illustrated in Figure 4.19 A. Successful integration into RN4220 strain 
results in loss of lipase activity due to interruption of the geh gene. Baird-Parker plates were 
used to examine the colonies. Potassium tellurite in Baird-Parker results in black colonies. 
RN4220 CYL316 strain was used as the positive control and generated a precipitation zone 
around colonies, indicating hydrolysis of lipids in the agar. The transformants displayed loss 
of lipase function proving correct integration of pKB-lspA-kanR plasmid into the 
chromosomal geh gene of RN4220 (Figure 4.19 B).        
Subsequently the pKB-lspA-kanR plasmid with gene insert was transferred from the 
RN4220 genome to lspA by bacteriophage transduction (method disclosed in Section 2.8.2), 
allowing homologous recombination of the gene into the genomic DNA. The resulting 
colonies were also verified on Baird-Parker plates with JE2 strain as positive control (Figure 
4.19 C). 
4.5.2.3 Complementation of lspA control strains 
Control strains for phenotype study of lspA+ in neutrophil cell death assay were also 
constructed. The empty pKasbar plasmid was isolated from SH4045 E. coli strain and 
transformed into RN4220 CYL316. The DNA fragment containing integrated plasmid was 
moved into both JE2 and lspA by phage transduction, to generate JE2-pKB and lspA-pKB 
controls. The successful integration was confirmed by bacterial growth on Baird-Parker 
plates (Figure 4.19 D).  
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Figure 4.19 Site specific integration of the pKB-lspA-kanR complementation plasmid into S. 
aureus RN4220 through homologous recombination between the attP site in pKasbar with 
attB site in the geh gene (A). Confirmation of successful integration of lspA promoter and 
gene insert into RN4220 CYL316 (B) and lspA (C) on Baird-Parker agar plates. Empty pKB 
integrated JE2 and lspA strains were also verified for use as control in further neutrophil cell 
death assay (D). S. aureus RN4220 CYL316, lspA or JE2 strains were used as positive 
controls generating a zone of precipitation around the colonies, indicating intact lipase 
function. 
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4.5.2.4 Growth curve of complemented strains 
Growth curves of the complemented strains were established from OD600 of 0.1 (method 
disclosed in section 2.4.1). JE2 generated standard growth curve and grew exponentially 
after 1 hr of sub-culture in fresh BHI. After 4 hr of incubation, the growth entered stationary 
phase and OD600 reached 4.1 at 5 hr. JE2-pKB strain showed highly similar growth pattern 
with JE2. Both lspA-pKB and lspA+ strains displayed standard growth curve with 
exponential growth phase during 1st to 4th hr of incubation. Although the bacterial intensity 
of earlier time points was comparatively lower than JE2, the final OD600 at 5 hr (3.9 and 4.0 
respectively) were not vastly different from the WT (Figure 4.20). ANOVA test showed no 
significant difference among the growth strains (p=0.9957).  
The clpP+ strain in S. aureus 8325 background produced a comparable growth curve to JE2 
and reached stationary phase after 4 hr of incubation with OD600 of 3.9. Meanwhile the clpP 
did not enter exponential growth until 4 hr. At 6 hr clpP displayed similar OD600 (3.7) with 
JE2 at 5th hr (3.9) (Figure 4.20).   
4.5.2.5 Neutrophil cell death assay of complemented strains 
The neutrophil cell death assay was performed with the lspA and clpP complemented and 
control strains (Table 4.9) with same method as the screen. The neutrophil cell death assay 
was repeated 3 times. 
The results of three repeating experiments were highly consistent, the media control 
displayed approximately 30,000-50,000 viable cells (Figure 4.21). Infection of JE2 leads to 
decreased viable neutrophils (<20,000). The clpP resulted in 30,000-60,000 viable cells, 
suggesting attenuation in cell lysis. The clpP+ infected samples contained approximately 
15,000 less viable neutrophils than corresponding clpP, indicating the concept of 
complemented virulence is achieved.  Comparing to lspA which resulted in 30,000-40,000 
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viable cells, lspA+ treatment reduced the viable count to 15,000-28,000. The co-incubation 
of JE2 complemented with empty pKB produced similar viable cell number (approx. 20,000) 
compared to JE2.  The insertion of empty pKB in lspA leads to comparable healthy cell 
count (30,000-40,000) to media control. Therefore, the integration of empty pKB had no 
effect on bacterial virulence, indicating the genetic complementation of lspA enhanced the 
neutrophil cell lysis ability of the lspA mutant.  
The flow cytometric FSC/SSC profiling and ToPro-3 histograms of a single experiment is 
shown as representative data (Figure 4.22). The F/T sample displayed 61.6% positive 
ToPro-3 intensity confirming successful ToPro-3 staining. Media control displayed a dense 
viable neutrophil population in the gated area, and 99.8% of ToPro-3 negativity. JE2 and 
JE2-pKB treatment lead to absence of viable neutrophil population in FSC/SSC plots 
together with reducing ToPro-3 negativity (79% and 86.7%), indicating profound cell lysis. 
Both lspA and lspA-pKB strains produced a high ToPro-3 negative count (96.6% and 97.3%) 
and a clear healthy neutrophil population, proving the integration of an empty pKB plasmid 
does not alter the virulence of S. aureus. Full neutrophil cell lysis was induced by the lspA+ 
(loss of viable cells and 73.2% ToPro-3 negativity) suggesting fully restored virulence of 
the complement strain. The clpP mutant showed similar attenuation in neutrophil cell death 
with media control, with 76.7% of cells remaining viable and 98.2% of negative ToPro-3. 
On the contrary, clpP+ generated massive killing of neutrophils (reduced population in 
gating area and 22.2% of positive ToPro-3), confirming the augmentation of bacterial 
virulence by genetic complementation.  
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Neutrophil controls 
PBS  
ToPro-3  
Media control 
S. aureus controls 
JE2 
JE2-pKB 
lspA transductant  lspA  
lspA control lspA-pKB   
lspA complement lspA+ 
clpP transductant clpP 
clpP complement clpP+ 
Table 4.9. Controls and complement strains of lspA and clpP studied in the neutrophil cell 
death assay. 
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Figure 4.20 Growth curve of lspA and clpP complementation and control strains. OD600 
measured hourly show comparable growth between the lspA, lspA+, lspA-pKB, clpP+ with 
JE2 and JE2-pKB. The clpP strain showed delayed growth pattern comparing to the 
remaining strains. The growth was established in BHI media at 37oC with shaking at 250 
rpm. Mean value and error bars (standard deviation) of measurements from 3 independent 
experiments are shown. 
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Figure 4.21 Viable neutrophil counts of after infection with complemented lspA and clpP strains. Primary human neutrophils were incubated with 
complemented and control strains at MOI of 10 for 3 hr. Viable cell counts were generated from flow cytometric data analysis. The quantification 
results from 3 independent experiments are shown in comparison between clpP and clpP+; lspA and lspA+; JE2+pKB and lspA+pKB, and media 
control with JE2 WT.  
JE2+pKB: JE2 complemented with empty pKasbar backbone; lspA+pKB:  lspA complemented with empty pKasbar backbone. 
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Figure 4.22 Representative flow cytometry results show genetically complemented lspA and 
clpP strains restored bacterial virulence in the neutrophil cell death assay. Neutrophils were 
co-incubated with S. aureus at MOI of 10 for 3 h at 37oC, followed by ToPro-3 (1:10,000) 
staining and Attune flow cytometric detection. F/T: Freeze/Thaw.    
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4.6 Discussion  
The NTML consists of 1,920 transposon insertion S. aureus strains in a clinically relevant 
CA-MRSA background. It is a valuable resource for research on S. aureus, and it has 
allowed this project to identify genes that are important for the modulation of immune cell 
strategies, in an unbiased and high-throughput experimental model. 
Screening of the NTML revealed mutations in 34 genes that resulted in attenuated neutrophil 
lysis. The 34 mutations included 5 genes categorised as transporters and 12 genes involved 
in biosynthetic pathways. Fourteen of the 34 genes have known functions, whereas 20 genes 
were hypothetical. Transposons from the most attenuated strains were transduced into a WT 
JE2 background and among them, 7 were attenuated in neutrophil lysis assays. Ten 
transductants failed to show attenuated neutrophil cell death which suggests that the original 
phenotype was perhaps the result of a mutation in other genomic DNA regions, rather than 
loss of the targeted gene function.  
After identifying the function of each of the 7 attenuated transductants, 4 genes that were 
not previously associated with S. aureus virulence were focussed on: lipoprotein signal 
peptidase (lspA), adenylosuccinate lyase (purB), ATP-dependent clp protease proteolytic 
subunit (clpP) and alpha subunit of pyruvate ferredoxin oxidoreductase (pfo). The clpP 
complement strain in 8325 background was later obtained from a collaborrator. 
Complementation of lspA using a pGM074 derivative generated a successful genetic 
complement. The fully restored bacterial virulence (with respect to neutrophil lysis) of lspA+ 
and clpP+ confirmed linkage between the phenotype and the mutant genes.  
4.6.1 Analysis of possible roles of identified genes in S. aureus-dependent neutrophil 
cell lysis  
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The attenuated neutrophil lysis phenotype was successfully repeated by genetic transduction 
of purB mutant, proving disruption of this gene is sufficient to reduce bacterial virulence in 
modulating immune cell response. PurB produces adenylosuccinate lyase which is known 
for catalysing two steps in purine biosynthesis in S. aureus. Even though the mutant did not 
exhibit a significant growth defect in rich nutrient media (BHI), whether SApurB replicate 
or express full virulence as per the WT in RPMI (+10% FBS) remains unclear. Hence, it is 
important to identify whether the phenotype of the purB mutant was caused by lack of 
nutrients or interaction with neutrophil immune strategies. Chemical complementation of 
purB mutant will be conducted in future work. 
pfo encodes pyruvate ferredoxin oxidoreductase α subunit, which catalyses pyruvate 
oxidation reaction in TCA cycle. Lack of function of this gene resulted in robust attenuation 
in bacterial virulence in this study. A possible reason could be that the pyruvate ferredoxin 
oxidoreductase plays an essential role in central metabolism of S. aureus. Continuous study 
will aim at identifying potential alternation of neutrophil cell responses caused by lack of 
Pfo, such as phagocytosis. 
The requirement for lspA and clpP in order to cause full neutrophil lysis was verified by 
genetic transduction and complementation. The lipoprotein signal peptidase expressed by 
lspA functions to remove signal peptides from prolipoproteins and further produce mature 
lipoproteins. Lipoprotein is anchored on the outer membrane of S. aureus (Nakayama et al., 
2012). It plays essential roles in host-pathogen interactions. It functions as pathogen-
associated molecule patterns and mediates inflammation through activating TLR2 
signalling cascades (Bubeck Wardenburg et al., 2006, Schmaler et al., 2010, Kim et al., 
2015).  Therefore, a question is raised by the significance of lspA in lipoprotein biosynthesis: 
is lipoprotein responsible for mediating staphylococcal induced infection of immune cells, 
and how lack of this membrane protein may affect the interaction with human neutrophil? 
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Although this is speculative, I propose that the absence of mature lipoprotein downregulated 
neutrophilic uptake of the bacteria, and therefore prevent post-phagocytotic S. aureus-
induced immune cell lysis. To address this hypothesis, experiments including phagocytic 
index assay would be helpful to underpin potential role of lspA mediation in neutrophil 
responses in future work.  
Caseinolytic protease proteolytic subunit, the product of clpP gene, is involved in ATP-
dependent protein hydrolysation process (Truscott et al., 2011). Much of what is known 
about removal of misfolded and aggregated proteins is that the protein hydrolysation process 
is crucial for S. aureus growth and functionality when they are exposed to a range of 
considerable environmental changes during infection. Presumably, the expression level of 
metabolism or other key virulence genes might also be determined by clpP-dependent 
control of gene regulator quantity. Consequently, lack of clpP could lead to irregulated 
protein homeostasis and compromised bacterial functionality, which failed to cause 
neutrophil lysis in the cell death assay. The potentially universal impact of protein 
degradation process indicates possibility of clpP to be involved in multiple mechanisms of 
S. aureus-neutrophil interaction. It is worthy of investigating potential attenuation of 
SAclpP in neutrophilic phagocytosis, bacterial growth during infection, and the 
pathogenesis in neutrophil-dependent manner.  
Attempts to characterise the pathogenic mechanism of the 4 genes of interest in S. aureus-
neutrophil interaction are the primary objectives of the next chapter.  
4.6.2 How representative are the genes identified in the NTML screen for S. aureus 
virulence? 
The two hypothetical leukocidin family genes (USA300_1974 and USA300_1975) resulted 
in attenuated bacterial virulence against human neutrophils. The outcome validated the 
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method established for the NTML screen since leukocidin is known to synergize with other 
virulent factors such as PVL to enhance the bacterial pathogenesis via induction of 
neutrophil lysis (Ventura et al., 2010).  Similarly, agrA and saeS genes selection from the 
screen is in agreement with two other screening results (Benson et al., 2012, Boles and 
Horswill, 2008), proving the importance of accessory gene regulator A and membrane-
associated protein kinase function for S. aureus virulence in modulating immune cells 
responses, and leading to neutrophil cell death.  
Two genes identified from the screen that are involved in nucleotide and amino acid 
metabolism (pyrP and aroB) were proved as highly important for adaptation of oxidative 
stress and pH shock in a screen of essential genes in ST398 S. aureus background 
(Christiansen et al., 2014). The hlg family gene (hlgA) identified from NTML consistently 
illustrated the role of γ-hemolysin in S. aureus virulence (Gordon and Lowy, 2008). The 
expression product of pdhB is a subunit of pyruvate dehydrogenase multienzyme complex, 
which exists in the membrane fractions of S. aureus and regulates adaptation of osmotic 
stress (Vilhelmsson and Miller, 2002). tatC synthesis higly conserved sec-independent 
protein translocase and function as protein translocation system with tatA in S. aureus 
(Goosens et al., 2014).  Unlike the most well-studied sec pathway as a general transport 
system, tat pathway was found with contribution of transporting virulence factors (Sibbald 
et al., 2006). A study performed in a mouse kidney abscess model showed significant lower 
virulence of S. aureus SAtatAC mutant than the wild type (Biswas et al., 2009). The luxS 
gene synthesis autoinducer producer protein which involves in ‘quorum sensing’, an 
essential mechanism for cell-cell signalling and therefore plays a key role in the formation 
of biofilms (Xu et al., 2006). According to Cluzel (Cluzel et al., 2010), luxS is involved in 
regulation of sporulation. Moreover, a novel metabolism role of S. aureus luxS has been 
found as monocistronic transcriptional subunit. The gene was transcribed throughout 
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intracellular growth in MAC-T cells (Doherty et al., 2006). The inactivation of luxS in 
several other pathogens leads to compromised virulence such as reduced expression of 
toxins (Vendeville et al., 2005). Streptococcus pneumoniae luxS mutant also resulted in 
attenuated infection in mice model (Stroeher et al., 2003), indicating a potentially important 
gene for S. aureus survival and bacterial virulence.  
The importance of the majority of functional genes identified in our NTML screening has 
been supported by other researchers. Several other screens of S. aureus gene library 
generated different results. A recent study for S. aureus (JLA531) genes involved in AMP 
resistance revealed a range of genes including stress response and cell wall stimulation gene 
yjbH and sgtB (Johnston et al., 2016).      
4.6.3 Limitation of NTML screen  
The main limitation of this neutrophil cell death assay is that the primary screen was only 
performed once. This may have led to false negatives.  False positives were also encountered 
but the 2nd round of screening refined these. Limitations of the screen method include the 
time frame only allowing assessing of maximum two NTML plates per day, because of 
which, variation of donor cell activity and neutrophil number per aliquot is bound to occur 
throughout the screen. This further makes it impossible to combine data from different days, 
and therefore limits the viability of comparing the 1,920 strains together. Additionally, 
although the bacterial intensity of NTML mutants has been verified within an acceptable 
range before co-incubation with neutrophils, the MOI of individual samples might not 
consistently be 10. Even though the methodology has limitations as described above, the 
solid neutrophil cell death assay model of the NTML screening provides robust targets for 
more in-depth studies of genetic mutants and functional assays. 
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CHAPTER 5 
Role of identified S. aureus genes in virulence 
5.1 Introduction 
The NTML screen in Chapter 4 revealed a potential role for four S. aureus genes that were not 
previously associated with neutrophil cell death, namely lspA, clpP, purB, and pfo. The 
neutrophil killing of lspA and clpP mutants was fully restored by genetic complementation, 
further validating their role in neutrophil interaction.  
The purB gene encodes adenylosuccinate lyase, which catalyses two reactions in the purine 
biosynthesis pathway: conversion of SAICAR (5'-phosphoribosyl-4-(N-
succinocarboxamide)-5-aminoimidazole) to AICAR (5-amino-1-(5-phospho-D-ribosyl) 
imidazole-4-carboxamide), and adenylosuccinate to AMP (adenosine-monophosphate); with 
fumarate as by product of both reactions (Fyfe et al., 2010). IMP (inosine monophosphate, 
Adenylo-succ, N6-(1,2-dicarboxyethyl)-AMP), an intermediate product in this pathway, is a 
branch point for further ATP and GTP synthesis (Figure 5.1 A). PurB has a role before and a 
role after pathway branching, suggesting it is highly likely essential for both ATP and GTP 
synthesis.   
Pfo is pyruvate ferredoxin oxidoreductase (PFOR) α subunit. It mediates the oxidative 
decarboxylation of pyruvate to acetyl-CoA and CO2 (Figure 5.1 B). PFOR functions as both 
pyruvate synthase and pyruvate oxidase in Clostridium thermoaceticum (Furdui and Ragsdale, 
2000). The dual roles of the enzyme links the Wood-Ljungdahl pathway of autotropic CO2 
fixation with incomplete reductive TCA (tricarboxylic acid) cycle in anaerobic organisms 
(Furdui and Ragsdale, 2000). Another study carried out in Trichomonas vaginalis revealed 
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PFOR, which normally located on the membranes of hydrogensosomes, is a surface-associated 
cell adhesion protein involved in host cell-binding activity (Meza-Cervantez et al., 2011).  
Analogues of nitazoxanide, an inhibitor of PFOR in anaerobic bacteria, have been tested in a 
minimum inhibitory concentration assay with a range of species including S. aureus (Warren 
et al., 2012). Out of 9 tested analogues, S. aureus was susceptible to 3 and resistant to the rest. 
However, the group claimed S. aureus do not express PFOR (without providing solid 
reference), concluding that the inhibitory effects displayed by the positive analogues were due 
to their broad-spectrum antimicrobial activity against non-PFOR targets.          
The lipoprotein signal peptidase encoded by lspA is a cytoplasmic membrane localized 
enzyme required for biogenesis of bacterial lipoproteins (Shahmirzadi et al., 2016). The 
peptidase functions through recognition of a diacylglycerol modification and cleaves between 
the modified cysteine residue and amino acid at position-1 (Hussain et al., 1982), which further 
generates mature lipoprotein (Figure 5.1 C). Lipoproteins are a distinctive class of membrane-
anchored proteins commonly found in Gram-negative and Gram-positive bacteria. In Gram-
positive microorganisms, lipoproteins are localized in the outer leaflet of the cytoplasmic 
membrane (Mazmanian et al., 2001). Known functions of lipoproteins include uptake of 
nutrients, protein secretion, antibiotic resistance, spore germination, etc (Sutcliffe and Russell, 
1995).   
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Figure 5.1 Diagrammatic illustration of roles of PurB, LspA, Pfo, and ClpP in S. aureus.  
A. Purine de novo biosynthesis pathway.  
B. Reaction of pyruvate oxidation in the TCA cycle.  
C. Maturation of lipoproteins on the outer layer of cytoplamic membrane.  
D. Mechanism of protein degradation regulated by the Clp protease.  
Abbreviations: SAICAIR, 5'-phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole; 
AICAIR, 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide; GMP, guanosine 
monophosphate; IMP, inosine monophosphate, Adenyl succinate, N6-(1,2-dicarboxyethyl)-
AMP; AMP, adenosine-monophosphate. Pathway information was acquired from the Kegg 
and Biocyc websites, and molecule images were obtained from WormFluxx. 
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ClpP is a caseinolytic protease proteolytic subunit, which forms part of the Clp chaperone 
protease complex with an ATPase specificity factor (ClpX and ClpC in S. aureus) (Frees et 
al., 2004). Clp proteases play a crucial role in misfolded or aggregated protein degradation 
and are therefore highly important for protein homeostasis (Kirstein et al., 2009). Substrates 
are recognized and bound by an ATPase such as ClpX. Subsequently the protein is unfolded 
and transferred into ClpP chamber, followed by proteolysis to complete degradation (Figure 
5.1 D). Apart from protein turnover, studies have revealed potential roles for ClpP involved 
in stress adaptation and bacterial virulence. A β-lactone inhibition study of ClpP in S. aureus 
attenuated the production of extracellular virulence factors such as hemolysins and lipases 
(Bottcher and Sieber, 2008). Loss of ClpP in S. aureus resulted in derepression of genes 
involved in heat shock regulation (hrcA and ctsR), oxidative stress response, SOS DNA repair, 
and metal homeostasis (Michel et al., 2006).  
All the genes identified in the NMTL screen have biochemical functions attributed to them. 
However, their link to neutrophil lysis is unknown. Hence, the primary objectives of the 
following chapter are to probe their importance to broader pathogenicity, and in particular S. 
aureus-neutrophil interactions.  
The zebrafish embryo model of S. aureus pathogenesis has been previously established (Henry 
et al., 2013, Ellett et al., 2015).  This host has many orthologs of the human innate immune 
system including neutrophils and cytokines (van der Vaart et al., 2012). Zebrafish neutrophils 
share highly similar morphological, biochemical, and functional features with human 
neutrophil (Lieschke et al., 2001), which readily permits understanding of neutrophil 
immunity against bacteria including S. aureus (Henry et al., 2013). S. aureus can be rapidly 
phagocytosed by neutrophils in the zebrafish embryo model. Yet the engulfed bacteria are not 
always eliminated subsequently (Prajsnar et al., 2008).  
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Results 
5.2 In vitro purB chemical complementation  
5.2.1 Adenine and inosine complementation assay for purine biosynthesis 
As the purine de novo biosynthesis pathway shows, PurB is necessary for the conversion of 
SAICAIR to AICAIR which further converts to IMP (Figure 5.1 A). Hence, the absence of 
PurB leads to absence of IMP, resulting in lack of GTP or ATP synthesis.  
Therefore, I hypothesised that lack of purines in the S. aureus-neutrophil coincubation leads 
to a defect in GTP/ATP synthesis which may inhibit the production of virulence factors that 
result in cell lysis. To determine whether neutrophil killing could be restored by chemical 
complementation, adenine and inosine (AI) were first added to solid BHI agar at a final 
concentration of 0.02 mg/mL for purB mutant growth. The chemicals were also added to 
RPMI media at the same concentration during the 3 hr co-incubation at MOI of 10. Neutrophils 
were stained with ToPro-3 and cell viability was assessed by Attune flow cytometry. 
5.2.2 Bacterial neutrophil killing is restored in the chemical complemented purB strain 
The viable neutrophil cell count and ToPro-3 negativity of each sample from a representative 
experiment is shown in Figure 5.2 A. A media control with and without AI complementation 
resulted in high viable neutrophil count (22,000-28,000) and high ToPro-3 negativity (>99%). 
AI positive and negative JE2 treatment lead to rapid neutrophil lysis, with approximately 
10,000 viable count and 85% of ToPro-3 negativity. The purB incubation without AI in RPMI 
regardless if the strain was grown on BHI agar with or without AI, resulted in attenuated 
neutrophil cell death (15,000-21,000 viable counts) compared to JE2. However, the presence 
of AI in RPMI caused a profound purB induced neutrophil lysis regardless if BHI was 
complemented with AI, where the viable cell counts (7,000-12,000) and ToPro-3 negativity 
(87-91%) are highly similar to JE2.  
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Figure 5.2. Chemical complementation of purB was performed with addition of adenine and inosine (AI) to solid BHI agar at a final concentration 
of 0.02 mg/mL, and RPMI media at same concentration during the 3 hr co-incubation at MOI of 10. The samples were stained with ToPro-3 and 
assessed by Attune flow cytometry. The assay was carried out 3 times in triplicates. Representative profiling from one independent experiment is 
shown. 
A. Viable neutrophil count and ToPro-3 negativity of each sample. Flow cytometry profiling of B-C, ToPro-3 staining controls; D, media controls; 
E, JE2 controls; F, treatment of purB growth from BHI and RPMI without AI; G, treatment of purB inoculated in plain BHI and AI complemented 
RPMI media; H, treatment of purB cultured from AI positive BHI and negative RPMI; I, treatment of purB from AI complemented BHI and RPMI.     
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To verify the results by flow cytometric profiling analysis, the F/T sample displayed high 
ToPro-3 positivity in the histogram compared to PBS control, suggesting successful ToPro-3 
staining (Figure 5.2 B-C). Both media control with and without adenine and inosine (AI) 
complementation showed a compact healthy population in the gated viable neutrophil area and 
very low ToPro-3 positivity, indicating the addition of AI does not cause neutrophil cell death 
(Figure 5.2 D). JE2 infected neutrophils with and without AI leads to profound cell lysis 
(leaving only a very small population in the viable neutrophils gate) and increased ToPro-3 
positivity (Figure 5.2 E), suggesting AI complementation does not prevent neutrophils from 
being lysed by S. aureus. Hence, the controls proved that the chemical complementation of AI 
in RPMI media has no direct effect on neutrophil viability or affect the ability of WT JE2 to 
lyse neutrophils. The purB cultured from BHI agar and RPMI media without AI were 
attenuated in their ability to lyse neutrophils (Figure 5.2 F). The triplicate samples all displayed 
a compact viable neutrophil population with low ToPro-3 positivity, which is consistent with 
the level of attenuation in the screen. The purB grown on BHI agar containing AI but incubated 
with neutrophils without AI, left predominantly viable neutrophils (Figure 5.2 H). On the 
contrary, the addition of AI to RPMI media fully restored the neutrophil lysis ability of purB, 
as demonstrated by massive viable cell loss, increased density of debris, and increased ToPro-
3 positivity (Figure 5.2 G&I). Clearly, chemical complementation was not required for purB 
to grow on BHI as this rich media is likely to contain sufficient purines, but was necessary 
during infection for purB to lyse neutrophils. Hence, lack of purine biosynthesis is a likely 
reason that purB fails to induce neutrophil cell lysis in vitro.  
5.3 In vitro bacterial killing assay  
The lspA, purB and pfo mutants showed robust attenuated neutrophil cell lysis compared to 
WT S. aureus. The attenuated cell lysis phenotype may be caused by a defect in either 
neutrophil phagocytosis or by enhanced killing of internalised bacteria. The bacterial killing 
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assay was therefore carried out with the 3 mutants to determine whether there are any 
differences in neutrophil uptake or neutrophil-mediated killing of the bacteria.  
The S. aureus strains were co-incubated with neutrophils at MOI 5 to prevent technical 
difficulties caused by massive cell lysis. The number of intracellular bacteria was determined 
after 30 and 90 min of co-culture. Lysostaphin was added to the culture at 90 min incubated 
for a further 30 min to eliminate all extracellular S. aureus. The intracellular bacterial load 
was measured at 120 min. The experiment was repeated 3 times. The mean values and data 
from three experiments are shown in Figure 5.3.  
Taking one independent assay as an example, the assay started with approximately 2.5x106 S. 
aureus. After 30 min, 4.1% of JE2, 7.9% of lspA, 4.2% of pfo, and 8.9% of purB were 
internalized by neutrophils. At 90 min, the intracellular bacterial percentage was reduced to 
2.1% of JE2, 2.2% of lspA, 5.0% of pfo, and 2.0% of purB, reflecting bacterial killing over 
this time period. The overall pattern of neutrophil uptake of the different S. aureus strains 
during the first hr of co-incubation is highly similar. Between the 90 and 120 mins, the absence 
of extracellular S. aureus provides an environment for neutrophil killing without further 
phagocytosis of bacteria. By comparing the internal bacterial number at 120 min with 90 min, 
91.2% of JE2, 94.1% of lspA, 92.0% of pfo, and 94.0% of purB were eliminated by neutrophils. 
The combined data shows no obvious deficiency in internalisation or bacterial killing for any 
mutants, or any significant differences among the mean values (Figure 5.3), suggesting the 
attenuation of neutrophil cell lysis was not likely to be caused by lack of neutrophil engulfment 
or increased killing activity against the mutants.  
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Figure 5.3 Neutrophils were co-cultured with S. aureus at MOI of 5. Phagocytosed bacterial 
numbers were quantified after 30 and 90 min by CFU plating. Lysostaphin was added to the 
culture (20µg/ml) at 90 min and incubated for a further 30 min to eliminate all extracellular S. 
aureus. The intracellular bacterial load was measured at 120 min. Mean values and standard 
deviations from 3 repeating experiments are shown.   
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5.4 In vitro phagocytic index assay  
In the bacterial killing assay, even though the same MOI of bacteria were used for all 
experiments, there is variation in bacterial number engulfed by individual neutrophils at the 
initial stage, which likely can generate different infection outcomes. Although the bacterial 
killing assay showed a similar pattern of bacterial uptake and killing when comparing mutant 
strains and the WT, a potential difference of neutrophil phagocytic activity amongst mutants 
remains unclear. Therefore, it is important to measure rates of internalisation using a 
phagocytic index assay which reflects not only the proportion of neutrophils that have taken 
up bacteria, but also how many bacteria each neutrophil contains.  
5.4.1 Quick-Diff staining images of S. aureus-neutrophils co-incubation  
Phagocytic indices were assessed morphologically by light microscopy (Chapter 2.10.4.1). 
Representative figures of three independent experiments are shown in Figure 5.4 and 
indicating the presence of S. aureus as small purple inclusions inside the neutrophil. Images 
of clpP treatment were failed to be captured due to technical errors.  
After 2 hr of co-incubation at MOI of 5, JE2 resulted in lysed neutrophils, some containing a 
high number of S. aureus (Figure 5.4). Treatment of lspA, purB, and pfo showed comparatively 
more viable neutrophils with small numbers of engulfed S. aureus (yellow arrows) than JE2, 
and fewer lysed neutrophils (red arrows). The results are in agreements with attenuated 
neutrophil cell death phenotypes shown in the NTML screen.  
Considering the potential confounding influence due to neutrophil cell death and S. aureus 
amplification by JE2 after 2 hr, phagocytic index assay was carried out after 1 hr co-incubation.  
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Figure 5.4. Diff-Quik staining images of S. aureus-neutrophil co-incubation. After 2 hr co-
incubation of neutrophils with S. aureus at MOI of 5, the WT leads to a combination of a 
neutrophil population including live cells with (yellow arrows) and without phagocytised 
bacteria (purple dots), and lysed cells with massively replicated bacteria (red arrows). The 
three S. aureus mutants all resulted in a similar phagocytosis pattern but with less neutrophil 
death.    
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5.4.2 Phagocytic index calculation by Diff Quik staining  
Neutrophils were incubated with S. aureus at an MOI of 10 for 1 hr. Cytospins were prepared 
for each group and 300 neutrophils were counted per slide. The number of engulfed bacteria 
and the number of neutrophils with and without engulfed bacteria were counted by light 
microscopy. To determine the variation in engulfment by neutrophils of the mutants 
comparing to the WT, the phagocytic index was calculated based on the formula below: 
Phagocytic index = (Total number of engulfed S. aureus/Total number of neutrophils) x (Total 
number of neutrophils containing engulfed S. aureus/Total number of neutrophils) x 100  
No significant difference in neutrophil phagocytic activity was observed between purB or pfo 
with JE2 (p>0.05). Both clpP (p=0.0002) and lspA (p=0.0018) showed significantly reduced 
neutrophil phagocytic activity in comparison to WT (Figure 5.5). Hence, defective neutrophil 
engulfment of clpP and lspA is a possible reason why these two mutants displayed attenuated 
neutrophil cell lysis.  
5.4.3 Alexa Fluor 647 and pHrodo staining of S. aureus 
The Diff Quik dyes allow effective staining of S. aureus but it is not possible to know the exact 
location of S. aureus, particularly whether the bacteria are in an intracellular compartment and 
within phagosomes. To address this, S. aureus were stained with pHrodo (Life Technologies) 
which is a pH sensitive red fluorescent cell wall dye that generates a fluorescent signal below 
pH 5, i.e. within the acidified phagosome (Zhu et al., 2015). This was used in combination 
with Alexa Fluor 647, which is a pH-insensitive, bright, far-red fluorescent dye. S. aureus 
strains were stained with pHrodo and Alexa Fluor 647 as described in section 2.11.1, followed 
by incubation with neutrophils for 1 hr at a MOI of 10 (and 50 due to dilution error). DAPI 
was used to stain the nucleus of neutrophils. The cells were imaged with an Olympus upright 
fluorescence microscopy system.  
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A representative figure of JE2 infected neutrophils at MOI of 50 showed S. aureus with red 
(pHrodo) and green (Alexa Fluor 647) fluorescence in neutrophils (Figure 5.6). Theoretically, 
Alex Fluor 647 shows all S. aureus (Figure 5.6 D) in the co-culture while pHrodo indicates 
bacteria within acidified phagosomes (Figure 5.6 C). However, quantification of fluorescent 
positive bacteria revealed that from all individual samples, the number of pHrodo positive S. 
aureus was consistently higher than the number of Alexa Fluor 647 positive bacteria, possibly 
caused by overall acidic environment. Attempts were made to further optimize the staining 
protocol and microscopy system. However imaging the of far-red channel failed to produce 
an adequate capture of the complete S. aureus population, suggesting low efficiency of Alexa 
staining. Additionally, the widespread pHrodo positive S. aureus covered most neutrophil 
intracellular compartments instead of only phagosomes as expected (Figure 5.6 A).  
The phagocytic index assay was carried out at an MOI for 1 hr. treatment of pKH67 (Sigma), 
a green fluorescent cell membrane labelling dye, was performed to stain neutrophil membranes, 
which provides distinct boundary for quantification per cell. The Alexa Fluor 647 dye was not 
used in this assay due to it poor staining efficiency in previous experiments. Images from 3 
independent experiments were taken using the same microscopy setting, a representative 
figure is shown in Figure 5.7 A. Among the thirty neutrophils, 16 cells remained intact in the 
absence of engulfed bacteria, 10 viable cells had phagocytosed S. aureus. The remaining 4 
dead cells showed a large number of expelled pHrodo positive pfo, suggesting potential post-
phagocytotic S. aureus survival and replication. The fluorescent stained cells displayed 
consistent results compared to neutrophil cell lysis result showed in section 5.4.1.  
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Figure 5.5 Phagocytic index assay of clpP, purB, lspA and pfo mutants in comparison to JE2. 
Healthy primary neutrophils were co-incubated with each strain at MOI of 10 for 1 hr followed 
by cytospin preparation with Quick-Diff staining. This assay was repeated 6 times, the mean 
values and standard deviations are shown. Both clpP (p=0.0002) and lspA (p=0.0018) showed 
significantly reduced neutrophil phagocytic activity in comparison to WT. 
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Figure 5.6 Representative images of a fluorescent stained neutrophil-S. aureus co-incubation. 
S. aureus was stained with pHrodo and Alexa Fluor 647 before co-incubation with neutrophils. 
Neutrophils were stained by DAPI and pKH67 after bacterial treatment. Fitters used for 
microscopy imaging were listed in Table 2.8. Co-culture of neutrophils and JE2 at MOI of 50 
for 1 hr.  
A. Overlay channel image 
B. DAPI channel for DAPI detection  
C. TxRed channel for pHrodo detection 
D. Cy5 channel for Alexa Fluor 647 detection   
A                                                                       B
C                                                                       D
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5.4.4 Phagocytic index calculation by fluorescent staining    
The number of pHrodo stained lspA, clpP, pfo and purB were counted automatically by ImageJ 
and the phagocytic index was determined accordingly, and shown in comparison with JE2 in 
Figure 5.7 B. JE2 displayed a phagocytic index of 3,701 on average, which is similar to pfo 
(3,470). lspA displayed comparatively higher phagocytic index (4,685), while purB (2,912) 
and clpP (1,955) showed lower phagocytic index. No significant difference was found in this 
assay, presumably because of the large variation of data. During the analysis of images, it was 
noticed that phagocytic index counts from one experiment was overall two-fold higher than 
the remaining two repeats, which compromised the combination of data and led to the large 
deviation. A few individual samples failed to produce sufficient countable cells due to 
technical errors. In addition, the range of phagocytic indices from the fluorescent staining is 
approximately 1000 to 8000 (Figure 5.7), which exceeds dramatically the normal range (50-
300) (Figure 5.5). The data suggests that S. aureus were probably exposed in an acidic 
environment during pHrodo staining.  
5.5 Analysis of S. aureus strains in vivo  
5.5.1 Zebrafish embryo model of infection 
The zebrafish embryo model of infectious disease has been developed for studying host 
pathogen interactions. It allows rapid, real-time in vivo pathogenesis studies of many microbes 
including S. aureus (Prajsnar et al., 2008). In order to explore the role of lspA, purB, clpP, and 
pfo in pathogenicity, the corresponding mutants were assessed using the zebrafish embryo 
model. A minimum of thirty LWT zebrafish embryos at 1 day old were injected with a dose 
of approximately 1500 CFU S. aureus strains. The bacteria were injected into the circulation 
valley of embryos (Figure 5.8) as described in section 2.12, a well-established route of 
infection. S. aureus infected embryos could be visually distinguished from un-infected 
embryos, based on the cloudy bacteria injected into the circulation valley (Figure 5.8). The 
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embryos were monitored twice a day till 92 hrs after injection and mortality was detected by 
cessation of heartbeat or destruction of tissue.  All in vivo experiments in this study were 
conducted with a PBS injection control group. The survival rates in the PBS group were > 90% 
confirming health of the embryos and good zebrafish injection skills. All statistical analysis 
was completed by GraphPad Prism Version 6.0. Representative data are shown from 
independent experiments, but not combined due to zebrafish batch variation.   
The survival curves of S. aureus infection demonstrated that mortality of zebrafish embryos 
is dependent on the infecting strain. As expected, embryos injected with WT mostly died 
(81.25%) within 92 hr (Figure 5.9 A). The lspA resulted in very similar survival curve to WT 
with a final death rate of 95.71% at 92 hr. In contrast, purB strain was not able to kill zebrafish 
embryos and resulted in only 10.55% of death. In separate experiment, WT consistently caused 
rapid embryo death, with a final survival rate of 3.85% (Figure 5.9 B). Although a delay of 
mortality pattern was observed, pfo produced similar survival rate to WT with 12.00% of 
viable embryos after 92 hr. Like purB, the clpP strain displayed attenuated embryo killing 
with 86.96% viability at 92 hr.  
Many virulence factors of S. aureus are human specific or have host-dependent effects (Spaan 
et al., 2013b). Hence, the potential significance of lspA and pfo in humans cannot be ruled out 
due to lack of attenuation result in the zebrafish model. On the other hand, the significantly 
reduced pathogenicity of purB and clpP mutants in vivo suggests an importance of these two 
genes in host-pathogen interactions. The following experiments were aimed at investigating 
why clpP and purB failed to cause high level of killing. It was hypothesised that the absence 
of ClpP and PurB affects S. aureus survival or bacterial growth in vivo. Thus, the growth of S. 
aureus mutants was determined in vivo. 
     
 
206 
 
 
Figure 5.7 Phagocytic index assay with fluorescent staining.  
A. Neutrophils treated with pfo at MOI of 10 for 1 hr. Overlay channels of DAPI (blue), 
pKH67 (green) and pHrodo (red) are shown in the image.  
B. Phagocytic index count of clpP, purB, lspA and pfo mutants from pHrodo staining. The 
assay was carried out at MOI of 10 and incubated for 1 hr. The experiment was repeated 3 
times, and a minimal total number of 300 neutrophils were counted from each strain. The mean 
value of calculated phagocytic index was used for comparison with the WT.   
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Figure 5.8 Representative images to show zebrafish embryo injection point, morphology of 
healthy and S. aureus infected embryos. Bacterial strains were injected into the circulation 
valley of the embryo at 1 dpf. PBS injection was conducted within every independent 
experiment as a control. The cloudy bacteria shown in S. aureus infected embryo is visually 
clear during the maintenance of zebrafish. The embryos were monitored twice a day until 92 
hr after injection and mortality was detected by cessation of heartbeat or destruction of tissue. 
The image showing circulation valley displays an embryo 24 hpf. The PBS and S. aureus 
injected embryos were imaged 48 hpf.    
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Figure 5.9 Virulence study of clpP, purB, lspA, and pfo in the zebrafish embryo model of 
infection. Survival of LWT zebrafish embryos was assessed upon injection of 1500 CFU JE2 
or mutants. *** p<0.0001   
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5.5.2 Growth of S. aureus mutants in vivo     
The survival study results raised a question as to whether the causality of attenuated zebrafish 
embryo killing involves deficiency of purB and clpP growth in vivo. To determine the bacterial 
growth in embryos, between 800-1000 CFU of S. aureus were injected in each zebrafish 
embryo at one dpf. From each experimental group, five live embryos and all dead embryos 
were collected, homogenised and plated out to measure bacterial CFU at each timepoint 
(Figure 5.10). The WT was able to kill a large number of zebrafish (53.6%) within 92 hr 
(Figure 5.10 E), and these dead fish contained over a thousand-fold more bacteria (>106 CFU) 
than the starting number (Figure 5.10 A), suggesting that WT has the ability to replicate in 
vivo and overcome the host. The embryos with less than 105 CFU (WT) remained viable. 
Similarly, pfo mutant was also able to replicate in vivo and kill zebrafish (53.6%) resulting 
in >106 CFU in dead embryos (Figure 5.10 B). Typically, the number of WT and pfo in 
infected live zebrafish gradually decreased following the injection, indicating clearing of S. 
aureus in vivo. Consistent with the in vitro neutrophil pathogenicity study (section 5.5.1). Both 
purB and clpP demonstrated defective virulence, with 96.87% and 87.5 % of survival at 92 hr 
respectively (Figure 5.10 F). All live infected embryos contain no more than 106 CFU of 
bacteria (Figure 5.10 C-D), indicating purB and clpP mutants failed to kill zebrafish due to 
either growth deficiency, or enhanced killing by immune cells in vivo.  
5.5.3 Virulence phenotype in zebrafish embryo with compromised innate immunity    
Following the growth assay, low bacterial numbers of purB and clpP has been identified as 
presumably the causality of attenuated zebrafish killing. Whether this was due to deficient 
replication, or better immune control by phagocytes was unknown. Even though lspA and pfo 
showed similar virulence as WT and led to zebrafish death, the importance of these two genes 
in staphylococcal modulation of human neutrophil was shown in NTML screen. Hence, it was 
important to determine pathogenesis in a phagocyte depleted model. Virulence of S. aureus 
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mutants was identified in zebrafish without neutrophil and macrophages. Morpholino 
oligonucleotides were used to induce a transient knock down of expression of myeloid cells. 
Morpholino refers to modified polynucleotides that are effectively able to block translation of 
a gene of interest. Its distinct structure consists of altered ribose or deoxyribose rings and 
phosphodiester bonds preventing hydrolysis upon injection (Bill et al., 2009). The morpholino 
used in this study is complementary to the translational start site of transcriptional factor, pu. 
1, and aligning over the AUG start codon of target mRNA. After transportation into the 
cytoplasm, this double stranded RNA fragment cannot be recognized by ribosomes and 
subsequently is degraded (Bill et al., 2009). Consequently, the appearance of neutrophils is 
delayed until 36 hpf and macrophages until 48 hpf (McKercher et al., 1996, Rhodes et al., 
2005, Klemsz et al., 1990). The pu.1 morpholino was injected into the yolk of embryos at the 
1-4 cell stage. Following this, approximately 1000 CFU of S. aureus were injected 30 hr post 
fertilisation.  
In the absence of neutrophils and macrophages, WT (JE2) leads to rapid zebrafish death at 22 
hr after injection, with only 6.7% survival (Figure 5.11), demonstrating the importance of these 
cells in host response to S. aureus. lspA and pfo were attenuated, resulting in 0% and 12.9% 
survival by 44 hr post infection. Interestingly, the clpP mutant resulted in rapid killing with 
16.85% alive zebrafish by 44 hr and 3.5% by 92 hr of infection, suggesting the pathogenicity 
was fully complemented by pu.1 morpholino treatment. However, the depletion of myeloid 
cells had no effect on virulence of purB, where 75% of embryos survived after 92 hr of 
infection.   
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Figure 5.10 Survival curves and growth of clpP, purB, pfo, and WT in LWT zebrafish embryos. 
LWT zebrafish embryos were injected with 1000 CFU JE2 or mutants. 
A-D). Growth of each bacterial population within zebrafish embryos. 
E-F). Survival curves of pfo, clpP, and purB injection.  
o = live embryos, • =dead embryos. At each timepoint 5 live embryos and any dead embryos 
were homogenized for CFU counts. N=1  
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Figure 5.11 Representative survival curves of clpP, purB, lspA, and pfo together with WT in 
pu.1 morpholino injected LWT zebrafish embryos. Survival of LWT zebrafish embryos was 
assessed upon injection of 1000 CFU JE2 or mutants. N=2  
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5.6 Discussion 
This chapter aimed to identify mechanisms responsible for the attenuation of neutrophil cell 
death, and to also characterise pathogenicity in vivo. Four genes not previously associated with 
S. aureus virulence against neutrophil responses namely purB, lspA, pfo and clpP were 
identified as being defective in lysing neutrophils (see Chapter 4). The virulence of the purB 
mutant was fully restored by chemical complementation of purines in co-culture media. 
Significantly reduced phagocytic index of clpP and lspA were observed in comparison to the 
WT in vitro. A S. aureus-zebrafish embryo model was performed to determine whether 
pathogenicity was affected in vivo. Out of the four strains, infection with clpP and purB were 
significantly less likely to result in death of zebrafish. Measurement of bacterial growth in 
zebrafish embryos revealed direct linkage of bacterial replication with host mortality. Low 
bacterial number compromised pathogenicity of clpP and purB in the zebrafish model. A 
transient gene knockdown using pu.1 morpholino resulted in loss of neutrophils and 
macrophages until 36-48 hpf respectively. Compared to the survival study in WT (phagocytes 
sufficient) zebrafish, WT, lspA and pfo infection resulted in enhanced embryo killing after a 
few hrs, suggesting the importance of phagocytes in host defence against S. aureus infection. 
Virulence of clpP was fully restored compared to JE2 in the absence of phagocytes 
demonstrating the importance of the clpP in phagocytic interactions. No change host survival 
was found with purB infection in the pu.1 knockdown likely indicating the attenuated 
phenotype resulted from de novo purine biosynthesis deficiency rather than regulation of 
phagocytes response.   
5.6.1 Analysis of purB     
Analysis of the purB mutant was carried out following the scheme shown in Figure 5.12. 
Adenylosuccinate lyase, the product of the purB gene, is a member of the aspartase-fumarase 
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superfamily of enzymes. The crystal structure of this protein has been determined from several 
organisms including Homo sapiens, E. coli, and S. aureus (Vedadi et al., 2007, Tsai et al., 
2007, Fyfe et al., 2010). The dual substrate specificity of adenylosuccinate lyase in S. aureus 
was demonstrated as metabolism of SAICAR and adenylosuccinate (Figure 5.1). Hence, it 
controls the levels of ATP and GTP synthesis via the purine biosynthesis pathway. Previous 
studies based on metabolic reconstructions and bioinformatic comparisons predicted the purB 
synthesized enzyme plays an essential role in S. aureus metabolism (Heinemann et al., 2005).  
The importance of purine biosynthesis in the S. aureus-mediated infection process is poorly 
characterised. Recently, purine antagonists were developed for potential anti-bacterial therapy, 
due to the essential metabolism involvement (Gottlieb and Shaw, 2013). From a S. aureus 
abscess study in a murine model, purA was found to be attenuated (Lan et al., 2010).   
Previous laboratory work (Dr. John Connolly) showed that purB is a purine auxotroph (data 
not published), which is consistent with a role of purB gene in S. aureus metabolism (Baxter-
Gabbard and Pattee, 1970). Attempts were also made by Connolly to chemically complement 
the purB strain in the zebrafish embryo model with adenine and inosine, yet the bacterial 
virulence was failed to be restored. Since it was not possible to verify uptake of adenine and 
inosine by zebrafish, the requirement of purines for host mortality remains unclear. The 
experiment suggested low availability of purines in zebrafish embryos, which is in agreement 
with the attenuation of purB mutant in our survival study; and explains the lack of bacterial 
replication in vivo. The attenuated host killing phenotype in this study suggests the de novo 
purine biosynthesis is the limiting factor for purB mutant growth and pathogenesis in the 
zebrafish model, not phagocytes interactions.  
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Figure 5.12 Diagram of the analysis of the purB gene.  
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Based on the assessment of phagocytic index (Figure 5.5), no deficiency in neutrophil uptake 
of purB mutant was found compared to WT, suggesting purB gene is not involved in 
modulation of phagocytosis. It was verified that BHI media is sufficient for normal growth of 
the purB mutant (Figure 4.12), while lack of chemical complementation in RPMI media lead 
to attenuated neutrophil lysis (Figure 5.2). Evidently, loss of purine biosynthesis is the limiting 
factor for post-phagocytosed S. aureus to lyse neutrophils, which implies the potential 
necessity of bacterial replication inside neutrophils for inducing immune cell death.     
5.6.2 Analysis of lspA     
Analysis of the lspA mutant was carried out following the scheme of the summarized data 
shown in Figure 5.13. The lipoprotein signal peptidase expressed by lspA is a cytoplasmic 
membrane localized enzyme required for biogenesis of bacterial lipoproteins (Shahmirzadi et 
al., 2016). LspA is anchored on the periplasmic leaflet of the membrane via a conserved lipid-
modified cysteine residue at the N-terminus (Nakayama et al., 2012). The maturation of 
lipoproteins includes two or three modification steps. First, a diacylglyceryl group is 
transferred onto a lipobox cysteine by phosphatidyl glycerol diacelyglyceryl transferase (Lgt). 
Next LspA recognizes and cleaves the signal peptide at the +1 S-diacylglyceryl cysteine of the 
prolipoproteins (Nakayama et al., 2012). Structurally there are two types of lipoprotein: 
diacylated, and triacylated. Both forms of lipoproteins have been reported in S. aureus 
(Kurokawa et al., 2009). Moreover, variation between diacylated and triacylated lipoprotein 
structure in S. aureus has been found to be environment-dependent, particularly pH -mediated 
(Kurokawa et al., 2012).   
Lipoproteins play essential roles in host-pathogen interactions. They function as pathogen-
associated molecule patterns and mediate inflammation through activating TLR2 signalling 
cascades (Bubeck Wardenburg et al., 2006, Schmaler et al., 2010, Kim et al., 2015). A few 
studies strongly suggest that S. aureus lipoproteins induce production inflammatory cytokines 
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including TNF-α and IL-6 (Kurokawa et al., 2009, Bubeck Wardenburg et al., 2006). In a 
murine infection model, lspA mutant in the S. aureus Newman background failed to replicate 
in liver or to develop acute, lethal disease. Another gene required for lipoprotein maturation: 
lgt, is required for lipoprotein acylation. The lgt mutant induces less TNF-α and IL-6 
production, proliferates to higher numbers compared to WT, and results in rapid and profound 
mortality of infected mice (Bubeck Wardenburg et al., 2006). In comparison to WT, infection 
of murine macrophages by lipoprotein deficient S. aureus results in lack of nitric oxide 
production, decreased expression of inducible nitric oxide synthase, and absence of TLR2 
activation (Kim et al., 2015). Hence, mature lipoprotein is essential for initiating and 
sustaining effective activation of host immunity. In agreement with the significance of 
lipoproteins in immune cell recognition, the significantly reduced phagocytic index result of 
the lspA mutant in our study suggests that lack of lipoproteins prevents efficient neutrophil 
uptake of S. aureus. As well as activation and recruitment, the TLR2 signalling pathway has 
been found to inhibit neutrophil apoptosis (Sabroe et al., 2005). Thus, lipoprotein induced 
TLR2 activation is relevant to neutrophil cell death and impaired host defences against 
bacterial infection (Roger and Calandra, 2009), which also implies that TLR2 activation of 
neutrophils may be necessary for S. aureus to cause immune cell lysis, and the attenuated 
phenotype caused by lspA in our study is due to lack of TLR2 activator: lipoprotein. To address 
this hypothesis, TLR2 blocking antibodies could be used to identify neutrophil-S. aureus 
interaction in future work. The importance of lspA in S. aureus pathogenicity was also reported 
with the attenuated virulence of lspA mutant in S. aureus RN6390 background, where this 
mutant failed to be recovered from spleens and blood of mice after co-infection with a mixture 
of 96 S. aureus strains, suggesting LspA is essential for bacterial replication in vivo (Mei et 
al., 1997).  
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5.6.3 Analysis of pfo 
Pfo encodes pyruvate ferredoxin oxidoreductase α subunit, which is involved in the oxidative 
decarboxylation of pyruvate to acetyl-CoA and CO2 (Figure 5.1 B). Pyruvate ferredoxin 
oxidoreductase is an essential enzyme of central metabolism (Ballard et al., 2010, Dubreuil et 
al., 1996, Finegold et al., 2009, Hoffman et al., 2007, Horner et al., 1999). To date, a pfo 
phenotype has not been described in S. aureus-neutrophil interaction and the role of pyruvate 
ferredoxin oxidoreductase in staphylococcal pathogenicity is poorly investigated. In a mouse 
infection model, inhibition of pyruvate ferredoxin oxidoreductase was found to be efficacious 
against Clostridium difficile infection (Warren et al., 2012). Warren et al suggests the pyruvate 
ferredoxin oxidoreductase is important for bacterial virulence, which is consistent with the 
robust attenuated neutrophil lysis demonstrated by pfo (Figure 5.14). A study carried out in T. 
vaginalis reveals the pyruvate ferredoxin oxidoreductase is a surface-associated cell adhesion 
protein involved in host cell-binding activity (Meza-Cervantez et al., 2011). Inhibition of 
pyruvate ferredoxin oxidoreductase in T. vaginalis led to decreased parasite proliferation and 
adhesion to vaginal epithelial cells, and smaller tissue abscess formation in mice (Song, 2016). 
However, interruption of the staphylococcal pfo gene gave no alteration of neutrophil 
phagocytosis or bacterial replication in zebrafish (Figure 5.14). Thus, the cell binding function 
and role in bacterial growth is less likely to be applicable to S. aureus pfo. In support, the 
augmentation of pfo virulence in phagocyte depleted zebrafish indicates the gene function is 
involved in modulation of host innate immune defences. It may be that lack of oxidative 
decarboxylation of pyruvate reduced metabolic activity, which further negatively regulated 
post phagocytosed S. aureus survival. Further research to identify the link between deficiency 
of pfo and neutrophil cell lysis is required. Fluorescent labelling and time lapse microscopy 
can be combined to visualise the progress of host-pathogen interaction.  
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5.6.4 Analysis of clpP      
Analysis of the clpP mutant was carried out following the scheme of the summarized data 
shown in Figure 5.15. Caseinolytic protease proteolytic subunit, the product of clpP gene, 
forms the Clp chaperone protease complex with an ATPase specificity factor. The main 
function of Clp proteases is protein degradation and the proteases are well conserved in most 
bacterial species (Savijoki et al., 2006, Frees et al., 2007). The chamber of Clp proteases 
consists of a barrel shaped structure that is formed by two heptameric ClpP rings (Figure 5.1). 
To be degraded, protein substrates are unfolded and translocated to the ClpP proteolytic 
chamber through Clp ATPase activity (Frees et al., 2007). In S. aureus, two ATPases namely 
ClpC and ClpX are found with this function (Figure 5.1 D). Additionally, two ATPases namely 
ClpL and ClpB act as chaperones without interaction with Clp peptidase (Martin et al., 2008).  
During infection, microorganisms are exposed to a range of environmental changes which can 
affect viability. This exposure to stresses such as changes in oxidative potential, temperature, 
pH and antimicrobial peptides may result in protein misfolding. Consequently, the removal of 
misfolded and aggregated non-native proteins is crucial for bacterial growth and functionality 
(Truscott et al., 2011). The ClpB and ClpL chaperones contribute to stress tolerance through 
preventing unfolding or facilitating protein disaggregation (Glover and Lindquist, 1998).  
ClpCP is believed to degrade non-native proteins in S. aureus mediated by a teicoplanin 
resistance factor A (TrfA) (Feng et al., 2013). Inhibition of ClpP, ClpB and ClpC in S. aureus 
leads to reduced bacterial growth at high temperature (Frees et al., 2003, Frees et al., 2004, 
Frees et al., 2012). A threefold transcription of S. aureus clpP was observed at 30oC, the 
expression at 20oC was fourfold than normal level (37oC), suggesting ClpP functionality plays 
an essential role in staphylococcal survival at low temperature (Michel et al. 2006). A global 
stress regulator known as Spx which positively modulated the disulphide-stress response, has 
been identified in the ClpP proteolytic chamber (Feng et al., 2013). The cellular homeostasis 
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under non-stress conditions are regulated by ClpXP degradation to achieve a low Spx 
concentration. Under disulphide stress, several oxidative stress tolerance genes are 
transcriptionally activated by stable Spx (Garg et al., 2009, Larsson et al., 2007, Nakano et al., 
2003, Engman et al., 2012). Clp proteases also target DNA damage repair proteins. The 
transcriptional repressor LexA is degraded by ClpXP and ClpCP in S. aureus (Butala et al., 
2009, Cohn et al., 2011).  
Apart from stress tolerance, a large number of proteins involved in S. aureus metabolism and 
cell division, such as cell division protein family Fts and the pentaglycine cross bridge 
formation family Fem, have been found among the ClpP substrates (Frees et al., 2012). 
Another category of roles of the Clp complex have been identified in antibiotic resistance. 
Mutation of the trfA gene increased susceptibility of glycopeptide intermediate sensitive S. 
aureus strains to vancomycin and teicoplanin, possibly due to antibiotic stress response in 
conjunction with ClpCP proteolysis (Renzoni et al., 2009). Inhibition of ClpXP led to 
increased USA300 β-lactam resistance via changes in cell wall metabolism (Baek et al., 2014). 
Evidence was found that clpP mutants in Newman, USA300, and ST59 backgrounds lead to 
increased expression of fibronectin- and fibrinogen-binding proteins, and thickened biofilm 
formation, which was caused by the decreased agr activity (Liu et al., 2017). Unlike the 
polysaccharide intercellular adhesion-dependent biofilm, the constituents of biofilm formed 
by strains lacking ClpP only contains proteins and extracellular DNA, due to enhanced activity 
of peptidoglycan hydrolase Sle1. Nonetheless, the virulence of clpP mutant was not 
compensated by the increased cell surface proteins and biofilm formation in a murine infection 
model (Liu et al., 2017).  
Without doubt the ClpP complex is essential for S. aureus protein maintenance and therefore 
closely involved in a range of key regulations of bacterial survival under stress and during 
antibiotic resistance. Moreover, significant phenotypes of clpP mutants were found in multiple 
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studies due to its role in regulating expression of virulence genes (Frees et al., 2003, Frees et 
al., 2005a, Frees et al., 2005b, Michel et al., 2006, Feng et al., 2013, Farrand et al., 2013). An 
approximately 100-fold decreased transcription of genes encoding extracellular protease 
including SspA, Aur, and Spl was found with deletion of clpP. Another example is 10-fold 
reduced transcription of α-hemolysin gene hla in S. aureus (Feng et al., 2013, Frees et al., 
2003). In addition, inactivation of clpP affected expression of virulence factors such as sspA 
and spa in a global transcriptomic and proteomic analysis in S. aureus (Frees et al., 2012).  
Although the stability of transcriptional virulence regulators in S. aureus is highly likely 
dependent on ClpXP, none of the regulators were identified as substrates of ClpP (Michalik et 
al., 2012, Feng et al., 2013). The possibility of direct ClpP proteolytic influence on these 
regulators cannot be ruled out due to regulatory proteins are small, highly basic, and at low 
amount, which increases the experimental challenge of molecule detection through MS or gel 
electrophoresis. Alternatively, an indirect link between the virulence gene regulation and 
ClpXP was proposed based on the theory that clpP deletion induced stress might result in 
metabolic signals that further modify cellular virulence control. Moreover, the change of cell 
wall structure may have a negative impact on signal transfer and therefore reducing expression 
of virulence genes in clpP mutants (Frees et al., 2014). Whatever is the mechanism, the 
involvement of ClpP in S. aureus virulence gene regulation and pathogenesis has been well 
established.  
The essential role of ClpP and ClpX in S. aureus virulence was found in a mouse model where 
inactivation of the proteases leads to absence of α-hemolysin expression and complete 
elimination of abscess formation (Mei et al., 1997, Frees et al., 2003). Abolished intracellular 
replication of clpP mutant was observed in bovine mammary cells (Frees et al., 2004). A 
recent study of clpP deficient Legionella pneumophila revealed lack of bacterial amplification 
and   poor escape from endosome-lysosomal pathway in mammalian cells (Zhao et al., 2016). 
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In another species, Lesteria monocytogenes, clpP is also required for bacterial survival in 
murine macrophages (Gaillot et al., 2000). Cao et al (2013) uses ClpP as an antigen for 
mucosal immunization use against Streptococcus pneumoniae. This induced systemic and 
mucosal antibodies, reduced lung colonization and mice deaths in an intraperitoneal-sepsis 
model. The existence of anti-ClpP antibody complemented polymorphonuclear leukocyte 
killing of S. pneumoniae in vitro (Cao et al., 2013). In dendritic cells, clpP expression 
upregulated S. pneumoniae uptake and phagocytosis, and apoptosis rate of the infected 
immune cells (Cao et al., 2013).   
Consistent with the evidence of universal significance of clpP in bacterial survival and 
virulence above, Tn disrupted clpP mutant showed decreased neutrophils uptake comparing 
to WT. The robust attenuated phenotype in neutrophil cell death assay indicated an essential 
role of clpP in S. aureus virulence against human neutrophils. It is highly likely that lack of 
ClpP function compromised stress resistance against the intra-phagosomal environment, 
leaving the bacteria static or killed by neutrophils, instead of lysing the immune cells. To test 
this, time lapse microscopy aimed at tracking post-phagosomal clpP could be conducted in 
further work. The other two genes encoding the Clp protease complex subunits in NTML 
namely clpB and clpC failed to show attenuated phenotype in the 1st round of screen. The clpC 
mutant lysed similar number of neutrophils comparing to JE2 (approx. 50%) st 3 hrs. The role 
of ClpB or ClpC may not be essential for S. aureus interaction with neutrophils in the sense 
that the intact ClpXP can maintain major functionality of the Clp protease complex; while the 
activity of clpB could be complemented by clpL. Results found upregulated gene expression 
of clpB and clpC following neutrophil phagocytosis of S. aureus, suggesting the ClpB 
chaperone and ClpC ATPase are likely to be actively involved in post-phagosomal survival 
and regulation of virulence factors (Voyich et al., 2005). I, however, did not identify clpB or 
clpC from the NTML, possibly due to false negativity bound by the nature of screen.   
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Figure 5.13 Diagram of lspA gene analysis summary.  
lspA
Phenotype of attenuation in neutrophils cell lysis was 
confirmed by gene transduction and complementation.  
Phagocytic index assay Zebrafish embryo analysis
Decreased uptake by 
neutrophils in 
comparison to the WT
No attenuation in zebrafish killing
No growth deficiency in zebrafish
Augment of pathogenicity in the 
absence of phagocytes
Conclusions:
• The importance of lspA gene of S. aureus in regulating neutrophil defence was confirmed from
both in vitro immune cell death assay and pu.1 morpholino injected zebrafish embryo model.
• LspA may facilitate bacterial uptake by neutrophils.
• The mechanism of LspA induced attenuated phenotype remains unclear.
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Figure 5.14 Diagram of the analysis of the pfo gene. 
  
pfo
Attenuation of neutrophils cell lysis was confirmed 
by gene transduction.  
Phagocytic index assay Zebrafish embryo analysis
Similar uptake rates 
by neutrophils in 
comparison to the WT
No attenuation in zebrafish killing
No growth deficiency in zebrafish
Augment of pathogenicity in the 
absence of phagocytes
Conclusions:
• The importance of pfo gene of S. aureus in regulating neutrophil defence was confirmed from
both in vitro immune cell death assay and pu.1 morpholino injected zebrafish embryo model.
• The mechanism of Pfo induced attenuated phenotype remains unclear.
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Figure 5.15 Diagram of the analysis of the clpP gene. 
  
clpP
Attenuation of neutrophils cell lysis was confirmed by 
gene transduction and complementation.  
Phagocytic index assay Zebrafish embryo analysis
Significantly reduced 
neutrophil uptake in 
comparison to the WT
Attenuated zebrafish killing
Growth deficiency in zebrafish
Significant restoration of pathogenicity 
in the absence of phagocytes
Conclusions:
• The attenuated neutrophil cell lysis is presumably caused by low number of engulfed clpP
mutants, suggesting post-phagocytosis survival and escape is a highly important for S. aureus to
overcome neutrophil defence.
• The ClpP plays an essential role in bacterial replication and modulating neutrophils immune
strategies in zebrafish, indicating it is a robust key virulence factor of S. aureus.
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CHAPTER 6 
Discussion 
6.1 Summary of the findings of this thesis 
I have identified four S. aureus genes, namely purB, lspA, clpP, and pfo, as having a role in 
the induction of human neutrophil cell death. These findings were generated by a genome-
wide genetic screen of 1,920 S. aureus mutants in a flow cytometric assay of neutrophil lysis. 
The blinded nature of this assay and the identification of genes known to be critical in 
neutrophil cell death (agrA and saeS) validated the design of the model, which to our 
knowledge, has not been done before. These findings were confirmed in transductions and 
complementation of mutations, verifying that the phenotype is as a result of a lesion in the 
target gene. An in vivo zebrafish infection model showed that the clpP, but not pfo or lspA 
mutants were attenuated in their ability to kill zebrafish and concomitant with this, 
demonstrated a profound growth defect in vivo. Infection of pu.1 phagocyte deficient zebrafish 
displayed a significant augmention of pathogenicity of the clpP, but not the purB mutant, 
suggesting staphylococcal ClpP is involved in neutrophil responses. 
For the purB mutant, a deficiency in purine biosynthesis and therefore a failure to properly 
replicate in a nutrient poor environment (i.e. the intra-neutrophil compartment) is likely to 
explain the reduction in neutrophil lysis. This was confirmed by the addition of adenine and 
inosine in chemical complementation experiments. In terms of pfo, pyruvate synthesis and 
oxidation reactions regulated by Pfo comprise a number of intermediate compounds in the 
TCA cycle, and lack of this metabolic modulator may be a limiting factor for S. aureus 
pathogenesis globally, although further experiments are required to elucidate the mechanism. 
A defect in phagocytosis of the lspA mutant suggests a potential role for lipoproteins in 
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neutrophil recognition and phagocytosis. Significantly reduced engulfment of the clpP mutant 
indicates that ClpP is required for neutrophil phagocytosis. Necessity of clpP for bacterial 
growth in vivo and killing of phagocyte competent zebrafish suggests the importance of clpP 
in bacterial survival and pathogenesis. This is possibly via Clp ATPase regulated post-
phagocytosed stress tolerance but perhaps more likely, clpP modulated expression of secreted 
toxins such as α-hemolysin (Feng et al., 2013).  
6.2 How the findings advance the understanding of neutrophil defence 
against S. aureus 
This is the first description for a role for lspA, clpP, purB and pfo in S. aureus induced 
neutrophil cell lysis. The fully restored virulence of the purB mutant by chemical 
complementation suggests that the attenuated phenotype was due to lack of de novo purine 
synthesis. The in vivo infection on the phagocyte depleted zebrafish embryo model displayed 
similar host survival compared to the phagocyte competent model, which further validated a 
phagocyte-independent role of PurB.  
Pyruvate metabolism has not been previously characterised as a limiting factor for the 
virulence of any aerobic bacteria. Previous studies revealed that pfo is required for parasite 
proliferation and anaerobic bacterial virulence (Warren et al., 2012, Song, 2016). The pfo 
mutant showed robust attenuated neutrophil lysis and enhanced host killing in phagocyte 
depleted zebrafish embryos. It is possible that the lack of downstream production of the 
pyruvate pathway inhibits ATP synthesis and therefore limits bacterial survival in the 
phagosome, due to lack of energy required for stress resistance and neutrophil cell lysis 
inducer production. In future experiments, time-lapse microscopy could be used to track and 
characterise neutrophil responses regulated by the pfo mutant in future work. Proliferation of 
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pfo mutants in S. aureus-neutrophil co-incubation can also be determined by a DNA staining 
assay.  
Although the importance of staphylococcal lipoproteins in human-pathogen interaction has 
been reported previously including recognition and activation of neutrophil inflammatory 
response through TLR2 activation (Kurokawa et al., 2009, Bubeck Wardenburg et al., 2006), 
the mechanisms involved in modulation of immune cell lysis is unknown. In this study, the 
lspA mutant led to attenuation of neutrophil cell lysis, and significantly lower phagocytic index 
compared to JE2 (WT), suggesting lytic factors might be expressed after bacterial 
phagocytosis. Taken together, my results may promote a hypothetical mechanism of 
staphylococcal regulated neutrophil responses, where mature lipoprotein induced signals are 
essential to cause host cell lysis. It could be speculated that this neutrophil response is triggered 
by membrane receptors including TLR2, which are expressed on the neutrophil surface. 
Although apoptosis is the most commonly characterised cell death mediated by TLRs 
(Kaczmarek et al., 2013), necroptosis, a form of necrosis, can be induced through TLR3 and 
TLR4 stimulation in murine macrophages (He et al., 2011). Potential TLR2 dependent 
lipoprotein induced neutrophil cell death can be tested using TLR2 inhibitors with lspA and 
lgt mutants.  
The pleotropic role of ClpP in protein homeostasis, stress adaption, and virulence factor 
expression (Truscott et al., 2011) means it is challenging to pinpoint exactly which process is 
key to the induction of neutrophil lysis. Nonetheless, this thesis presents a role for clpP in 
human neutrophil cell lysis for the first time. Based on the findings of this thesis, a three-step 
process is proposed here as the mechanism of clpP modulated neutrophil response. Firstly, 
clpP may be involved in neutrophil uptake of S. aureus. Following bacterial uptake, ClpP may 
be required to facilitate the stress adaption in the phagosomal environment, allowing bacterial 
survival. Thirdly, clpP promotes production of lytic factors which causes neutrophil cell death.  
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6.3 Implications of these findings for the development of novel therapeutic 
strategies  
The evolution of prevalent and multiple antibiotic resistance genes has significantly limited 
the effectiveness of antibiotic strategies (Brumfitt and Hamilton-Miller, 1989, Charles et al., 
2004). In light of this, novel antibacterial or immune activating drugs are urgently needed. The 
aim of this thesis was to identify mechanisms in which S. aureus disables neutrophils in order 
to develop preventative therapeutic strategies that would repair human immune responses. The 
results of the screen have likely identified global regulators of S. aureus biology and may 
induce neutrophil cell lysis in indirect ways.  
This thesis demonstrated a role for ClpP in both enhancing bacterial virulence in immune cell 
lysis in vitro, and promoting staphylococcal pathogenesis and interaction with neutrophils in 
vivo, making it the target with more therapeutic potential than the other genes. Inhibitors of 
ClpP could be a promising drug for clinical application to prevent S. aureus-induced 
neutrophil lysis and enhance bacterial elimination. Recently, the natural products 
acyldepsipeptides (ADEPs) were studied as potent modulators for ClpP protease activity 
(Brotz-Oesterhelt et al., 2005, Socha et al., 2010, Ye et al., 2016). The interaction of ADEPs 
with staphylococcal ClpP and ATPase leads to overactivation of ClpP and potent inhibition of 
bacterial activity (Ye et al., 2016). The bactericidal effect of ADEP4 against S. aureus has 
been demonstrated in a mouse model of chronic infection (Conlon et al., 2013), indicating a 
realistic step forward for in vivo application.  
6.4 Limitations of the approaches in this thesis 
Limitations of the NTML screen include a single 1st round of screening, which may have 
resulted in false negatives and missed ‘hits’. False positive strains were eliminated by a more 
focused and repeated 2nd round of screening. Multiple data analysis methods including viable 
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cell counts, ToPro-3 fluorescent intensity, and FSC/SSC flow cytometric profiling were 
combined to thoroughly quantify neutrophil cell death. Key virulence genes of S. aureus such 
saeS and agrA were identified among the 34 genes identified from NTML, demonstrating that 
the blindly conducted screen model successfully generated robust results. Also, I did not have 
the capacity to follow up on all 34 mutants with genetic transduction and complementation 
verification, prioritising mutants with the greatest and most reliable effects on neutrophil lysis, 
which may have also result in lost hits.    
Another limitation of the zebrafish model is the necessity of culture temperature at 28oC, at 
which, the expression of virulence factors might be compromised. Additionally, there are 
greater genetic variations between zebrafish and humans, which diverged 450 million years 
ago, compared to murine model at 112 million years ago (Woods et al., 2000). However, 
compared to murine models, it is less expensive and time consuming to maintain zebrafish 
embryos. Advantages of this models include the fact that the innate immune system of 
zebrafish embryo is highly similar to the human and the model also allows genetic 
manipulation of phagocyte development.   
Another general limitation is that many S. aureus virulence factors are human specific or have 
host-dependent effects (Spaan et al., 2013b), which might explain the lack of attenuated host 
killing caused by lspA and pfo. As S. aureus is not a natural pathogen of fish (Prajsnar et al., 
2008) and the virulence factors S. aureus use to evade the human immune system may not be 
relevant in the same way in zebrafish.  
6.5 Future work 
The robust attenuated neutrophil cell lysis, and significantly reduced phagocytic index result 
generated by the lspA mutant in this thesis suggests it is possible that lipoprotein signalling in 
neutrophils is necessary for S. aureus to induce necrosis. It is therefore important to identify 
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relevant neutrophil receptors involved in S. aureus lipoprotein interactions. Future work will 
involve investigating potential attenuation in neutrophil cell lysis caused by S. aureus with 
treatment of receptor blocking antibodies. Inhibition of candidate receptors including TLR2 
and TLR4 is expected to show reduced bacterial uptake and attenuated JE2 induced neutrophil 
cell lysis, and therefore validating the necessity of lipoprotein-TLR interaction in phagocytosis 
and S. aureus induced cell lysis.  
Apart from its significance in S. aureus growth and functionality, it was also reported that clpP 
has an impact in modulating expression of other bacterial virulence factors such as agrA and 
saeS which are known to be required for the expression of neutrophil lytic genes (Frees et al., 
2003, Frees et al., 2005a, Frees et al., 2005b, Michel et al., 2006, Feng et al., 2013, Farrand 
et al., 2013). Thus, clpP may modulate S. aureus-neutrophil interaction through phenotypic 
functions and possibly via multiple gene products. To further underpin the mechanism of clpP 
induced neutrophil cell lysis, qPCR can be used to interrogate the expression of major 
virulence genes including PVL and leukocidin. If the level of lytic gene expression is lower in 
clpP mutants compared to WT, indirectly clpP regulated neutrophil cell lysis can be 
characterised. Alternatively, the attenuated phenotype caused by the clpP mutant in our study 
may be due to lack of stress adaptation in the phagosomal environment. To address this 
hypothesis, fluorescent labelling and time lapse microscopy can be combined to visualise the 
interaction between S. aureus and neutrophils, both in vitro and in vivo. S. aureus stained with 
pHrodo and Alexa Fluor 647 can be used to infect neutrophils from either human or zebrafish 
embryos (Ellett et al., 2015, Starnes and Huttenlocher, 2012). The clpP mutant is expected to 
be phagocytosed by neutrophils but unable to proliferate or escape due to compromised stress 
responses.  
During data analysis for the phagocytic index assay in chapter 5, it was noticed that the 
majority of neutrophils that began to display a clear necrotic morphology containing high 
     
 
234 
 
numbers of S. aureus per cell, indicating large numbers of engulfed bacteria might generate 
high local concentrations of lytic factors. This suggested that the outcome of infections might 
depend on the initial contact between the pathogen and neutrophils. Hence, for additional 
understanding of the pathophysiology S. aureus induced neutrophil cell death, it is important 
to study what is the minimal number of the bacteria needed to lyse the immune cells. A JE2 
strain expressing enhanced GFP can be generated by transformation (Ellett et al., 2015) and 
applied to in vitro infection of human neutrophils. The neutrophils undergoing cell lysis can 
be determined by ToPro-3 staining and Attune flow cytometric detection. Gating methodology 
allows identification of the minimal bacterial number resulting in a ToPro-3 positive 
neutrophil population.  
6.6 Conclusion 
S. aureus is a common and successful human pathogen. The evaluation of its multiple 
virulence mechanisms and resistance to antibiotics brings an urgent challenge of clinical 
treatment. Neutrophils are the major cellular defence against this organism, yet staphylococcal 
activities undermine neutrophil immune responses on many levels. In this thesis, a genome-
wide library of S. aureus mutants was screened for their effects on neutrophil cell death, from 
which four genes namely lspA, purB, clpP, and pfo were identified as novel key virulence 
genes for bacterial regulation of neutrophil immunity. The findings not only reveal novel 
knowledge of the mechanisms underpinning the host-pathogen interaction between S. aureus 
and human neutrophils, but also provide potential targets for therapeutic development in the 
future.  
  
     
 
235 
 
References: 
ABECK and MEMPEL (1998) Staphylococcus aureus colonization in atopic dermatitis and its 
therapeutic implications. 
ALAM, M. T., et al. (2014) Dissecting vancomycin-intermediate resistance in Staphylococcus aureus 
using genome-wide association. Genome Biol Evol, 6 (5), 1174-85. 
ALY, R., et al. (1980) Role of teichoic acid in the binding of Staphylococcus aureus to nasal epithelial 
cells. J Infect Dis, 141 (4), 463-5. 
AMER, A. O. and SWANSON, M. S. (2002) A phagosome of one's own: a microbial guide to life in 
the macrophage. Curr Opin Microbiol, 5 (1), 56-61. 
AMULIC, B., et al. (2012) Neutrophil function: from mechanisms to disease. Annu Rev Immunol, 30, 
459-89. 
ANWAR, S., et al. (2009) The rise and rise of Staphylococcus aureus: laughing in the face of 
granulocytes. Clinical and experimental immunology, 157 (2), 216. 
ARIZA, J., et al. (1999) Vancomycin in surgical infections due to methicillin-resistant Staphylococcus 
aureus with heterogeneous resistance to vancomycin. In) Lancet.  Vol. 353.  England:  pp. 
1587-8. 
ASLAM, R., et al. (2013) Activation of Neutrophils by the Two- Component Leukotoxin LukE/ D 
from Staphylococcus aureus: Proteomic Analysis of the Secretions. J. Proteome Res., 12 (8), 
3667-3678. 
BABIOR, B. M. (1999) NADPH oxidase: an update. Blood, 93 (5), 1464-76. 
BAE, T., et al. (2008) Generating a collection of insertion mutations in the Staphylococcus aureus 
genome using bursa aurealis. Methods Mol Biol, 416, 103-16. 
BAEK, K. T., et al. (2014) beta-Lactam resistance in methicillin-resistant Staphylococcus aureus 
USA300 is increased by inactivation of the ClpXP protease. Antimicrob Agents Chemother, 
58 (8), 4593-603. 
BAGGETT, H. C., et al. (2003) An outbreak of community-onset methicillin-resistant Staphylococcus 
aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol, 24 (6), 397-
402. 
BAGGIOLINI, M. (1984) Phagocytes use oxygen to kill bacteria. Experientia, 40 (9), 906-9. 
BAINTON, D. F. (1993) Neutrophilic leukocyte granules: from structure to function. Adv Exp Med 
Biol, 336, 17-33. 
BALASUBRAMANIAN, D., et al. (2016) Staphylococcus aureus Coordinates Leukocidin Expression 
and Pathogenesis by Sensing Metabolic Fluxes via RpiRc. MBio, 7 (3). 
BALLARD, T. E., et al. (2010) Biological activity of modified and exchanged 2-amino-5-nitrothiazole 
amide analogues of nitazoxanide. Bioorg Med Chem Lett, 20 (12), 3537-9. 
BANG, R. L., et al. (2002) Septicaemia after burn injury: a comparative study. Burns, 28 (8), 746-751. 
BARDOEL, B. W. and STRIJP, J. A. (2011) Molecular battle between host and bacterium: recognition 
in innate immunity. J Mol Recognit, 24 (6), 1077-86. 
BARDOEL, B. W., et al. (2012) Evasion of Toll-like receptor 2 activation by staphylococcal 
superantigen-like protein 3. J Mol Med (Berl), 90 (10), 1109-20. 
BARTLETT, A. H., et al. (2008) Alpha-toxin facilitates the generation of CXC chemokine gradients 
and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J Infect Dis, 198 (10), 
1529-35. 
BAXTER-GABBARD, K. L. and PATTEE, P. A. (1970) Purine biosynthesis in Staphylococcus aureus. 
Arch Mikrobiol, 71 (1), 40-8. 
BEASLEY, F. C., et al. (2011) Staphylococcus aureus transporters Hts, Sir, and Sst capture iron 
liberated from human transferrin by Staphyloferrin A, Staphyloferrin B, and catecholamine 
stress hormones, respectively, and contribute to virulence. Infect Immun, 79 (6), 2345-55. 
BENJAMINI, E. (1988) Immunology: a short course.    New York: Liss. 
BENSON, M. A., et al. (2012) Rot and SaeRS cooperate to activate expression of the staphylococcal 
superantigen-like exoproteins. J Bacteriol, 194 (16), 4355-65. 
     
 
236 
 
BENTON, B. M., et al. (2004) Large-scale identification of genes required for full virulence of 
Staphylococcus aureus. J Bacteriol, 186 (24), 8478-89. 
BERA, A., et al. (2005) Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan 
O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus 
aureus. Mol Microbiol, 55 (3), 778-87. 
BERENDS, E. T., et al. (2010) Nuclease expression by Staphylococcus aureus facilitates escape from 
neutrophil extracellular traps. J Innate Immun, 2 (6), 576-86. 
BERUBE, B. J. and BUBECK WARDENBURG, J. (2013) Staphylococcus aureus alpha-toxin: nearly 
a century of intrigue. Toxins (Basel), 5 (6), 1140-66. 
BESTEBROER, J., et al. (2010a) Functional basis for complement evasion by staphylococcal 
superantigen- like 7. Cell Microbiol., 12 (10), 1506-1516. 
BESTEBROER, J., et al. (2010b) How microorganisms avoid phagocyte attraction. FEMS Microbiol 
Rev, 34 (3), 395-414. 
BESTEBROER, J., et al. (2007) Staphylococcal superantigen- like 5 binds PSGL- 1 and inhibits P- 
selectin- mediated neutrophil rolling. Blood, 109 (7), 2936-2943. 
BHAKDI, S. and TRANUM-JENSEN, J. (1991) Alpha-toxin of Staphylococcus aureus. Microbiol 
Rev, 55 (4), 733-51. 
BHATTA, D. R., et al. (2016) Association of Panton Valentine Leukocidin (PVL) genes with 
methicillin resistant Staphylococcus aureus (MRSA) in Western Nepal: a matter of concern 
for community infections (a hospital based prospective study). BMC Infect Dis, 16, 199. 
BILL, B. R., et al. (2009) A primer for morpholino use in zebrafish. Zebrafish, 6 (1), 69-77. 
BISWAS, L., et al. (2009) Role of the twin-arginine translocation pathway in Staphylococcus. J 
Bacteriol, 191 (19), 5921-9. 
BOGOMOLSKI-YAHALOM, V. and MATZNER, Y. (1995) Disorders of neutrophil function. Blood 
Rev, 9 (3), 183-90. 
BOLES, B. R. and HORSWILL, A. R. (2008) Agr-mediated dispersal of Staphylococcus aureus 
biofilms. PLoS Pathog, 4 (4), e1000052. 
BORREGAARD, N. and COWLAND, J. B. (1997) Granules of the human neutrophilic 
polymorphonuclear leukocyte. Blood, 89 (10), 3503-21. 
BORREGAARD, N., et al. (2007) Neutrophil granules: a library of innate immunity proteins. Trends 
Immunol, 28 (8), 340-5. 
BOTS, M. and MEDEMA, J. P. (2006) Granzymes at a glance. J Cell Sci, 119 (Pt 24), 5011-4. 
BOTTCHER, T. and SIEBER, S. A. (2008) Beta-lactones as specific inhibitors of ClpP attenuate the 
production of extracellular virulence factors of Staphylococcus aureus. J Am Chem Soc, 130 
(44), 14400-1. 
BOTTOMLEY, A. L., et al. (2014) Staphylococcus aureus DivIB is a peptidoglycan-binding protein 
that is required for a morphological checkpoint in cell division. Mol Microbiol. 
BRATTON, D. L. and HENSON, P. M. (2011) Neutrophil clearance: when the party is over, clean-up 
begins. Trends Immunol, 32 (8), 350-7. 
BRINKMANN, V., et al. (2004) Neutrophil extracellular traps kill bacteria. Science, 303 (5663), 1532-
5. 
BRITTAN, M., et al. (2012) A novel subpopulation of monocyte-like cells in the human lung after 
lipopolysaccharide inhalation. Eur Respir J, 40 (1), 206-14. 
BRONNER, S., et al. (2004) Regulation of virulence determinants in Staphylococcus aureus: 
complexity and applications. FEMS Microbiol Rev, 28 (2), 183-200. 
BROTZ-OESTERHELT, H., et al. (2005) Dysregulation of bacterial proteolytic machinery by a new 
class of antibiotics. Nat Med, 11 (10), 1082-7. 
BROWN, E. L., et al. (2015) Genome-Wide Association Study of Staphylococcus aureus Carriage in 
a Community-Based Sample of Mexican-Americans in Starr County, Texas. PLoS One, 10 
(11), e0142130. 
BROWN, G. E., et al. (2004) Distinct ligand-dependent roles for p38 MAPK in priming and activation 
of the neutrophil NADPH oxidase. J Biol Chem, 279 (26), 27059-68. 
BRUMFITT, W. and HAMILTON-MILLER, J. (1989) Methicillin-resistant Staphylococcus aureus. 
N Engl J Med, 320 (18), 1188-96. 
     
 
237 
 
BUBECK WARDENBURG, J., et al. (2008) Panton-Valentine leukocidin is not a virulence 
determinant in murine models of community-associated methicillin-resistant Staphylococcus 
aureus disease. J Infect Dis, 198 (8), 1166-70. 
BUBECK WARDENBURG, J., et al. (2006) Host defenses against Staphylococcus aureus infection 
require recognition of bacterial lipoproteins. Proc Natl Acad Sci U S A, 103 (37), 13831-6. 
BURDA, W. N., et al. (2014) Investigating the genetic regulation of the ECF sigma factor sigmaS in 
Staphylococcus aureus. BMC Microbiol, 14, 280. 
BUTALA, M., et al. (2009) The bacterial LexA transcriptional repressor. Cell Mol Life Sci, 66 (1), 82-
93. 
CAO, J., et al. (2013) Pneumococcal ClpP modulates the maturation and activation of human dendritic 
cells: implications for pneumococcal infections. J Leukoc Biol, 93 (5), 737-49. 
CARRENO PEREZ, L. (1999) Septic arthritis. Baillieres Best Pract Res Clin Rheumatol, 13 (1), 37-
58. 
CASADEVALL, A. and PIROFSKI, L. A. (1999) Host-pathogen interactions: redefining the basic 
concepts of virulence and pathogenicity. Infect Immun, 67 (8), 3703-13. 
CASEWELL, M. W. and HILL, R. L. (1986) The carrier state: methicillin-resistant Staphylococcus 
aureus. J Antimicrob Chemother, 18 Suppl A, 1-12. 
CHAMBERS, H. F. and DELEO, F. R. (2009) Waves of resistance: Staphylococcus aureus in the 
antibiotic era. Nat Rev Microbiol, 7 (9), 629-41. 
CHARLES, P. G., et al. (2004) Clinical features associated with bacteremia due to heterogeneous 
vancomycin-intermediate Staphylococcus aureus. Clin Infect Dis, 38 (3), 448-51. 
CHAVAKIS, T., et al. (2002) Staphylococcus aureus extracellular adherence protein serves as anti-
inflammatory factor by inhibiting the recruitment of host leukocytes. Nat Med, 8 (7), 687-93. 
CHEUNG, A. L., et al. (2004) Regulation of virulence determinants in vitro and in vivo in 
Staphylococcus aureus. FEMS Immunol Med Microbiol, 40 (1), 1-9. 
CHEUNG, G. Y., et al. (2011) Role of the accessory gene regulator agr in community-associated 
methicillin-resistant Staphylococcus aureus pathogenesis. Infect Immun, 79 (5), 1927-35. 
CHOI, K. H. and KIM, K. J. (2009) Applications of transposon-based gene delivery system in bacteria. 
J Microbiol Biotechnol, 19 (3), 217-28. 
CHRISTIANSEN, M. T., et al. (2014) Genome-wide high-throughput screening to investigate 
essential genes involved in methicillin-resistant Staphylococcus aureus Sequence Type 398 
survival. PLoS One, 9 (2), e89018. 
CHUA, T., et al. (2008) Molecular epidemiology of methicillin-resistant Staphylococcus aureus 
bloodstream isolates in urban Detroit. J Clin Microbiol, 46 (7), 2345-52. 
CHUANG, Y.-Y. and HUANG, Y.-C. (2013) Molecular epidemiology of community-associated 
meticillin-resistant Staphylococcus aureus in Asia. The Lancet Infectious Diseases, 13 (8), 
698-708. 
CLARKE, S. R. and FOSTER, S. J. (2006) Surface adhesins of Staphylococcus aureus. Adv Microb 
Physiol, 51, 187-224. 
CLUZEL, M. E., et al. (2010) The Staphylococcus aureus autoinducer-2 synthase LuxS is regulated 
by Ser/Thr phosphorylation. J Bacteriol, 192 (23), 6295-301. 
COHN, M. T., et al. (2011) Clp-dependent proteolysis of the LexA N-terminal domain in 
Staphylococcus aureus. Microbiology, 157 (Pt 3), 677-84. 
CONLON, B. P., et al. (2013) Activated ClpP kills persisters and eradicates a chronic biofilm infection. 
Nature, 503 (7476), 365-70. 
CRONSTEIN, B. N., et al. (1990) The adenosine/neutrophil paradox resolved: human neutrophils 
possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, 
respectively. J Clin Invest, 85 (4), 1150-7. 
CROWHURST, M. O., et al. (2002) Developmental biology of zebrafish myeloid cells. Int J Dev Biol, 
46 (4), 483-92. 
CUNNINGHAM, R., et al. (1996) Clinical and molecular aspects of the pathogenesis of 
Staphylococcus aureus bone and joint infections. Journal of medical microbiology, 44 (3), 157. 
DALE, D. C., et al. (1998) Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) 
on neutrophil kinetics and function in normal human volunteers. Am J Hematol, 57 (1), 7-15. 
     
 
238 
 
DANG, P. M., et al. (1999) Priming of human neutrophil respiratory burst by granulocyte/macrophage 
colony-stimulating factor (GM-CSF) involves partial phosphorylation of p47(phox). J Biol 
Chem, 274 (29), 20704-8. 
DAS, S., et al. (2016) Natural mutations in a Staphylococcus aureus virulence regulator attenuate 
cytotoxicity but permit bacteremia and abscess formation. Proc Natl Acad Sci U S A, 113 (22), 
E3101-10. 
DAUM, R. S., et al. (2002) A novel methicillin-resistance cassette in community-acquired methicillin-
resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis, 186 (9), 
1344-7. 
DAVID, M. Z. and DAUM, R. S. (2010) Community-associated methicillin-resistant Staphylococcus 
aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev, 
23 (3), 616-87. 
DE JONG, N. W. M., et al. (2017) Immune evasion by a staphylococcal inhibitor of myeloperoxidase. 
Proc Natl Acad Sci U S A, 114 (35), 9439-9444. 
DELEO, F. R., et al. (2009) Host Defense and Pathogenesis in Staphylococcus aureus Infections. Infect. 
Dis. Clin. North Am., 23 (1), 17-+. 
DELEO, F. R., et al. (1998) Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH 
oxidase assembly. J Clin Invest, 101 (2), 455-63. 
DESAI, J., et al. (2016) PMA and crystal-induced neutrophil extracellular trap formation involves 
RIPK1-RIPK3-MLKL signaling. Eur J Immunol, 46 (1), 223-9. 
DHANOA, A., et al. (2012) Acute haematogenous community-acquired methicillin-resistant 
Staphylococcus aureus osteomyelitis in an adult: case report and review of literature. BMC 
Infect Dis, 12, 270. 
DIEKEMA, D. J., et al. (2001) Survey of infections due to Staphylococcus species: frequency of 
occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, 
Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial 
Surveillance Program, 1997-1999. Clin Infect Dis, 32 Suppl 2, S114-32. 
DIEP, B. A., et al. (2010) Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-
Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A, 107 
(12), 5587-92. 
DOHERTY, N., et al. (2006) Functional analysis of luxS in Staphylococcus aureus reveals a role in 
metabolism but not quorum sensing. J Bacteriol, 188 (8), 2885-97. 
DOWNEY, G. P., et al. (1990) Retention of leukocytes in capillaries: role of cell size and deformability. 
J Appl Physiol (1985), 69 (5), 1767-78. 
DUBREUIL, L., et al. (1996) In vitro evaluation of activities of nitazoxanide and tizoxanide against 
anaerobes and aerobic organisms. Antimicrob Agents Chemother, 40 (10), 2266-70. 
DUMONT, A. L., et al. (2013) Staphylococcus aureus LukAB cytotoxin kills human neutrophils by 
targeting the CD11b subunit of the integrin Mac-1. Proc Natl Acad Sci U S A, 110 (26), 10794-
9. 
DURAN, N., et al. (2012) Antibiotic resistance genes & susceptibility patterns in staphylococci. Indian 
J Med Res, 135, 389-96. 
EASMON, C. S., et al. (1978) Use of lysostaphin to remove cell-adherent staphylococci during in vitro 
assays of phagocyte function. British journal of experimental pathology, 59 (4), 381-385. 
EDWARDS, S. (2005) Biochemistry and physiology of the neutrophil.    Cambridge University Press. 
ELLETT, F., et al. (2015) Defining the phenotype of neutrophils following reverse migration in 
zebrafish. J Leukoc Biol, 98 (6), 975-81. 
ELLIS, T. N. and BEAMAN, B. L. (2004) Interferon-gamma activation of polymorphonuclear 
neutrophil function. Immunology, 112 (1), 2-12. 
ENGMAN, J., et al. (2012) The YjbH adaptor protein enhances proteolysis of the transcriptional 
regulator Spx in Staphylococcus aureus. J Bacteriol, 194 (5), 1186-94. 
ERNST, C. M. and PESCHEL, A. (2011) Broad-spectrum antimicrobial peptide resistance by MprF-
mediated aminoacylation and flipping of phospholipids. Mol Microbiol, 80 (2), 290-9. 
ESTIVARIZ, C. F., et al. (2007) Emergence of community-associated methicillin resistant 
Staphylococcus aureus in Hawaii, 2001-2003. J Infect, 54 (4), 349-57. 
     
 
239 
 
FANG, F. C. (2004) Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. 
Nat Rev Microbiol, 2 (10), 820-32. 
FARRAND, A. J., et al. (2013) Regulation of host hemoglobin binding by the Staphylococcus aureus 
Clp proteolytic system. J Bacteriol, 195 (22), 5041-50. 
FENG, J., et al. (2013) Trapping and proteomic identification of cellular substrates of the ClpP protease 
in Staphylococcus aureus. J Proteome Res, 12 (2), 547-58. 
FEY, P. D., et al. (2013) A genetic resource for rapid and comprehensive phenotype screening of 
nonessential Staphylococcus aureus genes. MBio, 4 (1), e00537-12. 
FINEGOLD, S. M., et al. (2009) Study of the in vitro activities of rifaximin and comparator agents 
against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology 
involving bowel flora. Antimicrob Agents Chemother, 53 (1), 281-6. 
FINK, S. L. and COOKSON, B. T. (2005) Apoptosis, pyroptosis, and necrosis: mechanistic description 
of dead and dying eukaryotic cells. Infect Immun, 73 (4), 1907-16. 
FLANNAGAN, R. S., et al. (2015) Antimicrobial Mechanisms of Macrophages and the Immune 
Evasion Strategies of Staphylococcus aureus. Pathogens, 4 (4), 826-68. 
FLANNAGAN, R. S., et al. (2016) Intracellular replication of Staphylococcus aureus in mature 
phagolysosomes in macrophages precedes host cell death, and bacterial escape and 
dissemination. Cell Microbiol, 18 (4), 514-35. 
FORSGREN, A. and NORDSTROM, K. (1974) Protein A from Staphylococcus aureus: the biological 
significance of its reaction with IgG. Ann N Y Acad Sci, 236 (0), 252-66. 
FOSTER, T. J. (2005) Immune evasion by staphylococci. Nat Rev Microbiol, 3 (12), 948-58. 
FRANCIS, J. S., et al. (2005) Severe community-onset pneumonia in healthy adults caused by 
methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. 
Clin Infect Dis, 40 (1), 100-7. 
FREES, D., et al. (2012) New insights into Staphylococcus aureus stress tolerance and virulence 
regulation from an analysis of the role of the ClpP protease in the strains Newman, COL, and 
SA564. J Proteome Res, 11 (1), 95-108. 
FREES, D., et al. (2004) Clp ATPases are required for stress tolerance, intracellular replication and 
biofilm formation in Staphylococcus aureus. Mol Microbiol, 54 (5), 1445-62. 
FREES, D., et al. (2014) Clp chaperones and proteases are central in stress survival, virulence and 
antibiotic resistance of Staphylococcus aureus. Int J Med Microbiol, 304 (2), 142-9. 
FREES, D., et al. (2003) Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance 
and virulence. Mol Microbiol, 48 (6), 1565-78. 
FREES, D., et al. (2007) Clp ATPases and ClpP proteolytic complexes regulate vital biological 
processes in low GC, Gram-positive bacteria. Mol Microbiol, 63 (5), 1285-95. 
FREES, D., et al. (2005a) Global virulence regulation in Staphylococcus aureus: pinpointing the roles 
of ClpP and ClpX in the sar/agr regulatory network. Infect Immun, 73 (12), 8100-8. 
FREES, D., et al. (2005b) Staphylococcus aureus ClpYQ plays a minor role in stress survival. Arch 
Microbiol, 183 (4), 286-91. 
FRYDENLUND MICHELSEN, C., et al. (2016) Evolution of metabolic divergence in Pseudomonas 
aeruginosa during long-term infection facilitates a proto-cooperative interspecies interaction. 
Isme j, 10 (6), 1323-36. 
FUCHS, T. A., et al. (2007) Novel cell death program leads to neutrophil extracellular traps. J Cell 
Biol, 176 (2), 231-41. 
FURDUI, C. and RAGSDALE, S. W. (2000) The role of pyruvate ferredoxin oxidoreductase in 
pyruvate synthesis during autotrophic growth by the Wood-Ljungdahl pathway. J Biol Chem, 
275 (37), 28494-9. 
FURZE, R. C. and RANKIN, S. M. (2008) Neutrophil mobilization and clearance in the bone marrow. 
Immunology, 125 (3), 281-8. 
FYFE, P. K., et al. (2010) Structure of Staphylococcus aureus adenylo-succinate lyase (PurB) and 
assessment of its potential as a target for structure-based inhibitor discovery. Acta 
Crystallographica Section D: Biological Crystallography, 66 (Pt 8), 881-888. 
GAILLOT, O., et al. (2000) The ClpP serine protease is essential for the intracellular parasitism and 
virulence of Listeria monocytogenes. Mol Microbiol, 35 (6), 1286-94. 
     
 
240 
 
GAL-MOR, O. and FINLAY, B. B. (2006) Pathogenicity islands: a molecular toolbox for bacterial 
virulence. Cell Microbiol, 8 (11), 1707-19. 
GARG, S. K., et al. (2009) The YjbH protein of Bacillus subtilis enhances ClpXP-catalyzed proteolysis 
of Spx. J Bacteriol, 191 (4), 1268-77. 
GAUPP, R., et al. (2012) Staphylococcal response to oxidative stress. Front Cell Infect Microbiol, 2, 
33. 
GEIGER, T., et al. (2008) The virulence regulator Sae of Staphylococcus aureus: promoter activities 
and response to phagocytosis-related signals. J Bacteriol, 190 (10), 3419-28. 
GEN (2017) Phage Therapy Saves Patient from Drug-Resistant Microbes.) Genetic Engineering and 
Biotechnology News. http://www.genengnews.com/gen-news-highlights/phage-therapy-
saves-patient-from-drug-resistant-microbes/81254258. 
GIRAUDO, A. T., et al. (1994) Characterization of a Tn551-mutant of Staphylococcus aureus 
defective in the production of several exoproteins. Can J Microbiol, 40 (8), 677-81. 
GLOVER, J. R. and LINDQUIST, S. (1998) Hsp104, Hsp70, and Hsp40: a novel chaperone system 
that rescues previously aggregated proteins. Cell, 94 (1), 73-82. 
GOLDBLATT, D. and THRASHER, A. J. (2000) Chronic granulomatous disease. Clin Exp Immunol, 
122 (1), 1-9. 
GOLDENBERG, D. L. (1998) Septic arthritis. Lancet, 351 (9097), 197-202. 
GONZALEZ-BARCA, E., et al. (2001) Predisposing factors and outcome of Staphylococcus aureus 
bacteremia in neutropenic patients with cancer. Eur J Clin Microbiol Infect Dis, 20 (2), 117-9. 
GOOSENS, V. J., et al. (2014) The Tat system of Gram-positive bacteria. Biochim Biophys Acta, 1843 
(8), 1698-706. 
GORDON, R. J. and LOWY, F. D. (2008) Pathogenesis of methicillin-resistant Staphylococcus aureus 
infection. Clin Infect Dis, 46 Suppl 5, S350-9. 
GOTTLIEB, D. and SHAW, P. D. (2013) Antibiotics: Volume I Mechanism of Action. In)      Springer. 
GREENLEE-WACKER, M., et al. (2015) How methicillin-resistant Staphylococcus aureus evade 
neutrophil killing. Curr Opin Hematol, 22 (1), 30-5. 
GRESHAM, H. D., et al. (2000) Survival of Staphylococcus aureus inside neutrophils contributes to 
infection. J Immunol, 164 (7), 3713-22. 
GROSZ, M., et al. (2014) Cytoplasmic replication of Staphylococcus aureus upon phagosomal escape 
triggered by phenol-soluble modulin alpha. Cell Microbiol, 16 (4), 451-65. 
GUERRA, F. E., et al. (2017) Epic Immune Battles of History: Neutrophils vs. Staphylococcus aureus. 
Front Cell Infect Microbiol, 7, 286. 
GUICHARD, C., et al. (2005) Interleukin-8-induced priming of neutrophil oxidative burst requires 
sequential recruitment of NADPH oxidase components into lipid rafts. J Biol Chem, 280 (44), 
37021-32. 
HAAS, A. (2007) The phagosome: compartment with a license to kill. Traffic, 8 (4), 311-30. 
HAMASAKI, A., et al. (1998) Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the 
bcl-2-related A1 gene. J Exp Med, 188 (11), 1985-92. 
HAMER, L., et al. (2001) Recent advances in large-scale transposon mutagenesis. Curr Opin Chem 
Biol, 5 (1), 67-73. 
HAMPTON, M. B., et al. (1998) Inside the neutrophil phagosome: oxidants, myeloperoxidase, and 
bacterial killing. Blood, 92 (9), 3007-17. 
HART, S. P., et al. (2000) Molecular characterization of the surface of apoptotic neutrophils: 
implications for functional downregulation and recognition by phagocytes. Cell Death Differ, 
7 (5), 493-503. 
HARVIE, E. A. and HUTTENLOCHER, A. (2015) Neutrophils in host defense: new insights from 
zebrafish. J Leukoc Biol, 98 (4), 523-37. 
HAYES, F. (2003) Transposon-based strategies for microbial functional genomics and proteomics. 
Annu Rev Genet, 37, 3-29. 
HE, S., et al. (2011) Toll-like receptors activate programmed necrosis in macrophages through a 
receptor-interacting kinase-3-mediated pathway. Proc Natl Acad Sci U S A, 108 (50), 20054-
9. 
HEINEMANN, M., et al. (2005) In silico genome-scale reconstruction and validation of the 
Staphylococcus aureus metabolic network. Biotechnol Bioeng, 92 (7), 850-64. 
     
 
241 
 
HENRY, K. M., et al. (2013) Zebrafish as a model for the study of neutrophil biology. J Leukoc Biol, 
94 (4), 633-42. 
HERBERMAN, R. B. (1986) Natural killer cells. Annu Rev Med, 37, 347-52. 
HERBERT, S., et al. (2007) Molecular basis of resistance to muramidase and cationic antimicrobial 
peptide activity of lysozyme in staphylococci. PLoS Pathog., 3 (7), 981-994. 
HILL, P. C., et al. (2001) Prospective study of 424 cases of Staphylococcus aureus bacteraemia: 
determination of factors affecting incidence and mortality. Intern Med J, 31 (2), 97-103. 
HIRSCH, T., et al. (1997) The apoptosis-necrosis paradox. Apoptogenic proteases activated after 
mitochondrial permeability transition determine the mode of cell death. Oncogene, 15 (13), 
1573-81. 
HOFFMAN, P. S., et al. (2007) Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases 
of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni. 
Antimicrob Agents Chemother, 51 (3), 868-76. 
HOGAN, S. P., et al. (2013) Eosinophils in infection and intestinal immunity. Curr Opin Gastroenterol, 
29 (1), 7-14. 
HORNER, D. S., et al. (1999) A single eubacterial origin of eukaryotic pyruvate: ferredoxin 
oxidoreductase genes: implications for the evolution of anaerobic eukaryotes. Mol Biol Evol, 
16 (9), 1280-91. 
HOWDEN, B. P., et al. (2010) Reduced vancomycin susceptibility in Staphylococcus aureus, 
including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: 
resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev, 23 
(1), 99-139. 
HOWDEN, B. P., et al. (2006) Isolates with low-level vancomycin resistance associated with persistent 
methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother, 50 (9), 
3039-47. 
HUSSAIN, M., et al. (1982) Mechanism of signal peptide cleavage in the biosynthesis of the major 
lipoprotein of the Escherichia coli outer membrane. J Biol Chem, 257 (9), 5177-82. 
IADONATO, S. P. and KATZE, M. G. (2009) Genomics: Hepatitis C virus gets personal. In) Nature.  
Vol. 461.  England:  pp. 357-8. 
IBA, T., et al. (2013) Neutrophil cell death in response to infection and its relation to coagulation. J 
Intensive Care, 1 (1), 13. 
ISOGAI, S., et al. (2001) The vascular anatomy of the developing zebrafish: an atlas of embryonic and 
early larval development. Dev Biol, 230 (2), 278-301. 
ITOH, S., et al. (2010) Staphylococcal superantigen- like protein 10 ( SSL10) binds to human 
immunoglobulin G ( IgG) and inhibits complement activation via the classical pathway. Mol. 
Immunol., 47 (4), 932-938. 
IYER, S. S., et al. (2009) Necrotic cells trigger a sterile inflammatory response through the Nlrp3 
inflammasome. Proc Natl Acad Sci U S A, 106 (48), 20388-93. 
JABLONSKA, J. (2014) To NET or not to NET.), American Journal of Immunology. 
JEVONS, M. P. (1961) “Celbenin”-resistance staphylococci. BMJ, 1, 124. 
JOHANNESSEN, M., et al. (2012) Host- and microbe determinants that may influence the success of 
S. aureus colonization. Front Cell Infect Microbiol, 2, 56. 
JOHN CLANCY JR. (1998) Basic concepts in immunology : a student&#039;s survival guide.   New 
York ; London: New York ; London : McGraw-Hill, Health Professions Division, c1998. 
JOHNSTON, P. R., et al. (2016) Genomic Signatures of Experimental Adaptation to Antimicrobial 
Peptides in Staphylococcus aureus. G3 (Bethesda), 6 (6), 1535-9. 
JONGERIUS, I., et al. (2010a) Convertase Inhibitory Properties of Staphylococcal Extracellular 
Complement- binding Protein. J. Biol. Chem., 285 (20), 14973-14979. 
JONGERIUS, I., et al. (2010b) Staphylococcal complement inhibitor modulates phagocyte responses 
by dimerization of convertases. J Immunol, 184 (1), 420-5. 
JONGERIUS, I., et al. (2012) Staphylococcus aureus Virulence Is Enhanced by Secreted Factors That 
Block Innate Immune Defenses. J. Innate Immun., 4 (3), 301-311. 
JOSEFSSON, E., et al. (2001) Protection against experimental Staphylococcus aureus arthritis by 
vaccination with clumping factor A, a novel virulence determinant. J Infect Dis, 184 (12), 
1572-80. 
     
 
242 
 
KACZMAREK, A., et al. (2013) Necroptosis: the release of damage-associated molecular patterns and 
its physiological relevance. Immunity, 38 (2), 209-23. 
KENNEDY, A. D. and DELEO, F. R. (2009) Neutrophil apoptosis and the resolution of infection. 
Immunol Res, 43 (1-3), 25-61. 
KIM, J. and GIBSON, G. (2010) Insights from GWAS into the quantitative genetics of transcription 
in humans. Genet Res (Camb), 92 (5-6), 361-9. 
KIM, M. N., et al. (2000) Vancomycin-intermediate Staphylococcus aureus in Korea. J Clin Microbiol, 
38 (10), 3879-81. 
KIM, N. J., et al. (2015) Lipoprotein in the cell wall of Staphylococcus aureus is a major inducer of 
nitric oxide production in murine macrophages. Mol Immunol, 65 (1), 17-24. 
KING, M. D., et al. (2006) Emergence of community-acquired methicillin-resistant Staphylococcus 
aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern 
Med, 144 (5), 309-17. 
KIRSTEIN, J., et al. (2009) Adapting the machine: adaptor proteins for Hsp100/Clp and AAA+ 
proteases. Nat Rev Microbiol, 7 (8), 589-99. 
KITAZUMI, I. and TSUKAHARA, M. (2011) Regulation of DNA fragmentation: the role of caspases 
and phosphorylation. Febs j, 278 (3), 427-41. 
KJELDSEN, L., et al. (1994) Isolation and characterization of gelatinase granules from human 
neutrophils. Blood, 83 (6), 1640-9. 
KLEBANOFF, S. J. (2005) Myeloperoxidase: friend and foe. Journal of leukocyte biology, 77 (5), 598. 
KLEIN, E., et al. (2007) Hospitalizations and deaths caused by methicillin-resistant Staphylococcus 
aureus, United States, 1999-2005. Emerg Infect Dis, 13 (12), 1840-6. 
KLEMSZ, M. J., et al. (1990) The macrophage and B cell-specific transcription factor PU.1 is related 
to the ets oncogene. Cell, 61 (1), 113-24. 
KLIONSKY, D. J. (2004) Cell biology: regulated self-cannibalism. In) Nature.  Vol. 431.  England:  
pp. 31-2. 
KLOOS and BANNERMAN (1999) Manual of Clinical Microbiology. (Staphylococcus and 
Micrococcus)   ASM Press. 
KLUYTMANS, J., et al. (1997) Nasal carriage of Staphylococcus aureus: epidemiology, underlying 
mechanisms, and associated risks. Clin Microbiol Rev, 10 (3), 505-20. 
KOBAYASHI, S. D., et al. (2010) Rapid neutrophil destruction following phagocytosis of 
Staphylococcus aureus. J Innate Immun, 2 (6), 560-75. 
KOBAYASHI, S. D. and DELEO, F. R. (2009) An update on community-associated MRSA virulence. 
Curr Opin Pharmacol, 9 (5), 545-51. 
KOBAYASHI, S. D., et al. (2015) Pathogenesis of Staphylococcus aureus abscesses. Am J Pathol, 
185 (6), 1518-27. 
KOBAYASHI, S. D., et al. (2011) Comparative analysis of USA300 virulence determinants in a rabbit 
model of skin and soft tissue infection. J Infect Dis, 204 (6), 937-41. 
KOBAYASHI, S. D., et al. (2002) Global changes in gene expression by human polymorphonuclear 
leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene 
expression. Proc Natl Acad Sci U S A, 99 (10), 6901-6. 
KRETSCHMER, D., et al. (2010) Human formyl peptide receptor 2 senses highly pathogenic 
Staphylococcus aureus. Cell Host Microbe, 7 (6), 463-73. 
KUMAR, A., et al. (2009) Critically ill patients with 2009 influenza A(H1N1) infection in Canada. 
Jama, 302 (17), 1872-9. 
KUROKAWA, K., et al. (2009) The Triacylated ATP Binding Cluster Transporter Substrate-binding 
Lipoprotein of Staphylococcus aureus Functions as a Native Ligand for Toll-like Receptor 2. 
J Biol Chem, 284 (13), 8406-11. 
KUROKAWA, K., et al. (2012) Novel bacterial lipoprotein structures conserved in low-GC content 
gram-positive bacteria are recognized by Toll-like receptor 2. J Biol Chem, 287 (16), 13170-
81. 
LAARMAN, A. J., et al. (2012) Staphylococcus aureus Staphopain A inhibits CXCR2-dependent 
neutrophil activation and chemotaxis. Embo j, 31 (17), 3607-19. 
LAARMAN, A. J., et al. (2011) Staphylococcus aureus Metalloprotease Aureolysin Cleaves 
Complement C3 To Mediate Immune Evasion. J. Immunol., 186 (11), 6445-6453. 
     
 
243 
 
LACY, P. (2006) Mechanisms of degranulation in neutrophils. Allergy Asthma Clin Immunol, 2 (3), 
98-108. 
LAM, S. H., et al. (2004) Development and maturation of the immune system in zebrafish, Danio rerio: 
a gene expression profiling, in situ hybridization and immunological study. Dev Comp 
Immunol, 28 (1), 9-28. 
LAMBERT, P. A. (2005) Bacterial resistance to antibiotics: modified target sites. Adv Drug Deliv Rev, 
57 (10), 1471-85. 
LAN, L., et al. (2010) Golden pigment production and virulence gene expression are affected by 
metabolisms in Staphylococcus aureus. J Bacteriol, 192 (12), 3068-77. 
LANGONE, J. J. (1982) Protein A of Staphylococcus aureus and related immunoglobulin receptors 
produced by streptococci and pneumonococci. Advances in immunology, 32, 157. 
LARSSON, J. T., et al. (2007) YjbH is a novel negative effector of the disulphide stress regulator, Spx, 
in Bacillus subtilis. Mol Microbiol, 66 (3), 669-84. 
LEE, C. Y., et al. (1991) Construction of single-copy integration vectors for Staphylococcus aureus. 
Gene, 103 (1), 101-5. 
LEE, L. Y. L., et al. (2004) Inhibition of complement activation by a secreted Staphylococcus aureus 
protein. J. Infect. Dis., 190 (3), 571-579. 
LENTINO, J. R., et al. (2008) New antimicrobial agents as therapy for resistant gram-positive cocci. 
Eur J Clin Microbiol Infect Dis, 27 (1), 3-15. 
LEY, K., et al. (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. 
Nat Rev Immunol, 7 (9), 678-89. 
LIANG, X., et al. (2006) Inactivation of a two-component signal transduction system, SaeRS, 
eliminates adherence and attenuates virulence of Staphylococcus aureus. Infect Immun, 74 (8), 
4655-65. 
LIESCHKE, G. J., et al. (2001) Morphologic and functional characterization of granulocytes and 
macrophages in embryonic and adult zebrafish. Blood, 98 (10), 3087-96. 
LILES, W. C., et al. (1996) Differential expression of Fas (CD95) and Fas ligand on normal human 
phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med, 184 (2), 
429-40. 
LIN, B., et al. (2007) Acute phase response in zebrafish upon Aeromonas salmonicida and 
Staphylococcus aureus infection: striking similarities and obvious differences with mammals. 
Mol Immunol, 44 (4), 295-301. 
LIPINSKA, U., et al. (2011) Panton-Valentine leukocidin does play a role in the early stage of 
Staphylococcus aureus skin infections: a rabbit model. PLoS One, 6 (8), e22864. 
LIPSKY, B. A. (1997) Osteomyelitis of the foot in diabetic patients. Clin Infect Dis, 25 (6), 1318-26. 
LIU, C. and CHAMBERS, H. F. (2003) Staphylococcus aureus with heterogeneous resistance to 
vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic 
methods. Antimicrob Agents Chemother, 47 (10), 3040-5. 
LIU, C., et al. (2008) A population-based study of the incidence and molecular epidemiology of 
methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect 
Dis, 46 (11), 1637-46. 
LIU, G. Y., et al. (2005) Staphylococcus aureus golden pigment impairs neutrophil killing and 
promotes virulence through its antioxidant activity. J. Exp. Med., 202 (2), 209-215. 
LIU, Q., et al. (2017) The ATP-Dependent Protease ClpP Inhibits Biofilm Formation by Regulating 
Agr and Cell Wall Hydrolase Sle1 in Staphylococcus aureus. Front Cell Infect Microbiol, 7, 
181. 
LOFFLER, B., et al. (2010) Staphylococcus aureus panton-valentine leukocidin is a very potent 
cytotoxic factor for human neutrophils. PLoS Pathog, 6 (1), e1000715. 
LONG, J., et al. (2016) Identification of disease-associated pathways in pancreatic cancer by 
integrating genome-wide association study and gene expression data. Oncol Lett, 12 (1), 537-
543. 
LONGWORTH, D. L. (2001) Microbial drug resistance and the roles of the new antibiotics. Cleve 
Clin J Med, 68 (6), 496-7, 501-2, 504. 
LOOD, C., et al. (2016) Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are 
interferogenic and contribute to lupus-like disease. Nat Med, 22 (2), 146-53. 
     
 
244 
 
LOWY, F. D. (1998) Staphylococcus aureus infections - Reply. N. Engl. J. Med., 339 (27), 2026-2027. 
LUO, H. R. and LOISON, F. (2008) Constitutive neutrophil apoptosis: mechanisms and regulation. 
Am J Hematol, 83 (4), 288-95. 
MAIANSKI, N. A., et al. (2004) Functional characterization of mitochondria in neutrophils: a role 
restricted to apoptosis. Cell Death Differ, 11 (2), 143-53. 
MALACHOWA, N. and DELEO, F. R. (2010) Mobile genetic elements of Staphylococcus aureus. 
Cell Mol Life Sci, 67 (18), 3057-71. 
MALACHOWA, N., et al. (2012) Staphylococcus aureus leukotoxin GH promotes inflammation. J 
Infect Dis, 206 (8), 1185-93. 
MALACHOWA, N., et al. (2013) Staphylococcus aureus leukotoxin GH promotes formation of 
neutrophil extracellular traps. J Immunol, 191 (12), 6022-9. 
MALACHOWA, N., et al. (2011) Characterization of a Staphylococcus aureus Surface Virulence 
Factor That Promotes Resistance to Oxidative Killing and Infectious Endocarditis. Infect. 
Immun., 79 (1), 342-352. 
MALAWISTA, S. E., et al. (1992) Evidence for reactive nitrogen intermediates in killing of 
staphylococci by human neutrophil cytoplasts. A new microbicidal pathway for 
polymorphonuclear leukocytes. J Clin Invest, 90 (2), 631-6. 
MANDELL, G. L. (1975) Catalase, superoxide dismutase, and virulence of Staphylococcus aureus. In 
vitro and in vivo studies with emphasis on staphylococcal-- leukocyte interaction. The Journal 
of clinical investigation, 55 (3), 561. 
MANDERS, S. M. (1998) Toxin- mediated streptococcal and staphylococcal disease.) J. Am. Acad. 
Dermatol. 
MANI, N., et al. (1993) Isolation and characterization of autolysis-defective mutants of 
Staphylococcus aureus created by Tn917-lacZ mutagenesis. J Bacteriol, 175 (5), 1493-9. 
MANOLIO, T. A. (2010) Genomewide association studies and assessment of the risk of disease. N 
Engl J Med, 363 (2), 166-76. 
MARCHESE, A., et al. (2000) Heterogeneous vancomycin resistance in methicillin-resistant 
Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol, 38 (2), 866-
9. 
MARTIN, A., et al. (2008) Pore loops of the AAA+ ClpX machine grip substrates to drive 
translocation and unfolding. Nat Struct Mol Biol, 15 (11), 1147-51. 
MAZMANIAN, S. K., et al. (2001) Sortase-catalysed anchoring of surface proteins to the cell wall of 
Staphylococcus aureus. Mol Microbiol, 40 (5), 1049-57. 
MCCLINTOCK, B. (1948) Carnegie Institute of Washington Yearbook. 
MCDOUGAL, L. K., et al. (2010) Emergence of resistance among USA300 methicillin-resistant 
Staphylococcus aureus isolates causing invasive disease in the United States. Antimicrob 
Agents Chemother, 54 (9), 3804-11. 
MCGANN, L. E., et al. (1988) Manifestations of cell damage after freezing and thawing. Cryobiology, 
25 (3), 178-85. 
MCGUINNESS, W. A., et al. (2017) Vancomycin Resistance in Staphylococcus aureus. Yale J Biol 
Med, 90 (2), 269-281. 
MCKERCHER, S. R., et al. (1996) Targeted disruption of the PU.1 gene results in multiple 
hematopoietic abnormalities. Embo j, 15 (20), 5647-58. 
MCLUCKIE A (2009) In) Respiratory disease and its management.    New York: Springer, p. 51. 
MEDIAVILLA, J. R., et al. (2012) Global epidemiology of community-associated methicillin resistant 
Staphylococcus aureus (CA-MRSA). Curr Opin Microbiol, 15 (5), 588-95. 
MEI, J. M., et al. (1997) Identification of Staphylococcus aureus virulence genes in a murine model of 
bacteraemia using signature-tagged mutagenesis. Mol Microbiol, 26 (2), 399-407. 
MEZA-CERVANTEZ, P., et al. (2011) Pyruvate:ferredoxin oxidoreductase (PFO) is a surface-
associated cell-binding protein in Trichomonas vaginalis and is involved in trichomonal 
adherence to host cells. Microbiology, 157 (Pt 12), 3469-82. 
MICHALIK, S., et al. (2012) Life and death of proteins: a case study of glucose-starved 
Staphylococcus aureus. Mol Cell Proteomics, 11 (9), 558-70. 
     
 
245 
 
MICHEL, A., et al. (2006) Global regulatory impact of ClpP protease of Staphylococcus aureus on 
regulons involved in virulence, oxidative stress response, autolysis, and DNA repair. J 
Bacteriol, 188 (16), 5783-96. 
MILES, A. A., et al. (1938) The estimation of the bactericidal power of the blood. J Hyg (Lond), 38 
(6), 732-49. 
MIOULANE, M., et al. (2012) Development of high content imaging methods for cell death detection 
in human pluripotent stem cell-derived cardiomyocytes. J Cardiovasc Transl Res, 5 (5), 593-
604. 
MISHRA, N. N., et al. (2011) Carotenoid- Related Alteration of Cell Membrane Fluidity Impacts 
Staphylococcus aureus Susceptibility to Host Defense Peptides. Antimicrob. Agents 
Chemother., 55 (2), 526-531. 
MONTGOMERY, C. P., et al. (2008) Comparison of virulence in community-associated methicillin-
resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. 
J Infect Dis, 198 (4), 561-70. 
MONTGOMERY, C. P., et al. (2010) Importance of the global regulators Agr and SaeRS in the 
pathogenesis of CA-MRSA USA300 infection. PLoS One, 5 (12), e15177. 
MOORE, K. L., et al. (1995) P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils 
on P-selectin. J Cell Biol, 128 (4), 661-71. 
MORGAN, M. J., et al. (2008) TNFalpha and reactive oxygen species in necrotic cell death. Cell Res, 
18 (3), 343-9. 
MORGAN, M. S. (2007) Diagnosis and treatment of Panton–Valentine leukocidin (PVL)-associated 
staphylococcal pneumonia. International Journal of Antimicrobial Agents, 30 (4), 289-296. 
MOULDING, D. A., et al. (2001) BCL-2 family expression in human neutrophils during delayed and 
accelerated apoptosis. J Leukoc Biol, 70 (5), 783-92. 
MURPHY, J. M. and VINCE, J. E. (2015) Post-translational control of RIPK3 and MLKL mediated 
necroptotic cell death. F1000Res, 4. 
MURPHY, P. (1976) The Neutrophil.    Plenum Medical Book Company 
New York and London  
NAGELKERKE, S. Q., et al. (2014) Failure to detect functional neutrophil B helper cells in the human 
spleen. PLoS One, 9 (2), e88377. 
NAIMI, T. S., et al. (2003) Comparison of community- and health care-associated methicillin-resistant 
Staphylococcus aureus infection. Jama, 290 (22), 2976-84. 
NAKANO, S., et al. (2003) Spx-dependent global transcriptional control is induced by thiol-specific 
oxidative stress in Bacillus subtilis. Proc Natl Acad Sci U S A, 100 (23), 13603-8. 
NAKAYAMA, H., et al. (2012) Lipoproteins in bacteria: structures and biosynthetic pathways. Febs 
j, 279 (23), 4247-68. 
NELSON, C. L., et al. (2014) A genome-wide association study of variants associated with acquisition 
of Staphylococcus aureus bacteremia in a healthcare setting. BMC Infect Dis, 14, 83. 
NICHOLS, R. L. and RAAD, I. I. (1999) Management of bacterial complications in critically ill 
patients: surgical wound and catheter-related infections. Diagnostic Microbiology and 
Infectious Disease, 33 (2), 121-130. 
NORIS, M. and REMUZZI, G. (2013) Overview of complement activation and regulation. Semin 
Nephrol, 33 (6), 479-92. 
NOVICK, R. P. (2003a) Autoinduction and signal transduction in the regulation of staphylococcal 
virulence. Mol Microbiol, 48 (6), 1429-49. 
NOVICK, R. P. (2003b) Mobile genetic elements and bacterial toxinoses: the superantigen-encoding 
pathogenicity islands of Staphylococcus aureus. Plasmid, 49 (2), 93-105. 
NOVICK, R. P., et al. (1993) Synthesis of staphylococcal virulence factors is controlled by a regulatory 
RNA molecule. Embo j, 12 (10), 3967-75. 
NUNOSHIBA, T., et al. (1995) Roles of nitric oxide in inducible resistance of Escherichia coli to 
activated murine macrophages. Infect Immun, 63 (3), 794-8. 
NYGAARD, T. K., et al. (2010) SaeR binds a consensus sequence within virulence gene promoters to 
advance USA300 pathogenesis. J Infect Dis, 201 (2), 241-54. 
     
 
246 
 
OOGAI, Y., et al. (2011) Expression of virulence factors by Staphylococcus aureus grown in serum. 
Appl Environ Microbiol, 77 (22), 8097-105. 
OTTER, J. A. and FRENCH, G. L. (2010) Molecular epidemiology of community-associated 
meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis, 10 (4), 227-39. 
OTTO, M. (2014) Phenol-soluble modulins. Int J Med Microbiol, 304 (2), 164-9. 
PALMQVIST, N., et al. (2002) Protein A is a virulence factor in Staphylococcus aureus arthritis and 
septic death. Microb Pathog, 33 (5), 239-49. 
PAPAYANNOPOULOS, V., et al. (2010) Neutrophil elastase and myeloperoxidase regulate the 
formation of neutrophil extracellular traps. J Cell Biol, 191 (3), 677-91. 
PESCHEL, A., et al. (2001) Staphylococcus aureus resistance to human defensins and evasion of 
neutrophil killing via the novel virulence factor MprF is based on modification of membrane 
lipids with l-lysine. J Exp Med, 193 (9), 1067-76. 
PFIZER (2007) Zyvox (Linezolid) Datasheet.). 
PHE, P. H. E. (2017) Staphylococcus aureus (MRSA and 
MSSA) bacteraemia mandatory reports 
2016/17.). 
PHILLIPSON, M., et al. (2006) Intraluminal crawling of neutrophils to emigration sites: a molecularly 
distinct process from adhesion in the recruitment cascade. J Exp Med, 203 (12), 2569-75. 
PRAJSNAR, T. K., et al. (2008) A novel vertebrate model of Staphylococcus aureus infection reveals 
phagocyte-dependent resistance of zebrafish to non-host specialized pathogens. Cell Microbiol, 
10 (11), 2312-25. 
PRAJSNAR, T. K., et al. (2012) A privileged intraphagocyte niche is responsible for disseminated 
infection of Staphylococcus aureus in a zebrafish model. Cell Microbiol, 14 (10), 1600-19. 
PRAT, C., et al. (2009) A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from 
Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR. J Immunol, 
183 (10), 6569-78. 
PRINCE, L. R., et al. (2012) Staphylococcus aureus induces eosinophil cell death mediated by alpha-
hemolysin. PLoS One, 7 (2), e31506. 
QUIE, P. G., et al. (1967) In vitro bactericidal capacity of human polymorphonuclear leukocytes: 
diminished activity in chronic granulomatous disease of childhood. J Clin Invest, 46 (4), 668-
79. 
RAFAI, M., et al. (2013) Evolution of a fatal septic arthritis caused by a Panton-Valentine leukocidin 
(PVL)-producing Staphylococcus aureus strain. Joint Bone Spine, 80 (5), 525-7. 
RATNARAJA, N. V. and HAWKEY, P. M. (2008) Current challenges in treating MRSA: what are 
the options? Expert Rev Anti Infect Ther, 6 (5), 601-18. 
RECSEI, P., et al. (1986) Regulation of exoprotein gene expression in Staphylococcus aureus by agar. 
Mol Gen Genet, 202 (1), 58-61. 
RENZONI, A., et al. (2009) Identification by genomic and genetic analysis of two new genes playing 
a key role in intermediate glycopeptide resistance in Staphylococcus aureus. Antimicrob 
Agents Chemother, 53 (3), 903-11. 
RHODES, J., et al. (2005) Interplay of pu.1 and gata1 determines myelo-erythroid progenitor cell fate 
in zebrafish. Dev Cell, 8 (1), 97-108. 
RIGBY, K. M. and DELEO, F. R. (2012) Neutrophils in innate host defense against Staphylococcus 
aureus infections. Semin Immunopathol, 34 (2), 237-59. 
RODRIGUEZ-FERNANDEZ, A., et al. (2013) Eosinophil as a protective cell in S. aureus ventilator-
associated pneumonia. Mediators Inflamm, 2013, 152943. 
ROGER, T. and CALANDRA, T. (2009) TLR2-mediated neutrophil depletion exacerbates bacterial 
sepsis. Proc Natl Acad Sci U S A, 106 (17), 6889-90. 
ROOIJAKKERS, S. H., et al. (2005a) Immune evasion by a staphylococcal complement inhibitor that 
acts on C3 convertases. Nat Immunol, 6 (9), 920-7. 
ROOIJAKKERS, S. H., et al. (2005b) Staphylococcal innate immune evasion. Trends Microbiol, 13 
(12), 596-601. 
ROSEN, H. and KLEBANOFF, S. J. (1979) Bactericidal activity of a superoxide anion-generating 
system. A model for the polymorphonuclear leukocyte. J Exp Med, 149 (1), 27-39. 
     
 
247 
 
ROSENZWEIG, S. D. and HOLLAND, S. M. (2004) Phagocyte immunodeficiencies and their 
infections. J Allergy Clin Immunol, 113 (4), 620-6. 
SABROE, I., et al. (2005) The role of Toll-like receptors in the regulation of neutrophil migration, 
activation, and apoptosis. Clin Infect Dis, 41 Suppl 7, S421-6. 
SARALAHTI, A., et al. (2014) Adult zebrafish model for pneumococcal pathogenesis. Dev Comp 
Immunol, 42 (2), 345-53. 
SASAKI, K., et al. (1995) Accumulation and massive cell death of polymorphonuclear neutrophils in 
the developing bone marrow of the mouse: a histological study. Acta Anat (Basel), 153 (2), 
111-8. 
SAVIJOKI, K., et al. (2006) Proteolytic systems of lactic acid bacteria. Appl Microbiol Biotechnol, 71 
(4), 394-406. 
SAWATZKY, D. A., et al. (2006) The involvement of the apoptosis-modulating proteins ERK 1/2, 
Bcl-xL and Bax in the resolution of acute inflammation in vivo. Am J Pathol, 168 (1), 33-41. 
SCHMALER, M., et al. (2010) Staphylococcal lipoproteins and their role in bacterial survival in mice. 
Int J Med Microbiol, 300 (2-3), 155-60. 
SCHULZE-OSTHOFF, K., et al. (1998) Apoptosis signaling by death receptors. Eur J Biochem, 254 
(3), 439-59. 
SEELEANG, K., et al. (2013) Outpatient Management of Skin and Soft Tissue Infections Associated 
With Community-Associated Methicillin-Resistant Staphylococcus aureus: An Evidence-
Based Approach. The Journal for Nurse Practitioners, 9 (9), 600-605. 
SEGAL, A. W. (2005) How neutrophils kill microbes. Annu Rev Immunol, 23, 197-223. 
SEGAL, A. W., et al. (1980) Kinetics of fusion of the cytoplasmic granules with phagocytic vacuoles 
in human polymorphonuclear leukocytes. Biochemical and morphological studies. J Cell Biol, 
85 (1), 42-59. 
SEGAL, A. W., et al. (1981) The respiratory burst of phagocytic cells is associated with a rise in 
vacuolar pH. Nature, 290 (5805), 406-9. 
SHAHMIRZADI, S. V., et al. (2016) Evaluation of Staphylococcus aureus Lipoproteins: Role in 
Nutritional Acquisition and Pathogenicity. Front Microbiol, 7, 1404. 
SHARFF, K. A., et al. (2013) Clinical management of septic arthritis. Curr Rheumatol Rep, 15 (6), 
332. 
SHAW, L. N., et al. (2005) Cytoplasmic control of premature activation of a secreted protease 
zymogen: deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a 
profound pleiotropic phenotype. J Bacteriol, 187 (5), 1751-62. 
SHELEF, M. A., et al. (2013) Neutrophil migration: moving from zebrafish models to human 
autoimmunity. Immunol Rev, 256 (1), 269-81. 
SHEPPARD, S. K., et al. (2013) Genome-wide association study identifies vitamin B5 biosynthesis as 
a host specificity factor in Campylobacter. Proc Natl Acad Sci U S A, 110 (29), 11923-7. 
SIBBALD, M. J., et al. (2006) Mapping the pathways to staphylococcal pathogenesis by comparative 
secretomics. Microbiol Mol Biol Rev, 70 (3), 755-88. 
SIEPRAWSKA-LUPA, M., et al. (2004) Degradation of human antimicrobial peptide LL-37 by 
Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother, 48 (12), 4673-9. 
SOCHA, A. M., et al. (2010) Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the 
discovery of a potent antibacterial agent. Bioorg Med Chem, 18 (20), 7193-202. 
SONG, H. O. (2016) Influence of 120 kDa Pyruvate:Ferredoxin Oxidoreductase on Pathogenicity of 
Trichomonas vaginalis. Korean J Parasitol, 54 (1), 71-4. 
SOWASH, M. G. and UHLEMANN, A. C. (2014) Community-associated methicillin-resistant 
Staphylococcus aureus case studies. Methods Mol Biol, 1085, 25-69. 
SPAAN, A. N., et al. (2013a) The staphylococcal toxin Panton-Valentine Leukocidin targets human 
C5a receptors. Cell Host Microbe, 13 (5), 584-94. 
SPAAN, A. N., et al. (2013b) Neutrophils versus Staphylococcus aureus: a biological tug of war. Annu 
Rev Microbiol, 67, 629-50. 
STAPELS, D. A., et al. (2014) Staphylococcus aureus secretes a unique class of neutrophil serine 
protease inhibitors. Proc Natl Acad Sci U S A, 111 (36), 13187-92. 
STARNES, T. W. and HUTTENLOCHER, A. (2012) Neutrophil reverse migration becomes 
transparent with zebrafish. Adv Hematol, 2012, 398640. 
     
 
248 
 
STEFANI, S., et al. (2012) Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology 
and harmonisation of typing methods. Int J Antimicrob Agents, 39 (4), 273-82. 
STROEHER, U. H., et al. (2003) Mutation of luxS of Streptococcus pneumoniae affects virulence in 
a mouse model. Infect Immun, 71 (6), 3206-12. 
SUMMERTON, J. and WELLER, D. (1997) Morpholino antisense oligomers: design, preparation, and 
properties. Antisense Nucleic Acid Drug Dev, 7 (3), 187-95. 
SUREWAARD, B. G., et al. (2013) Staphylococcal alpha-phenol soluble modulins contribute to 
neutrophil lysis after phagocytosis. Cell Microbiol, 15 (8), 1427-37. 
SUTCLIFFE, I. C. and RUSSELL, R. R. (1995) Lipoproteins of gram-positive bacteria. J Bacteriol, 
177 (5), 1123-8. 
SUZUKI, M., et al. (2016) A genome-wide association study identifies a horizontally transferred 
bacterial surface adhesin gene associated with antimicrobial resistant strains. Sci Rep, 6, 37811. 
SWAIM, L. E., et al. (2006) Mycobacterium marinum infection of adult zebrafish causes caseating 
granulomatous tuberculosis and is moderated by adaptive immunity. Infect Immun, 74 (11), 
6108-17. 
TENG, T. S., et al. (2017) Neutrophils and Immunity: From Bactericidal Action to Being Conquered. 
J Immunol Res, 2017, 9671604. 
TENOVER and GAYNES (2000) Gram-positive pathogens.   Washington, D.C.: Washington, D.C. : 
ASM Press, c2000. 
THAMMAVONGSA, V., et al. (2009) Staphylococcus aureus synthesizes adenosine to escape host 
immune responses. J Exp Med, 206 (11), 2417-27. 
THAMMAVONGSA, V., et al. (2015) Staphylococcal manipulation of host immune responses. Nat 
Rev Microbiol, 13 (9), 529-43. 
THAMMAVONGSA, V., et al. (2013) Staphylococcus aureus degrades neutrophil extracellular traps 
to promote immune cell death. Science, 342 (6160), 863-6. 
THOENDEL, M., et al. (2011) Peptide signaling in the staphylococci. Chem Rev, 111 (1), 117-51. 
THURLOW, L. R., et al. (2011) Staphylococcus aureus biofilms prevent macrophage phagocytosis 
and attenuate inflammation in vivo. J Immunol, 186 (11), 6585-96. 
THURLOW, L. R., et al. (2012) Virulence strategies of the dominant USA300 lineage of community-
associated methicillin-resistant Staphylococcus aureus (CA-MRSA). FEMS Immunol Med 
Microbiol, 65 (1), 5-22. 
TIETZ, A., et al. (2005) Transatlantic spread of the USA300 clone of MRSA. In) N Engl J Med.  Vol. 
353.  United States:  pp. 532-3. 
TORRACA, V., et al. (2014) Macrophage-pathogen interactions in infectious diseases: new 
therapeutic insights from the zebrafish host model. Dis Model Mech, 7 (7), 785-97. 
TRAKULSOMBOON, S., et al. (2001) First report of methicillin-resistant Staphylococcus aureus with 
reduced susceptibility to vancomycin in Thailand. J Clin Microbiol, 39 (2), 591-5. 
TREDE, N. S., et al. (2001) Fishing for lymphoid genes. Trends Immunol, 22 (6), 302-7. 
TRUSCOTT, K. N., et al. (2011) Unfolded protein responses in bacteria and mitochondria: a central 
role for the ClpXP machine. IUBMB Life, 63 (11), 955-63. 
TSAI, M., et al. (2007) Substrate and product complexes of Escherichia coli adenylosuccinate lyase 
provide new insights into the enzymatic mechanism. J Mol Biol, 370 (3), 541-54. 
TSIODRAS, S., et al. (2001) Linezolid resistance in a clinical isolate of Staphylococcus aureus. In) 
Lancet.  Vol. 358.  England:  pp. 207-8. 
TSUJI, B. T., et al. (2007) Community- and health care-associated methicillin-resistant Staphylococcus 
aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. 
Diagnostic Microbiology and Infectious Disease, 58 (1), 41-47. 
TUAZON, C. U., et al. (1975) Staphylococcus aureus among insulin-injecting diabetic patients. An 
increased carrier rate. Jama, 231 (12), 1272. 
TUAZON, C. U. and SHEAGREN, J. N. (1974) Increased rate of carriage of Staphylococcus aureus 
among narcotic addicts. J Infect Dis, 129 (6), 725-7. 
VAITKUS, M., et al. (2013) Reactive oxygen species in peripheral blood and sputum neutrophils 
during bacterial and nonbacterial acute exacerbation of chronic obstructive pulmonary disease. 
Inflammation, 36 (6), 1485-93. 
     
 
249 
 
VALEVA, A., et al. (1997) Transmembrane beta-barrel of staphylococcal alpha-toxin forms in 
sensitive but not in resistant cells. Proc Natl Acad Sci U S A, 94 (21), 11607-11. 
VALOUR, F., et al. (2013) [Staphylococcus aureus broncho-pulmonary infections]. Rev Pneumol Clin, 
69 (6), 368-82. 
VAN DER VAART, M., et al. (2012) Pathogen recognition and activation of the innate immune 
response in zebrafish. Adv Hematol, 2012, 159807. 
VARDAKAS, K. Z., et al. (2013) Incidence, characteristics, and outcomes of patients with bone and 
joint infections due to community-associated methicillin-resistant Staphylococcus aureus: a 
systematic review. Eur J Clin Microbiol Infect Dis, 32 (6), 711-21. 
VEDADI, M., et al. (2007) Genome-scale protein expression and structural biology of Plasmodium 
falciparum and related Apicomplexan organisms. Mol Biochem Parasitol, 151 (1), 100-10. 
VENDEVILLE, A., et al. (2005) Making 'sense' of metabolism: autoinducer-2, LuxS and pathogenic 
bacteria. Nat Rev Microbiol, 3 (5), 383-96. 
VENTURA, C. L., et al. (2010) Identification of a novel Staphylococcus aureus two-component 
leukotoxin using cell surface proteomics. PLoS One, 5 (7), e11634. 
VESTERGAARD, M., et al. (2016) Genome-Wide Identification of Antimicrobial Intrinsic Resistance 
Determinants in Staphylococcus aureus. Front Microbiol, 7, 2018. 
VILHELMSSON, O. and MILLER, K. J. (2002) Synthesis of pyruvate dehydrogenase in 
Staphylococcus aureus is stimulated by osmotic stress. Appl Environ Microbiol, 68 (5), 2353-
8. 
VIRREIRA WINTER, S., et al. (2016) Genome-wide CRISPR screen reveals novel host factors 
required for Staphylococcus aureus alpha-hemolysin-mediated toxicity. Sci Rep, 6, 24242. 
VON EIFF, C., et al. (2003) In vitro activity of recombinant lysostaphin against Staphylococcus aureus 
isolates from anterior nares and blood. Antimicrobial agents and chemotherapy, 47 (11), 3613. 
VOYICH, J. M., et al. (2005) Insights into mechanisms used by Staphylococcus aureus to avoid 
destruction by human neutrophils. J Immunol, 175 (6), 3907-19. 
VOYICH, J. M., et al. (2009) The SaeR/S gene regulatory system is essential for innate immune 
evasion by Staphylococcus aureus. J Infect Dis, 199 (11), 1698-706. 
WALENKAMP, A. M., et al. (2009) Staphylococcal superantigen-like 10 inhibits CXCL12-induced 
human tumor cell migration. Neoplasia, 11 (4), 333-44. 
WALPORT, M. J. (2001) Complement. Second of two parts. N Engl J Med, 344 (15), 1140-4. 
WANG, R., et al. (2007) Identification of novel cytolytic peptides as key virulence determinants for 
community-associated MRSA. Nat Med, 13 (12), 1510-4. 
WANG, W. K., et al. (2009) [Analysis of the molecular epidemiology and distribution of pathogenic 
bacteria in burn wards of Ruijin Hospital from 2004 to 2006]. Zhonghua Shao Shang Za Zhi, 
25 (2), 94-7. 
WARREN, C. A., et al. (2012) Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, 
shows efficacy against Clostridium difficile in a mouse infection model. Antimicrob Agents 
Chemother, 56 (8), 4103-11. 
WEISS, E. C., et al. (2009) Impact of sarA on daptomycin susceptibility of Staphylococcus aureus 
biofilms in vivo. Antimicrob Agents Chemother, 53 (10), 4096-102. 
WENZEL, R. P. and PERL, T. M. (1995) The significance of nasal carriage of Staphylococcus aureus 
and the incidence of postoperative wound infection. J Hosp Infect, 31 (1), 13-24. 
WESTERFIELD, M. (2000) The zebrafish book: A guide for the laboratory use of zebrafish. .   
University of Oregon Press, Eugene. 
WONG, S. S., et al. (2000) Bacteremia due to Staphylococcus aureus with reduced susceptibility to 
vancomycin. Diagn Microbiol Infect Dis, 36 (4), 261-8. 
WOODS, I. G., et al. (2000) A comparative map of the zebrafish genome. Genome Res, 10 (12), 1903-
14. 
WUNDERINK, R. G. (2013) How Important is Methicillin-Resistant Staphylococcus aureus as a 
Cause of Community-Acquired Pneumonia and What is Best Antimicrobial Therapy? 
Infectious Disease Clinics of North America, 27 (1), 177-188. 
XU, L., et al. (2006) Role of the luxS quorum-sensing system in biofilm formation and virulence of 
Staphylococcus epidermidis. Infect Immun, 74 (1), 488-96. 
YANG, Y., et al. (2015) Programmed cell death and its role in inflammation. Mil Med Res, 2, 12. 
     
 
250 
 
YARWOOD, J. M., et al. (2002) Characterization and expression analysis of Staphylococcus aureus 
pathogenicity island 3. Implications for the evolution of staphylococcal pathogenicity islands. 
J Biol Chem, 277 (15), 13138-47. 
YE, F., et al. (2016) The development of small-molecule modulators for ClpP protease activity. Mol 
Biosyst, 13 (1), 23-31. 
YIPP, B. G., et al. (2012) Infection- induced NETosis is a dynamic process involving neutrophil 
multitasking in vivo. Nature medicine, 18 (9), 1386. 
YOONG, P. and PIER, G. B. (2012) Immune-activating properties of Panton-Valentine leukocidin 
improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia. 
Infect Immun, 80 (8), 2894-904. 
YOUSEFI, S. and SIMON, H. U. (2016) NETosis - Does It Really Represent Nature's "Suicide 
Bomber"? Front Immunol, 7, 328. 
YU, V. L., et al. (1986) Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. 
Efficacy of antibiotic prophylaxis. N Engl J Med, 315 (2), 91-6. 
ZHAO, B. B., et al. (2016) ClpP-deletion impairs the virulence of Legionella pneumophila and the 
optimal translocation of effector proteins. BMC Microbiol, 16 (1), 174. 
ZHU, F., et al. (2015) Role of JAK-STAT signaling in maturation of phagosomes containing 
Staphylococcus aureus. Sci Rep, 5, 14854. 
 
